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  Cognitive deficits constitute a core feature of schizophrenia, are persistent across the 
course of the illness and are the best predictor of long-term functional outcome. Dysfunction in 
certain cognitive processes, such as working memory, are common in subjects with 
schizophrenia and have been attributed to aberrant function of the dorsolateral prefrontal cortex 
(DLPFC). This dysfunction appears to reflect, at least in part, alterations in excitatory 
neurotransmission. Cortical pyramidal neurons, the principal source of cortical glutamate 
neurotransmission, exhibit highly robust molecular and morphological alterations in 
schizophrenia. These alterations appear to be most pronounced in DLPFC deep layer 3, the 
same microcircuit necessary for the generation of neural oscillations in the γ-frequency range 
that sustain working memory function. Understanding how dysfunction in DLPFC cortical circuits 
in deep layer 3 might give rise to the pathophysiology of altered γ-frequency oscillations and 
working memory deficits in schizophrenia require an interrogation of the mechanisms by which 
these neuropathological alterations may arise, but also the normal developmental trajectories of 
these vulnerable microcircuits. In this dissertation, we provide evidence for pyramidal cell type-
specific molecular disturbances and synapse-specific structural impairments in DLPFC deep 
layer 3, and cell type-specific and layer-specific nature of postnatal developmental refinements 
in pyramidal cells in the DLPFC, within the circuitry that subserves γ-frequency oscillations and 
working memory. Accordingly, we have identified alterations in the expression of numerous 
molecular regulators of the actin cytoskeleton in a layer-specific and cell type-specific manner in 
DLPFC deep layer 3 in individuals with schizophrenia that might be a critical “upstream” cause 
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in the pathogenesis of the illness. Additionally, using novel triple-label fluorescence 
immunohistochemistry and spinning-disk confocal microscopy, we characterize specific synaptic 
connections onto DLPFC deep layer 3 pyramidal cells in schizophrenia. Finally, we demonstrate 
that the developmental trajectories of primate DLPFC deep layer 3 pyramidal neurons are 
protracted, and layer-specific and posit that the molecular maturation of GABA synapses on 
pyramidal cells may account, at least in part, for the maturation of synchronized pyramidal cell 
firing which is crucial for γ-frequency oscillations. 
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1.0  GENERAL INTRODUCTION 
1.1 OVERVIEW OF SCHIZOPHRENIA 
1.1.1 Burden of schizophrenia 
Schizophrenia is a debilitating, chronic neuropsychiatric disease that is highly prevalent 
and afflicts a large population (0.5-1%) globally (Lewis & Lieberman 2000).  The illness is 
conceptualized as a neurodevelopmental disease whose symptoms are first manifested during 
late adolescence or early adulthood with most patients experiencing a life-long course of the 
disease (Lewis & Lieberman 2000). The disease is associated with personal suffering for the 
patients and is associated with problems related to employment, personal relationships, and 
self-care. Subsequently, patients with schizophrenia have a greater propensity to suffer from 
homelessness, poverty, unemployment, comorbid medical issues such as depression, 
excessive use of nicotine, alcohol and cannabis and increased susceptibility to commit suicide 
with approximately 30% of patients attempting suicide (Insel & Scolnick 2006, Radomsky et al 
1999). As a result of these issues, the average life expectancy in patients with schizophrenia is 
reduced by about 1-3 decades (Saha et al 2007). Moreover, schizophrenia ranks #14 as the 
leading cause of disability worldwide and accounts for 3% of the total years of healthy life lost 
due to disability (WHO 2008).  
In addition to the personal suffering endured by patients themselves, the illness is linked 
with significant emotional burden on caregivers, many of whom are family members, and society 
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at large (Gibbons et al 1984). Family members who are often the primary caretakers have to 
also bear immense financial costs associated with the illness. Based on the last estimate in 
2002, the costs associated with schizophrenia in the United States amassed to $62.7 billion 
dollars (Wu et al 2005). The financial costs to society as a whole include both direct (inpatient 
and outpatient hospitalization and long-term medication costs) and indirect costs (years of lost 
productivity from patients with the disease and community at large) (Wu et al 2005). Indeed, 
comprehensive evaluation of the high societal financial burden of schizophrenia globally has 
revealed that the illness accounts for 1-3% of the total national healthcare expenditure in 
developed economies (Knapp et al 2004). The burden of schizophrenia is compounded by the 
general stigma associated with the disease and lack of empathy towards patients suffering from 
the illness (Penn et al 1994). The stigmatization of individuals with schizophrenia has negative 
consequences such as loss of independent functioning and reduced life opportunities (Penn et 
al 1994). In spite of the efforts to increase public awareness in order to reduce the 
stigmatization of patients with schizophrenia, this problem still persists and places a significant 
burden on patients (Thornicroft et al 2009).    
1.1.2 Etiology of Schizophrenia 
Schizophrenia is a highly heterogeneous syndrome and the disease pathogenesis is 
multifactorial, involving numerous etiological factors that aggravate the chance for developing 
the disease (Insel & Scolnick 2006, Lewis et al 2005). There is a general view that the illness 
involves interplay between several genetic liabilities, environmental risk factors and 
developmental processes to unleash pathogenetic mechanisms which produce a pathological 
entity, a constrained set of neuropathological alterations in brain structure (Lewis & Gonzalez-
Burgos 2006). These cellular and molecular perturbations alter brain circuits and normal 
physiology and the resulting pathophysiology manifests in the various heterogeneous symptoms 
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of the disease (Lewis & Gonzalez-Burgos 2006). Genetic predisposition is certainly a major 
driving force in the pathogenesis of schizophrenia with variable estimate measures suggesting 
that it can account for 70-80% of cases (Cardno & Gottesman 2000). Monozygotic “identical” 
twins who share exactly the same genes have a 48% chance of developing schizophrenia, 
whereas dizygotic “fraternal” twins who share half the number of genes have a significantly 
lower 17% chance of developing schizophrenia (Gottesman 1991). Moreover, adoption studies 
have revealed that there is an elevated risk for developing schizophrenia in adopted-away 
biological offspring of schizophrenia patients (Gottesman & Shields 1976, Rosenthal 1971). 
Recent breakthroughs involving genome-wide association analyses (GWAS) from the 
Schizophrenia Working Group of the Psychiatric Genomic Consortium, analyzing more than 
150,000 people, have revealed 108 risk loci identified by single nucleotide polymorphisms 
(SNPs) to be associated with schizophrenia which is thought to contribute to disease 
susceptibility (International Schizophrenia et al 2009, Schizophrenia Working Group of the 
Psychiatric Genomics 2014). Exome sequence variations and copy number variations (CNVs) in 
the form of microdeletions or microduplications have also been proposed to confer increased 
risk for schizophrenia (Malhotra & Sebat 2012, Rippey et al 2013, Walsh et al 2008). In addition, 
linkage disequilibrium studies have identified chromosomal translocations and duplications in 
various regions such as 3q29, 5q33, 6q21-22, 15q13.3, 16p11.2, 22q11 (Berry et al 2003, 
Purcell et al 2014). In spite of the advancements in genomic studies in schizophrenia, the 
individual contribution of individual genes is low due to limited penetrance and the polygenic 
burden involving thousands of common alleles increase risk for the illness (International 
Schizophrenia et al 2009). 
A plethora of environmental risk factors and insults during prenatal and postnatal 
development can confer enhanced risk for schizophrenia (Hoftman & Lewis 2011, van Os et al 
2008). Epidemiological studies have shown that maternal immune activation due to infection 
and obstetrical complications pose an increased risk for the illness (Cannon et al 2002). A wide 
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variety of postnatal factors that can increase risk for the development of schizophrenia include 
minority group position, urbanicity, childhood trauma and cannabis use (van Os et al 2010). 
These findings support the notion that gene-environment interactions could be pivotal in driving 
pathogenesis of schizophrenia and genetic predisposition, in conjunction with various 
environmental insults, can alter brain development. As a result, clinical manifestation of the 
disease may not represent the onset of the illness, but a downstream consequence of years of 
pathogenic processes in operation. 
1.1.3 Epidemiology and clinical features of schizophrenia 
Around a century ago, Dr. Emile Kraepelin originally described an assemblage of 
symptoms as “dementia praecox”, which was coined as “schizophrenia” later by Eugene 
Bleuler. Although our understanding of disease pathogenesis has greatly advanced over the 
course of time, the prevalence and incidence of schizophrenia has remained almost the same 
(Insel 2010). Meta-analysis studies using population-based data suggest that the prevalence 
and incidence of schizophrenia is a global phenomenon affecting people across cultures 
(Messias et al 2007). Interestingly, there is a greater incidence rate in men than women and 
also some indication that the prognosis is worse in men compared to women (Grossman et al 
2008, McGrath et al 2008). Epidemiological studies suggest that numerous factors can predict 
the severity of schizophrenia. For example, family history is a positive factor that influences 
several negative and cognitive symptoms (Malaspina et al 2000, Tabares-Seisdedos et al 
2003). Moreover, patients who have a lower age of onset typically have a more severe course 
of disease (Hollis 2000). In addition, patients diagnosed with schizophrenia, as opposed to 
schizoaffective disorder, which is characterized by symptoms of schizophrenia along with 
symptoms of mood disorders, have more severe positive, negative, and cognitive symptoms 
(Cheniaux et al 2008). 
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The constellation of clinical symptoms of subjects with schizophrenia can be grouped 
into three categories: positive, negative and cognitive (Psychiatric Association 1994). The most 
striking feature of the illness and the clinical symptom that first brings individuals to clinical 
attention are the positive symptoms, and include disturbances such as delusions, hallucinations 
and thought organization. Positive symptoms typically reflect the presence of abnormal 
behaviors that create altered perceptions of reality and falsify normative behaviors. Delusions 
are erroneous beliefs that persist despite significant evidence to suggest otherwise, and include 
a wide range of themes such as persecution, reference and grandeur. For example, delusions 
of persecution might force an individual with schizophrenia to believe that they are being treated 
with malicious intent. Hallucinations are internal sensory perceptions experienced in the 
absence of external stimuli and can occur in any sensory modality, but are most typically 
auditory in nature (Andreasen & Flaum 1991, Thomas et al 2007). Auditory hallucinations are 
present in the majority of subjects with schizophrenia who may hear multiple voices that are 
distinguishable, yet may lack the ability to discern if they were internally generated or externally 
generated (Andreasen & Flaum 1991). Thought disorganization usually involves the inability to 
connect thoughts into logical sequences and is also associated with disorganized inappropriate 
behavior.  
In contrast, negative symptoms reflect the absence of certain behaviors that are present 
in normal individuals and include flattened or inappropriate affect (affect dysregulation), lack of 
initiative (avolition), poverty of speech (alogia), inability to experience pleasure (anhedonia) and 
social withdrawal (asociality). These symptoms often result in various emotional and social 
impairments and are clinically difficult to recognize as part of the disorder since they can be 
mistaken for other neuropsychiatric conditions such as depression.  
Lastly, cognitive deficits, although not currently included in the diagnostic criteria for 
schizophrenia, but highlighted importantly in the DSM-IV-TR (2000) description of the disease, 
are thought to represent a core feature of dysfunction in schizophrenia (Elvevag & Goldberg 
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2000). Cognitive deficits refer to abnormalities related to thinking and intellectual skills that allow 
one to perceive, acquire, understand and respond to information. Over the last decade, the 
National Institute of Mental Health has formalized various programs to combine cognitive 
remediation with pharmacological interventions in treating the cognitive deficits in schizophrenia. 
These include the Measurement and Treatment of Research to Improve Cognition in 
Schizophrenia (MATRICS) and more recently, Cognitive Neuroscience Approaches to the 
Treatment of Impaired Cognition in Schizophrenia (CNTRICS). These initiatives have 
emphasized a handful of cognitive domains that deserve special attention in relation to 
schizophrenia such as working memory, attention, perception, episodic memory, executive 
function and social/emotional processing (Carter et al 2008). In light of recent developments to 
understand cognitive impairments in schizophrenia, I will primarily focus on this symptom 
domain and provide evidence for why they are considered to be core features of the disease in 
the following sections.           
1.1.4 Cognitive impairments as a critical component of schizophrenia 
Cognitive deficits emerge prior to the onset of psychosis, persist throughout the lifetime 
of individuals with schizophrenia and are thought to be present in a majority of patients (Elvevag 
& Goldberg 2000, Kahn & Keefe 2013, Lesh et al 2011, Reichenberg et al 2010). Approximately 
70-80% of patients with schizophrenia show impairments in a battery of neuropsychological 
tests, although this data might have actually underestimated the prevalence (Kremen et al 2000, 
Palmer et al 1997). Almost all cognitive domains are affected in the illness with patients with 
schizophrenia performing ~1-2 standard deviations below the mean performance level of 
comparison subjects (Heaton et al 2001, Wilk et al 2004). Genetic assessments in identical 
twins discordant for schizophrenia suggest that the twin with schizophrenia fared poorly 
compared to the healthy twin in all metrics (Goldberg et al 1995). Cognitive dysfunction is 
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present in medication-naïve, first-episode patients and also present in a milder form in first-
degree relatives of subjects with schizophrenia, indicating that it is not an artifact of neuroleptic 
treatment and is indeed intrinsic to genetic predisposition and the disease process (Sitskoorn et 
al 2004). Moreover, when cognitive dysfunction is defined as falling below predicted levels 
(based on premorbid intellectual functioning and parental education), nearly all schizophrenia 
subjects (98%) show significant disturbances (Goldberg et al 1990). 
Cognitive deficits are the best predictor of long-term functional outcome (Green et al 
2000). Recent meta-analysis results suggest that cognitive function, but not positive symptom 
severity, was the best predictor of employment outcome (Tsang et al 2010). Furthermore, 
cognitive deficits predict the ability of individuals with schizophrenia to integrate into society and 
future employment potential (Addington & Addington 1999). In sum, cognitive impairments are 
considered to be a core feature of schizophrenia. 
1.1.5 Treatment and outcome 
Historically, the treatment of schizophrenia has revolved around the use of antipsychotic 
drugs that were discovered serendipitously. Originally, drugs such as chlorpromazine, 
fluphenazine and haloperidol belonging to the class of “typical” antipsychotics were effective in 
treatment of positive symptoms by blocking dopamine D2 receptors. Unfortunately, blockade of 
D2 receptors also causes extrapyramidal symptoms which include parkinsonian symptoms 
(e.g., tremor), dystonia, dyskinesia, akathisia, and tardive dyskinesia. Development of 
pharmacotherapy resulted in the advent of “atypical” antipsychotics such as clozapine and 
olanzapine, which in addition to blockade of dopamine, also blocked serotonin receptors. These 
drugs caused a lower incidence of extrapyramidal symptoms and are associated with fewer side 
effects such as weight gain, diabetes and hypertension (Howes & Kapur 2009). Although these 
antipsychotic drugs ameliorate, to some degree, the positive symptoms of the illness, they have 
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little to no effect on negative and cognitive features (Buchanan et al 1998, Harvey & Keefe 
2001).  
In spite of reasonable success in treating positive symptoms of schizophrenia, the long-
term functional outcome for patients is poor and subjects with schizophrenia have limited 
“recovery”. Longitudinal studies support the notion that ~40% of schizophrenia subjects have 
limited social and functional recovery (Lambert et al 2008, Menezes et al 2006). Partial recovery 
enables some patients to integrate into society to a greater extent by living independently and 
involves improvements in social and vocational functioning. However, only 14% of patients 
undergo prolonged recovery within the first 5 years of the first psychotic outbreak whereas an 
additional 16% experience late-phase recovery (Harrison et al 2001, Robinson et al 2004). 
Therefore, the discovery of novel pharmacotherapy approaches to treat these cognitive deficits 
and improve long-term functional outcome in patients with schizophrenia is of utmost 
importance.  
1.2 DORSOLATERAL PREFRONTAL CORTEX AND PYRAMIDAL CELLS: 
CRITICAL MEDIATORS OF WORKING MEMORY AND COGNITIVE FUNCTION 
1.2.1 Cognitive dysfunction and the dorsolateral prefrontal cortex in 
schizophrenia 
As described above, schizophrenia is characterized by an overarching deficit in cognitive 
function across a variety of domains and these impairments are the best predictor of long-term 
functional outcome. Impaired cognition in schizophrenia may reflect a general perturbation in 
cognitive control, the ability to adjust thoughts or behaviors in order to achieve goals (Lesh et al 
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2011). Cognitive control is contingent on the activity of numerous brain regions such as the 
dorsolateral prefrontal cortex (DLPFC), anterior cingulate cortex and parietal cortex (Cohen et al 
1997). Due to its extensive extrinsic and intrinsic anatomical connectivity across numerous 
sensory and motor brain regions, the prefrontal cortex occupies a critical hub in modulating top-
down control of behavior (Miller & Cohen 2001). 
Of the various domains of cognitive control dysregulation in schizophrenia, working 
memory, the ability to actively maintain and manipulate a limited amount of information in a 
transient fashion to guide future thought or behavior, is a prototypical example of a cognitive 
control process that has been extensively interrogated in rodent and primate models. Working 
memory can be divided into the following components: 1) Central executive, the dominant 
attention-controlling system; 2) Visuospatial sketch pad, to manipulate visual images; 3) 
Phonological loop, to store and rehearse speech-based information (Baddeley 1992, Baddeley 
2003). In schizophrenia, an extensive body of literature has revealed robust alterations that are 
primarily pronounced in central executive function (Barch 2006, Kim et al 2004), and these 
alterations are associated with dysfunction of the DLPFC which is known to be crucial for 
executive function (Callicott et al 2003). A myriad of studies using regional cerebral blood flow 
and functional magnetic resonance imaging, reflective of neural activity, have documented 
hypoactivity in the DLPFC in schizophrenia (Cannon et al 2005, Glahn et al 2005, Ingvar & 
Franzen 1974, Minzenberg et al 2009, Perlstein et al 2001). Furthermore, in healthy volunteers, 
there appears to be an “inverted U” shaped relationship between DLPFC activation and working 
memory, exhibiting marginal activation at low and high loads, and significantly elevated activity 
at intermediate loads (Callicott et al 1999). In schizophrenia, the “inverted U” appears to be left-
shifted such that they have elevated DLPFC activity and normal performance at low memory 
loads, but reduced activation and altered performance at higher memory loads (Callicott et al 
2003). In aggregate, these findings support a clear connection between disturbances in working 
memory function and DLPFC activity in subjects with schizophrenia.   
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1.2.2 Deep layer 3 pyramidal cells: “cellular” basis of working memory 
Within DLPFC microcircuits, a cellular mechanism that may subserve working memory 
function involves the spatially and temporally synchronized activity of ensembles of pyramidal 
cells during the delay period of working memory tasks. Pyramidal cells are the principal source 
of cortical glutamate neurotransmission, as well as the targets of the majority of cortical 
glutamate axon terminals and partake in a myriad of complex circuit operations. These cells 
constitute ~75% of total cortical neurons and can be readily discerned from other cell-types 
based on their triangular shaped cell bodies and well defined apical dendrites directed towards 
the pia mater and numerous short basilar dendrites. In particular, the persistent neural firing 
during the delay period of working memory is thought to arise from recurrent excitation between 
DLPFC pyramidal cells in deep layer 3 (Goldman-Rakic 1995). The seminal work from Fuster, 
Kubota and Goldman-Rakic using in vivo electrophysiology in the DLPFC in monkeys 
performing working memory tasks, such as the oculomotor delayed response (ODR) task, 
showed highly tuned, persistent activity during the delay period even in the absence of external 
stimulation (Funahashi et al 1989, Fuster 1973, Fuster & Alexander 1971, Kubota & Niki 1971). 
The ODR task is a spatial working memory task that has been used to scrutinize the 
physiological profile of DLPFC circuits in monkeys (Hikosaka & Wurtz 1983). The task requires 
subjects to remember the spatial position of the most recent cue over a delay period of multiple 
seconds, followed by a saccade to the memorized position. Deep layer 3 pyramidal cells in the 
DLPFC are often referred to as “Delay” cells because they show persistent, spatially tuned firing 
during the delay period in the ODR task (Arnsten 2009). Therefore, the activity of deep layer 3 
pyramidal cells is believed to constitute the “cellular” basis of working memory (Goldman-Rakic 
1995).     
Anatomical tract tracing experiments have suggested that pyramidal neurons in deep 
layer 3 furnish extensive horizontal ramifications enabling recurrent excitatory connections in the 
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DLPFC for pyramidal cells with similar spatial tuning characteristics (Kritzer & Goldman-Rakic 
1995). These studies corroborated previous experiments which found a similar columnar 
innervation pattern from the parietal association cortices suggesting that deep layer 3 pyramidal 
cells with similar spatial tuning properties were reciprocally connected across brain regions 
(Cavada & Goldman-Rakic 1989, Schwartz & Goldman-Rakic 1984). Moreover, direct 
physiological evidence support the opinion that spatially segregated clusters of pyramidal cells 
with similar spatial tuning and temporal profiles of activation across task epochs maintain the 
network of recurrent connections during working memory tasks (Constantinidis et al 2001). 
Recent data from iontophoresis studies in monkeys argues that the persistent firing properties of 
deep layer 3 pyramidal cells depends on N-methyl-D-aspartic acid (NMDARs) receptors that are 
enriched for the GluN2B subunit, found primarily on dendritic spines of long and thin spines 
(Paspalas et al 2013, Wang et al 2013). GluN2B-containing NMDARs are particularly adapted to 
maintain DLPFC network firing in the absence of sensory stimulation due to the slower kinetics 
whereas the faster kinetics of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors 
(AMPARs) can lead to dynamic instability and network collapse (Wang et al 2013, Wang 2001). 
Consistent with these findings, computational modeling studies propose that persistent neuronal 
firing requires slower kinetics of NMDAR as opposed to AMPARs for reverberating excitation 
(Compte et al 2000, Lisman et al 1998, Wang 1999).   
1.2.3 Cortical pyramidal neurons in different laminar locations subserve unique 
functions 
Pyramidal cells have often been conceptualized as one homogenous entity which differs 
starkly from inhibitory neurons, which can be demarcated into subgroups based on unique 
morphological, neurochemical and electrophysiological properties. However, pyramidal neurons 
can be divided into subgroups based on the brain region targeted by their principal axonal and 
 12 
sources of excitatory inputs (Figure 1) (Shepherd 2011, Spruston 2008). Pyramidal cells occupy 
discrete laminar locations and the specification and differentiation of pyramidal neuron subtypes 
involves precise temporal and molecular regulation during embryonic and postnatal 
development to impart laminar positional information (Greig et al 2013, Molyneaux et al 2007, 
Rakic 1988, Rakic et al 1974). In general, superficial pyramidal cells (layers 2-3) primarily target 
other cortical areas via extrinsic and long-range intrinsic collaterals; pyramidal cells in deeper 
layers project to the striatum (layer 5) and thalamus (layer 6) (Jones 1984). Quantitative 
reconstruction of axon collaterals and principal axon projections furnished by pyramidal cells in 
the supragranular layers of the monkey PFC have elegantly defined the extent of the local axon 
collaterals (within 300μm of the cell body) and long-range axon collaterals that project through 
the gray matter before forming distinct stripe-like clusters in the same cortical region (Levitt et al 
1993, Pucak et al 1996). Interestingly, consistent with the general “inside-out” pattern of cortical 
neurogenesis and migration, pyramidal neurons in the infragranular layers (layer 5 and 6) are 
generated first and achieve adult size of dendritic arbor earlier than pyramidal cells in the 
supragranular layers (layers 2 and 3) (Rakic 1988, Rakic 2008). 
The molecular, morphological and functional properties of pyramidal cells vary 
substantially between different cortical layers, regions and across species and these differences 
are most pronounced for pyramidal cells in deep layer 3. For example, studies examining 
dendritic complexity in primates suggest that the number of spines in deep layer 3 pyramidal 
cells in the PFC of humans is significantly greater than macaque and marmoset monkeys 
(Elston 2000). PFC pyramidal cells are more spinous and branched than temporal or occipital 
lobes and the differences in magnitude are particularly striking in the basilar dendrites of deep 
layer 3 pyramidal cells, with the PFC having a ~10 fold increase in spine number compared to 
V1 (Elston 2003, Elston & Rosa 2000). The electrophysiological profiles of pyramidal cells in 
layer 3 also show great areal specialization with significant differences in input resistance, 
depolarized resting membrane potential, action potential firing rates and kinetics between V1 
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and the PFC in monkeys using whole-cell, patch clamp in vitro recordings (Amatrudo et al 2012, 
Luebke et al 2015). These findings reveal important differences in deep layer 3 pyramidal cells 
across species and between brain regions, substantiating the specialized role of deep layer 3 
pyramidal cells in higher order cognitive processes such as working memory.  
Pyramidal cells in deep layer 3 that are most critical for working memory receive 
presynaptic afferents from several different sources (Figure 1): 1) local axon collaterals from 
surrounding pyramidal cells (Levitt et al 1993), 2) long-distance axon collaterals from pyramidal 
cells in the same cortical region (Melchitzky et al 1998, Pucak et al 1996), 3) association and 
calossal projections from pyramidal neurons from several different anatomical regions 
(Felleman & Van Essen 1991), 4) innervations from the mediodorsal (MD) nucleus of the 
thalamus, although other thalamic nuclei such as the pulvinar nucleus have minor contributions 
(Giguere & Goldman-Rakic 1988). Therefore, among the different laminar locations of pyramidal 
cells, those located in deep layer 3 appear to be of particular importance to neuronal network 
function since they are critically positioned to modulate the flow of excitatory neurotransmission 
through thalamocortical and corticocortical circuits.  
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Figure 1. Cytoarchitecture of pyramidal cell organization across laminar locations in the primate 
DLPFC.  
Based on size and packing density of neurons, the cerebral cortex can be stratified into six layers 
or lamina, from the pial surface of the cortex to the underlying white matter. Pyramidal cells, the 
primary source of excitatory neurotransmission in the brain, are distributed across these layers 
and comprise ~75% of total cortical neurons. Pyramidal cells occupying discrete laminar locations 
subserve unique functions and exhibit specific anatomical connectivity patterns. For example, 
pyramidal cells in superficial layers such as layer 3 primarily innervate other cortical regions via 
ipsilateral (same hemisphere) or contralateral (opposite hemisphere) projections and also furnish 
local, intrinsic axon collaterals that innervate local pyramidal cells. Pyramidal cells in deeper 
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layers such as layer 5 project to the striatum and brainstem, and layer 6 pyramidal cells primarily 
target the thalamus. These pyramidal cells also differ in the source of their excitatory inputs. For 
example, pyramidal cells in layer 3 receive feedforward cortical inputs from reciprocally 
connected cortical areas and also axonal inputs from the mediodorsal nucleus of the thalamus, 
whereas inputs from association cortices are distributed throughout all layers of the cortex. This 
figure was modified from Glausier and Lewis (2013). 
 
 
 
1.2.4 Spatial tuning of deep layer 3 pyramidal cells is determined by GABA 
interneurons 
The synchronization of pyramidal cell activity and specificity of spatial tuning of deep 
layer 3 pyramidal cells required for working memory, arises from local feedback and lateral 
inhibition provided by γ-aminobutyric acid (GABA) interneurons (Constantinidis et al 2002, Rao 
et al 2000, Wilson et al 1994). Ultrastructural analyses in monkey PFC have found that 
pyramidal cells in deep layer 3 furnish intrinsic axon collaterals that contact local GABA 
interneurons which in turn provide feedback inhibition to pyramidal cells to modulate 
postsynaptic response properties (Melchitzky et al 2001, Melchitzky & Lewis 2003). GABA 
interneurons in the monkey DLPFC demonstrate delay period activity that is isodirectionally 
tuned to nearby pyramidal cells in deep layer 3 (Rao et al 1999). According to the working 
model, the preferred direction of GABA interneurons is opposite to the preferred direction of 
pyramidal cells, such that the firing of pyramidal cells increases as the firing of GABA 
interneurons decreases (Constantinidis et al 2001). Furthermore, pharmacological application of 
GABA antagonists in the DLPFC suppresses the spatial tuning of DLPFC deep layer 3 
pyramidal cells required for task related neuronal firing consistent with this working model (Rao 
et al 2000). Therefore, the sharpening of stimulus selectivity required for spatial tuning is 
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contingent on concomitant interactions between deep layer 3 pyramidal cells and local GABA 
interneurons (Constantinidis & Goldman-Rakic 2002). In addition to determining the spatial 
properties of pyramidal cells, GABA interneurons also subserve a temporal function and control 
when pyramidal cells are active during different phases of working memory (Goldman-Rakic 
2002). Therefore, GABA interneurons perform the critical function of modulating the strength of 
persistent firing during working memory and enhance signal to noise. 
 
1.2.5 Role of DLPFC GABA interneurons in sculpting pyramidal cell activity for 
cognitive control 
GABA interneurons are highly heterogeneous and can be classified into non-overlapping 
populations based on several characteristics which include axonal and dendritic connectivity 
patterns, morphology, intrinsic physiological properties, molecular and neuropeptide expression 
patterns, developmental origins and temporal firing properties during various phases of network 
activity (DeFelipe et al 2013, Kepecs & Fishell 2014, Klausberger & Somogyi 2008). Distinct 
subclasses of GABA interneurons are particularly suited to modulate the postsynaptic firing 
properties of pyramidal cells (Buzsaki & Wang 2012). Based on electrophysiological properties, 
GABA interneurons can be subdivided into two groups: fast-spiking and non-fast spiking cells. 
The feedback and lateral inhibition required to spatially tune pyramidal cells in DLPFC deep 
layer 3 for sustained, synchronized neural activity is primarily mediated by fast-spiking GABA 
interneurons that express the calcium-binding protein parvalbumin (PV) (Bartos et al 2007, 
Gonzalez-Burgos & Lewis 2008). PV interneurons are preferentially localized in deep layer 3 
and 4 of the cortex and are often referred to as fast-spiking cells because they have fast, non-
accommodating firing patterns and fast membrane time constants (Galarreta & Hestrin 2002, 
Gonzalez-Burgos et al 2005, Hu et al 2014). PV interneurons comprise ~25% of GABA cells in 
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the primate PFC (Conde et al. 1994) and consist primarily in two separate classes: basket 
(PVb) and chandelier (PVCh) cells that innervate the perisomatic compartment and axon initial 
segment (AIS) of pyramidal cells, respectively. As a result of their specific regulation of the site 
of action potential generation in pyramidal cells, PV interneurons are thought to be critical 
determinants of the output of pyramidal cells (Hu et al 2014). Additionally, PV interneurons 
make multiple synaptic contacts with numerous pyramidal cells forming a widespread inhibitory 
network to modulate the postsynaptic excitatory input mediated depolarization of pyramidal cells 
(Hu et al 2014, Lee et al 2012). This extensive divergent arborization of PV interneurons allows 
it to synchronize the activity of multiple pyramidal cells (Bezaire & Soltesz 2013).  
There appear to be a plethora of different non-fast spiking GABA interneurons that 
contribute to the heterogeneity of GABA interneurons. For example, the activity of pyramidal 
cells and PV interneurons in DLPFC deep layer 3 is influenced by inputs from another 
functionally and anatomically distinct subtype of GABA basket interneurons that are 
immunoreactive for cholecystokinin (CCK). In contrast to the unique electrophysiological profiles 
of PV interneurons, CCK cells have regular-spiking properties due to accommodating firing 
patterns and slower time constants. In the PFC, the terminals of CCK basket cells are highly 
enriched with the cannabinoid receptor 1 (CB1R) and activation of these receptors with 
endogenous and exogenous cannabinoids can suppress GABA release following depolarization 
of postsynaptic pyramidal cells, a process termed depolarization-induced suppression of 
inhibition (DSI) (Eggan et al 2010, Pistis et al 2002, Wilson & Nicoll 2001).        
Another class of GABA interneurons that exhibits exquisite spatial specificity in terms of 
innervations patterns includes those that express the calcium-binding protein calbindin (CB). 
These cells can be subdivided into subgroups such as Martinotti, neuragliaform and double 
bouquet cells. Calbindin GABA interneurons are regular-spiking and have accommodating firing 
patterns and slower time constants. In contrast to PV interneurons, calbindin cells primarily 
innervate the distal dendrites of pyramidal cells (Kawaguchi & Kubota 1998, Zaitsev et al 2005). 
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Finally, the last group of GABA interneurons that comprise ~50% of GABAergic cells in the 
monkey DLPFC express the calcium-binding protein calretinin (CR) and neuropeptide 
vasoactive intestinal peptide (VIP) and have similar firing properties as calbindin cells 
(Kawaguchi & Kubota 1996, Melchitzky et al 2005, Pi et al 2013). In addition to innervating distal 
dendrites of pyramidal cells, calretinin cells also target other GABAergic interneurons 
(Melchitzky et al 2005).   
1.2.6 Molecular heterogeneity in GABA receptors 
The postsynaptic compartment of GABA inputs is also highly heterogeneous and 
GABAergic inhibition is primarily mediated by type A receptors (Farrant & Nusser 2005, Jacob 
et al 2008). Type A GABA receptors (GABAARs) are ionotropic channels that permit the 
passage of chloride and bicarbonate ions. GABAARs operate by producing a minor change in 
membrane potential but generate large conductances that shunt excitatory input-mediated 
depolarization following GABA activation. GABAARs mediate fast synaptic GABA 
neurotransmission and are heteropentamers that are typically composed of 2α, 2β, and 1γ 
subunits from 7 different families (α1-6, β1-3, γ1-3, δ, ε, θ, ρ1-3) (Farrant & Nusser 2005). 
GABAARs with different subunit composition are spatially organized in different subcellular 
compartments along the pyramidal cell somatodendritic axis and have different physiological 
and pharmacological properties. The assembly, membrane trafficking and spatial organization 
of GABA receptors is determined by multifarious trafficking mechanisms to produce the 
immense heterogeneity for postsynaptic regulation (Jacob et al 2008). GABAARs have been 
particularly relevant in clinical settings for pharmacological drug targets that have anesthetic, 
sedative and anticonvulsant function (Henschel et al 2008).    
Different subtypes of GABA interneurons selectively target different domains on 
pyramidal cells and regulate their activity through different GABAARs (Figure 2) (Farrant & 
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Nusser 2005, Huang 2014, Huang et al 2007, Klausberger & Somogyi 2008). For example, PVb 
cells preferentially innervate GABAARs that contain the α1 and β2 subunits which are 
specifically localized to the perisomatic compartment and proximal dendrites (Doischer et al 
2008, Nusser et al 1996). In contrast, PVCh cells form unique vertical terminal arrays called 
cartridges and preferentially innervate α2-containing GABAARs at the AIS of pyramidal cells 
(Loup et al 1998, Nusser et al 1996). Distal dendrite targeting SST-containing Martinotti cells 
primarily innervates α5-containing GABAARs localized on the dendritic shaft of pyramidal cells 
(Ali & Thomson 2008, Serwanski et al 2006). Finally, GABAARs can also be delineated into 
different subtypes based on proximate localization to a GABAergic presynaptic input. For 
example, γ2-containing GABAARs co-assemble with the α1, α2, α5 and β2 subunits to mediate 
phasic inhibition which involves the synchronized activation of receptors following GABA release 
into the synaptic cleft (Farrant & Nusser 2005, Jacob et al 2008). In contrast, δ-containing 
GABAARs are spatially dispersed in a stochastic manner in extrasynaptic locations and are 
activated by ambient GABA to mediate tonic inhibition (Farrant & Nusser 2005, Jacob et al 
2008). Importantly, the molecular heterogeneity of GABAARs has significant functional 
repercussions, since α1-containing GABAARs have much faster decay kinetics than currents 
generated by GABAARs containing other α subunits (Lavoie et al 1997).  
Given the sheer complexity of GABA interneuron subtypes and the myriad of 
physiological properties that have important ramifications for network operations, elucidating the 
specific subpopulations that are preferentially affected in schizophrenia has been an area of 
active investigation. Moreover, elucidating the developmental trajectories of GABA inputs to 
pyramidal cells across laminar location in a cell-type specific fashion is critical in understanding 
the maturation of pyramidal cells, which are essential for working memory function. The next 
few sections will focus on abnormalities related to glutamate and GABA signaling in 
schizophrenia. 
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Figure 2. Canonical subcellular distribution of postsynaptic GABA and glutamate receptor 
subunits in cortical pyramidal cells. 
The diagram illustrates the exquisite specificity by which different morphological classes of 
GABA interneurons innervate and regulate the output of pyramidal cells by targeting different 
subtypes of GABAARs. Different subtypes of GABA interneurons target discrete subcellular 
compartments along the somatodendritic arbor of pyramidal cells to enable spatial control. 
Parvalbumin (PV) and the cholecystokinin (CCK) expressing basket cells primarily innervate the 
perisomatic compartment of pyramidal cells and signal through α1- and α2-containing 
GABAARs. PV chandelier cells specifically target the AIS of pyramidal cells and signal through 
α2-containing GABAARs. By contrast, calbindin-expressing cells (double bouquet, neurogliaform 
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and Martinotti) provide inhibitory inputs to the distal dendrites of pyramidal cells and signal 
through α5-containing GABAARs. GABAAR-mediated synaptic neurotransmission is primarily 
mediated by γ2-containing GABAARs which when bound to GABA released presynaptically 
produces synchronous opening of ion channels. However, low GABA concentrations in the 
extracellular space can also produce persistent or tonic activation of GABAARs mediated by δ-
containing GABAARs. As opposed to the spatial heterogeneity of GABAARs, glutamate 
neurotransmission is primarily mediated by AMPA Glur1 and NMDA Grin1 containing AMPA 
and NMDA receptors, respectively, localized on dendritic spines. 
1.3 EVIDENCE FOR ALTERED EXCITATION AND INHIBITION IN 
SCHIZOPHRENIA 
1.3.1 Aberration in excitatory neurotransmission in schizophrenia 
A constellation of findings support the idea that DLPFC cortical alterations in 
schizophrenia may arise, at least in part, from aberrant excitatory neurotransmission. Previous 
postmortem studies have identified morphological disturbances in pyramidal cells in subjects 
with schizophrenia. These morphological changes include a lower density of dendritic spines, 
which reflect the number of excitatory innervations to pyramidal cells. For example, basilar 
dendritic spine density in Golgi-impregnated pyramidal cells was significantly lower by ~25% on 
deep layer 3 pyramidal cells in subjects with schizophrenia relative to normal comparison 
subjects and lower by 16% in psychiatrically ill comparison subjects (Glantz & Lewis 2000). 
Within the same subjects, these alterations are laminar-specific since the findings in the DLPFC 
are most pronounced in deep layer 3, present to a milder degree in superficial layer 3 and 
unaltered in layer 5 and 6 (Kolluri et al 2005).The decrement in spine density in subjects with 
schizophrenia has been observed in multiple brain areas in addition to the DLPFC, such as the 
temporal cortex and subiculum within the hippocampal formation, although the magnitude of 
difference between subjects groups has varied considerably (Broadbelt et al 2002, Garey et al 
1998, Konopaske et al 2014, Rosoklija et al 2000, Shelton et al 2015, Sweet et al 2009). For 
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example, recent studies using multi-label confocal microscopy approaches have identified 
putative dendritic spines using a combination of postsynaptic markers, and have found a 
marked decrease in dendritic spine density in deep layer 3 in the auditory cortex in 
schizophrenia (Shelton et al 2015, Sweet et al 2009). Importantly, dendritic spine density 
alterations were not found in monkeys chronically exposed to antipsychotic medication, 
suggesting that spine density perturbations observed in subjects with schizophrenia is not 
related to antipsychotic use (Sweet et al 2009).  
In addition to morphological alterations in dendritic spines, somal size and dendritic 
arbor of deep layer 3 pyramidal cells is reduced in subjects with schizophrenia in the DLPFC 
and auditory cortices and unchanged in pyramidal cells in the deeper layers (Glantz & Lewis 
2000, Pierri et al 2001, Rajkowska et al 1998, Sweet et al 2004). For example, mean somal 
volume of Nissl-stained DLPFC deep layer 3 pyramidal cells was ~10% smaller in subjects with 
schizophrenia relative to matched normal comparison subjects, an alteration that was not 
explained by either antipsychotic medication history or duration of illness (Pierri et al 2001). 
These findings are compelling because alterations in somal size may indicate disturbances in 
neural connectivity since somal size is correlated with measures of dendritic and axonal arbor 
(Hayes & Lewis 1996, Lund et al 1975). Thus, morphological alterations are specific to or at 
least most prominent in deep layer 3 in the DLPFC of subjects with schizophrenia, are found in 
other cortical areas, and reflect the underlying disease process and not confounding variables.   
Subjects with schizophrenia have also been reported to have smaller whole brain 
volumes during the prodromal stage, around the onset of overt psychosis and throughout all 
stages of the disease (Lawrie & Abukmeil 1998, Steen et al 2006), reductions in gray matter 
(Glahn et al 2008), and neuropil (Dorph-Petersen et al 2009). Together, the morphological 
alterations in pyramidal cells such as reduced spine density and dendritic arbor are conserved 
pathological deficits across brain regions and may contribute to reduced brain volumes and 
cortical neuropil. 
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1.3.2 Dendritic spines: structure and function 
Dendritic spines are morphologically unique and biochemically discrete entities that 
emanate from the dendritic shafts of cortical and hippocampal pyramidal neurons, cortical spiny 
stellate cells, cerebellar Purkinje cells and medium spiny neurons of the striatum (Gray 1959, 
Harris & Kater 1994). Santiago Ramon y Cajal originally described dendritic spines using a 
silver impregnation method developed by Camillo Golgi and hypothesized that “such spines 
could be the points where electrical charge or current is received” (Ramon y Cajal, 1888). 
Decades later, it was established that the vast majority of excitatory synapses in the central 
nervous system (approximately 80-95%) are formed onto dendritic spines (DeFelipe & Farinas 
1992, Gray 1959), avoiding dendritic shafts. These morphologically refined structures standout 
as the anatomical hallmark of distributed neural networks and has been the focus of several 
lines of investigation.  
Subsequent studies using electron microscopy have exquisitely reconstructed dendrites 
and spines from serial sections to reveal the three-dimensional ultrastructure of spines on 
dendrites. The prototypical dendritic spines are membranous protrusions from dendritic shafts 
and consist of a bulbous head linked to the shaft through a thin spine neck (Harris & Kater 
1994). Based on such findings, dendritic spines have been categorized into different subtypes 
using morphological parameters such as spine head size and neck length (Peters & Kaiserman-
Abramof 1970). As per the most widely used nomenclature, dendritic spines can be demarcated 
into the following subtypes: thin, stubby, mushroom and filopodia (Peters & Kaiserman-Abramof 
1970). Dendritic spine morphology correlates with strength of synapse with larger spines 
containing higher levels of AMPARs, enhanced response to glutamate stimulation and greater 
postsynaptic density protein networks (Matsuzaki 2007). High frequency activity patterns that 
induce long-term potentiation (LTP), a well-characterized memory consolidation paradigm, are 
also associated with morphological changes such as increases in synaptic efficacy and 
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enlargement of spine heads (Kasai et al 2003). More recently, live imaging in vivo studies using 
modern digital microscopy methods such as 2-photon laser scanning microscopy (2PLSM) 
suggest that some dendritic spines are highly dynamic structures changing in size and shape 
over timescales of seconds to days in rodents (Alvarez & Sabatini 2007, Holtmaat et al 2006, 
Stettler et al 2006). Therefore, although dendritic spines exist in various morphological 
subtypes, these in vivo studies have proposed the idea that dendritic spine subtypes could be a 
part of a continuum of morphologically plastic structures (Yuste 2011).  
Time-lapse studies of dendritic spine structural plasticity in vitro and in vivo, have put 
forward the view that dendritic spine structural plasticity is strongly correlated with synaptic 
plasticity (Hayashi & Majewska 2005, Holtmaat & Svoboda 2009). Moreover, dendritic spines 
are dynamically regulated by activity-dependent and experience-dependent modulatory 
mechanisms (Trachtenberg et al 2002). For example, elimination of presynaptic input following 
deafferentation produces a striking loss in dendritic spine density lending credence to the idea 
that neurotransmission acts as a signal to maintain the structural integrity of spines (Valverde 
1967). Dendritic spines are particularly adapted to respond to neural activity because they 
contain the postsynaptic density, an electron-rich region juxtaposed to the presynaptic bouton 
active zone where neurotransmitters are released into the synaptic cleft (Scannevin & Huganir 
2000). Together, although the exact function of dendritic spines remains enigmatic, these highly 
specialized structures help neural circuits achieve three important goals: (1) spines help to 
make the circuit connectivity matrix more distributed by augmenting synaptic connectivity 
between pyramidal cells (Yuste et al 2000); (2) to make excitatory input integration 
nonsaturating and linear by electrically isolating inputs (Araya et al 2006, Bloodgood & Sabatini 
2005); (3) spines perform the critical function of ensuring that these connections are 
independently plastic by ensuring input-specific synaptic plasticity (Yuste 2011).  
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1.3.3 Actin cytoskeleton: Crucial regulators of Dendritic Spines 
Dendritic spine structure, shape and stability are determined internally by the actin 
cytoskeleton which is thought to be crucial in regulating the postsynaptic signaling machinery 
and molecular composition of synapses within spines (Sheng & Hoogenraad 2007, Tada & 
Sheng 2006). The actin cytoskeleton exists in a dynamic equilibrium between monomeric 
globular (G)-actin and polymerized fibrous, or filamentous, (F)-actin and exhibits a high 
turnover rate via continuous treadmilling (Honkura et al 2008). The actin meshwork is apposed 
to the spine membrane and long-term changes in synaptic efficacy require optimal regulation of 
F-actin (Koleske 2013). For example, actin-GFP Fluorescence Resonance Energy Transfer 
(FRET) experiments have shown that actin polymerization is necessary for LTP induction in 
spines, whereas long-term depression (LTD) induction is associated with actin depolymerization 
(Honkura et al 2008, Okamoto et al 2004). Moreover, stabilization of dendritic spines and arbors 
is inextricably linked to polymerization of F-actin, particularly during neurodevelopment, when 
nascent synapses are preserved or eliminated depending on the source of presynaptic input 
(Cline & Haas 2008, Wu et al 1999). In addition, numerous genetic and pharmacological 
experiments indicate that activity-dependent actin cytoskeleton reorganization is necessary for 
morphological plasticity of spines and long-lasting changes in synaptic efficacy (Cingolani & 
Goda 2008, Matus 2000).   
A plethora of extracellular molecules bind to cell surface adhesion receptors such as 
cadherins, integrins, immunoglobulin superfamily receptor complexes and ephrin receptors to 
activate numerous signal transduction pathways. These signaling pathways have been 
proposed to regulate the actin cytoskeleton in order to influence the establishment, development 
and plasticity of dendritic spines. In particular, the Rho family of GTPases (Ras Homolog family 
member A (RhoA), Ras-related C3 botulinum toxin substrate 1 (RAC1) and cell division cycle 
42 (CDC42)) is a crucial mediator of the actin cytoskeleton and has a significant impact on spine 
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morphogenesis (Saneyoshi et al 2010). These GTPases are highly concentrated in spines and 
have differential effects on spine regulation. For example, constitutive activation of RAC1 and 
CDC42 promote spine growth and stability while RhoA inhibits spinogenesis (Hall 1998, 
Soderling et al 2007). CDC42 and RAC1 are both crucial for the formations of filopodia and 
lamellopodia which may develop into mature spines, suggesting that these Rho GTPases are 
needed for the establishment of the full complement of dendritic spines (Ridley 2006). Recent 
studies using two-photon fluorescence lifetime imaging microscopy (2pFLIM) have 
demonstrated that activation of Rho GTPases is restricted to stimulated spines undergoing 
structural plasticity and exhibited a steep gradient at the spine necks (Murakoshi et al 2011).     
Rho family proteins can bind to both GTP and GDP and have intrinsic GTPase activity 
(Chardin 2006). In the GTP-bound state, they can interact with and activate numerous 
downstream effector proteins, whereas, in the GDP-bound state, they are held in an inactive 
conformation (Bourne & Harris 2008). The activity of Rho GTPases is primarily modulated by 
guanine nucleotide exchange factors (GEFs) and GTP-ase activating proteins (GAPs). GEFs 
stimulate the release of GDP, allowing GTP to bind and priming it for activation to modulate 
various downstream effectors. GAPs catalyze GTP hydrolysis, transforming Rho GTPases to a 
GDP-bound inactive state. Finally, the activities of Rho GTPases are also determined by Rho 
guanine nucleotide dissociation inhibitors (GDIs) that control the dissociation of GTP and GDP 
and subcellular localization of Rho GTPases (Bourne & Harris 2008).  
Rho GTPases use a multitude of molecular mechanisms to control actin polymerization 
and regulate the structural stability and functional plasticity of dendritic spines (Figure 3). For 
example, Rho GTPases can induce actin depolymerization by modulating the activity of the 
cofilin family of proteins, an actin-filament severing and actin depolymerizing factor (Hotulainen 
et al 2009). The cofilin family of actin-severing proteins is densely packed in the spine shell 
juxtaposed next to the presynaptic bouton, where F-actin filaments are less densely packed but 
are more dynamic (Honkura et al 2008). Mechanistically, this pathway is mediated by Rho 
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GTPase activation of p21-activated serine/threonine protein kinases (PAK), which in turn 
phosphorylate and activate LIM domain-containing serine/threonine protein kinases (LIMK) to 
regulate actin disassembly through cofilin (Arber et al 1998, Yang et al 1998). Similarly, RAC1 
and CDC42 stimulate actin polymerization via the actin-related protein-2/3 (ARP2/3) complex 
which stimulates the formation of new actin filament branching off existing filaments (Goley & 
Welch 2006). The ARP2/3 complex is highly concentrated in spines (Racz & Weinberg 2008) 
and knockdown in in vitro preparations have revealed its critical role in filopodia initiation and 
spine structural integrity (Hotulainen et al 2009). The activity state of ARP2/3 is determined by 
several nucleation-promotion factors (NPF) such as the Neuronal Wiskott-Aldrich syndrome 
proteins (N-WASP) which are directly activated by Rho GTPases such as CDC42 (Millard et al 
2004). 
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Figure 3. Regulatory actin cytoskeleton CDC42 signaling pathways for dendritic spine 
stabilization. 
Calcium influx through NMDA receptors activates CAMKII which activates CDC42, a Rho 
GTPase that is a critical regulator of actin cytoskeleton dynamics in dendritic spines. The activity 
of CDC42 is regulated, at least in part, by ARHGDIA, a guanine nucleotide dissociation inhibitor 
that suppresses intrinsic GTPase activity. Once active, CDC42 can regulate the contribution of 
F-actin to dendritic spine structure through multiple pathways: 1) CDC42-CDC42EP pathway: 
Activated CDC42 inhibits CDC42 effector proteins (CDC42EP), which dissociate the complex of 
septin filaments consolidated by SEPT7 in the spine neck. The transient disruption of the septin 
barrier allows the entry of various molecules from the dendritic shaft to the spine to facilitate F-
actin mediated growth of spines in response to excitatory stimulation; 2) CDC42-PAK-LIMK 
pathway: CDC42 activates the family of p21-activated serine/threonine protein kinases (PAK), 
which in turn activate LIM domain-containing serine/threonine protein kinases (LIMK) by 
phosphorylation. Activation of this signal transduction pathway inhibits the cofilin family of actin 
severing proteins that determine the recycling of F-actin necessary for spine stabilization; 3) 
CDC42-N-WASP-ARP2/3 pathway: Activated CDC42 activates nucleation promotion factors 
such as N-WASP which promote actin nucleation of the actin-related protein-2/3 (ARP2/3) 
complex. The ARP2/3 complex is a critical determinant of activity-dependent structural plasticity 
of spines and stimulates de novo actin polymerization to generate F-actin branched filament 
networks to modulate spine morphogenesis.    
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1.3.4 Impairments in actin cytoskeleton in schizophrenia 
Aberrant synaptic connectivity arising from destabilization of dendritic spines and arbors 
in DLPFC deep layer 3 pyramidal cells may be a consequence of alterations in the molecular 
mechanisms that establish the integrity of the actin cytoskeleton. Previous studies in total gray 
matter in the DLPFC have found decreased levels of CDC42 in subjects with schizophrenia, 
which were also found to be strongly correlated with spine density measurements from DLPFC 
deep layer 3 pyramidal cells (Hill et al 2006). Since CDC42 is instrumental in moderating actin 
polymerization required for the generation of mature spines, lower levels of CDC42 may impair 
the ability of pyramidal cells in the DLPFC in subjects with schizophrenia to maintain a full 
complement of excitatory inputs. Moreover, previous studies have also found lower mRNA 
levels of Kalirin, a RAC GEF that is highly concentrated in spines and regulates spine integrity 
through regulation of RAC1 and CDC42 (Cahill et al 2009, Hill et al 2006) and these changes 
were also correlated with spine density measures in deep layer 3 pyramidal cells (Hill et al 
2006). These findings are compelling in light of genetic studies suggesting that the KALRN 
locus is associated with risk for schizophrenia (Ikeda et al 2011). Also, missense mutations in 
KALRN have been reported in subjects with schizophrenia, although future studies need to 
replicate these findings in larger cohorts (Kushima et al 2012). Recently, protein studies in the 
auditory cortex found no change in protein levels of Kalirin-5, -7, -12, but a significant 
upregulation in Kalirin-9 (Deo et al 2012), which is a negative regulator of dendritic length. In 
aggregate, alterations in CDC42 and Kalirin would be expected to result in an inability to form 
new spines and impaired maintenance of existing, mature spines.  
The laminar specificity of the decrement in spine density in deep layer 3 may reflect the 
pathological disturbances in molecules that are expressed selectively in those layers. For 
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example, CDC42 effector proteins (CDC42EP) are preferentially expressed in the supragranular 
layers (layers 2-3) of the DLPFC (Arion et al 2007) and postmortem studies have found the 
expression levels of CDC42EP3 to be upregulated in schizophrenia (Ide & Lewis 2010). 
Activation of CDC42 following glutamate stimulation inhibits CDC42EP activity, which 
dissociates the complex of septin filaments in the spine neck, thereby facilitating the influx of 
postsynaptic molecules (cytoskeletal proteins and second messengers), from the dendritic shaft 
to the spine, required for F-actin mediated growth of spines and synaptic potentiation (Ide & 
Lewis 2010). In schizophrenia, lower levels of CDC42 and higher levels of CDC42EPs might 
lead to decreased capacity to dissociate the septin filament barrier, suppressing the influx of 
molecules required for spine plasticity, ultimately resulting in spine loss (Ide & Lewis 2010). In 
aggregate, these findings support the notion that reduced number of excitatory inputs to DLPFC 
deep layer 3 pyramidal cells may be a consequence of an intrinsic abnormality to these 
pyramidal cells which could preclude the maintenance of a normal complement of excitatory 
inputs. However, these prior studies have all been conducted in total gray matter tissue 
homogenates where transcript level measurements may be obscured by unaffected cell types. 
For example, in studies in total gray matter homogenates, changes in gene expression might 
reflect either a difference in relative number of cells expressing the transcript or altered level of 
expression in a cell-type specific fashion. Therefore, gene expression patterns in specific 
vulnerable neuronal populations in subjects with schizophrenia may be particularly illuminating 
in informing us about novel pharmacotherapy targets.   
An increasing number of large-scale studies have proposed a genetic basis for 
dysregulation of the actin cytoskeleton in subjects with schizophrenia. Consistent with this idea, 
de novo mutations in proteins that regulate actin filaments dynamics and glutamate postsynaptic 
networks are preferentially found in individuals with schizophrenia (Fromer et al 2014). GWAS 
studies highlight several genes involved in glutamatergic neurotransmission in schizophrenia 
and several genetic risk factors for schizophrenia are related to the regulation of actin 
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polymerization and actin filament bundle assembly (Kirov et al 2012, Ripke et al 2013, Roussos 
et al 2012). These findings offer a plausible proximal cause for a primary alteration in dendritic 
spines and the excitatory inputs they receive in subjects with schizophrenia. Based on 
postmortem findings, this genetic predisposition could be moderated by cell-type specific and 
laminar-specific patters of gene expression to selectively induce morphological alterations in a 
laminar-specific manner in deep layer 3 pyramidal cells. In concert, the alterations in the actin 
cytoskeleton in schizophrenia support the notion that decreased excitatory drive to layer 3 
pyramidal cells is “upstream” in the disease process (Lewis et al 2012).  
1.3.5 Alterations in presynaptic afferents in the DLPFC: Potential source of 
dendritic spine alterations 
The reduction in excitatory inputs to deep layer 3 pyramidal cells in the DLPFC in 
schizophrenia may also be a consequence of a laminar-specific reduction in the number of 
excitatory afferents. The thalamus is a key structure in gating sensory information and 
modulating the flow of information to the cortex (Steriade & Deschenes 1984). Excitatory inputs 
from the MD nucleus of the thalamus comprise the primary source of thalamic afferents to the 
DLPFC and these afferents primarily innervate deep layer 3 and layer 4 pyramidal cells and 
GABA interneurons (Barbas et al 1991, Giguere & Goldman-Rakic 1988). Intriguingly, the 
laminar-specific arborization of thalamic afferents from the MD nucleus to deep layer 3 and 4 
parallels the laminar location of dendritic spine and somal volume alterations in schizophrenia. 
Therefore, reduction in inputs or activity from the thalamus could provide a plausible mechanism 
for the loss in dendritic spines in deep layer 3 pyramidal cells in schizophrenia. Original studies 
showed a decrement in the number of neurons in the MD nucleus (Byne et al 2002, Pakkenberg 
1990, Young et al 2000), although follow up studies using larger sample sizes and appropriate 
stereological sampling techniques have failed to detect any differences (Cullen et al 2003, 
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Dorph-Petersen et al 2004). However, numerous diffusion-weighted neuroimaging studies have 
revealed alterations in the structural integrity between thalamocortical loops in schizophrenia 
(Wheeler & Voineskos 2014). The equivocal findings related to the number of neurons in the 
MD nucleus in schizophrenia do not rule out the possibility that the activity state of 
thalamocortical connectivity is reduced in schizophrenia especially since decreases in activity 
are associated with dendritic spine loss (Shi & Ethell 2006, Star et al 2002).   
The vast majority of dendritic spines receive corticocortical afferents that are not as 
specific to laminar locations as thalamocortical afferents, but are thought to account for 
approximately 85-90% of total excitatory afferents in the DLPFC. Previous studies have shown 
reduced levels of synaptophysin, a marker of axon terminals, in the DLPFC in subjects with 
schizophrenia (Glantz & Lewis 1997), although this approach was not able to disentangle 
whether thalamocortical or corticocortical afferents were altered in the DLPFC. Moreover, it 
remains unknown whether these presynaptic boutons to DLPFC deep layer 3 pyramidal cells in 
subjects with schizophrenia never fully develop, are extensively eliminated during synaptic 
pruning periods, or are internalized later in life.  
Furthermore, although dendritic spines primarily receive excitatory synaptic inputs from 
glutamate axon terminals, 15-30% of dendritic spines also receive synaptic input from GABA 
axon terminals (Beaulieu et al 1992, Jones & Powell 1969, Knott et al 2002, Kubota et al 2007, 
van Versendaal et al 2012). For example, EM studies have revealed that surprisingly large 
fractions of symmetrical synaptic appositions were formed onto dendritic spines that were co-
innervated by an asymmetrical terminal (Beaulieu et al 1992, Jones & Powell 1969, Kubota et al 
2007). In addition, a recent study using different isoforms of the vesicular glutamate transporter 
(Vglut), Vglut1 and Vglut2, to discriminate between corticocortical and thalamocortical 
excitatory boutons, respectively, showed that the dual-innervated spines selectively received 
thalamocortical afferents but almost never corticocortical afferents (Kubota et al 2007). From a 
functional standpoint, GABA inputs onto spines, rather than merely suppressing depolarization 
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mediated by excitatory afferents, may actually sculpt neuronal activity at the subcellular level 
(Chiu et al 2013, Higley 2014). Pharmacological and computational studies suggest that GABA 
inhibition onto spines can suppress Ca2+ transients by inhibiting voltage-gated Ca2+ channels 
(VGCCs) and NMDA receptors (Chiu et al 2013). At a mechanistic level, GABA mediated 
inhibition onto spines can induce spine elimination by activating the actin-depolymerizing factor 
(ADF)/cofilin, a downstream target of the CDC42 pathway (Hayama et al 2013). However, 
previous studies in postmortem tissue in subjects with schizophrenia have not investigated if 
there are any deficits in the proportion of dual-innervated spines. Therefore, it remains to be 
determined if the spine deficits in DLPFC deep layer 3 pyramidal cells are associated with fewer 
axospinous afferents from particular sources.  
1.3.6 Alterations in GABA interneurons are most pronounced in DLPFC deep 
layer 3 in schizophrenia  
The proximal deficit in excitatory activity in DLPFC deep layer 3 has been postulated to 
result in homeostatic compensatory mechanisms to reduce feedback inhibition of these 
pyramidal cells (Figure 4; Lewis et al. 2012). This idea is supported by various pre- and 
postsynaptic alterations related to GABAergic neurotransmission in schizophrenia in response 
to an intrinsic deficit in deep layer 3 pyramidal cells (Lewis et al 2012). For example, numerous 
studies using a plethora of different approaches such as quantitative PCR, in situ hybridization 
and DNA microarray, have consistently found lower levels of the gene encoding the 67-kDa 
isoform of GAD (GAD67), the principal enzyme that synthesizes GABA (Akbarian et al 1995, 
Curley et al 2011, Mirnics et al 2000, Volk et al 2000). GAD67 expression is activity-dependent 
and is thought to account for ~90% of total GABA synthesized in the brain and deletion of the 
gene is embryonically lethal (Benson et al 1994, Lau & Murthy 2012). At the cellular and laminar 
level, the density of neurons with detectable levels of GAD67 mRNA was lower by 25-35% 
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across layers 1-5 in subjects with schizophrenia, with the remaining GABA neurons with 
detectable GAD67 mRNA levels showing no change (Volk et al 2000). Moreover, the deficits in 
GAD67 mRNA are accompanied by corresponding changes in the cognate protein in 
schizophrenia (Curley et al 2011, Guidotti et al 2000). In contrast to the decreased levels of 
GAD67, mRNA and protein levels of the 65-kDa isoform of GAD (GAD65), the other enzyme 
responsible for GABA synthesis, are unaltered between comparison and schizophrenia subjects 
(Hashimoto et al 2008a). Furthermore, the density of GAD65-IR terminals is also unaltered in 
schizophrenia (Benes et al 2000).  
The alterations in GAD67 seem to be pronounced in PV interneurons in DLPFC deep 
layer 3, the same layer where pyramidal cells show the most prominent molecular and 
morphological perturbations in schizophrenia (Figure 4). For example, previous studies suggest 
that GAD67 mRNA decrement is strikingly altered ~30% of DLPFC interneurons, and dual in 
situ hybridization studies show that GAD67 mRNA is not detectable in ~50% of PV cells 
(Hashimoto et al 2003). Furthermore, levels of PV mRNA are also lower in subjects with 
schizophrenia in layer 3 and 4, although there is no change in the density of PV cells detectable 
by PV mRNA or the density of PV-IR neurons (Beasley et al 2002, Fung et al 2010, Hashimoto 
et al 2003, Mellios et al 2009). Consequently, these findings suggest that GAD67 mRNA levels 
are decreased in PV interneurons that have lower, but still detectable levels of PV mRNA. 
Moreover, using multi-label confocal light microscopy approaches, it appears as though the 
alterations in GAD67 and PV protein are more exacerbated in the presynaptic axon terminals of 
PVb cells, the primary site of GABA production and function, and these changes are specific to 
DLPFC layers 3 and 4 (Curley et al 2011, Glausier et al 2014). These alterations are 
accompanied by concomitant changes in the postsynaptic component of PVb inputs with a 
marked decrement in the GABAA α1 subunit within DLPFC layer 3-4 and the lower GABAA α1 
subunit levels were found in deep layer 3 pyramidal cells but not interneurons (Beneyto et al 
2011, Glausier & Lewis 2011). In addition, markers of PVCh inputs to pyramidal cell AIS are 
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also affected. For example, the density of GABA membrane transporter 1 (GAT1)-IR cartridges, 
the protein primarily responsible for reuptake of GABA into the axon terminals, is 40% lower in 
schizophrenia (Pierri et al 1999, Woo et al 1998). In the postsynaptic component of PVCh cells, 
there is a robust increase in GABAA α2 subunit protein levels in the pyramidal cell AIS (Volk et 
al 2002). These synergistic alterations have been hypothesized to decrease GABA reuptake 
and provide greater postsynaptic receptors to enable neurotransmitter binding to strengthen 
GABA signaling (Lewis et al 2012).  
Various other subpopulations of GABA interneurons are also affected in the illness as 
the lower levels of GAD67 mRNA in the DLPFC are found in layers 1-2 and 5, where PV mRNA 
is unaltered (Hashimoto et al 2003). Among the various subpopulations of GABA interneurons, 
perisomatic targeting CCK interneurons have received considerable attention. Previous 
postmortem studies have found lower levels of CCK mRNA and CB1 mRNA and protein levels 
in subjects with schizophrenia, and the alterations in GAD67, CCK, and CB1 mRNA are strongly 
correlated in the same subjects (Eggan et al 2008, Hashimoto et al 2008a, Hashimoto et al 
2008b). Additionally, dendrite targeting somatostatin (SST) interneurons, a subtype of CB cells, 
are also affected with previous studies reporting lower SST mRNA with corresponding changes 
in the GABAA α5 subunit-containing receptors that are postsynaptic to SST inputs (Beneyto et al 
2011, Hashimoto et al 2008a, Hashimoto et al 2008b, Morris et al 2008) and these changes are 
also strongly associated with GAD67 mRNA levels in the same subject pairs. Contrary to this 
pattern of alteration, CR-containing GABA interneurons which comprise ~50% of GABA 
interneurons in the PFC, are relatively unaltered in CR or GAD67 mRNA levels (Hashimoto et al 
2003).  
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Figure 4. Schematic summarizing alterations in DLPFC circuitry in schizophrenia. 
Pyramidal cells in deep layer 3 exhibit morphological abnormalities, such as smaller cell bodies, 
shorter dendrites and fewer dendritic spines. Reduced excitatory drive to deep layer 3 pyramidal 
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cells is balanced by compensatory, homeostatic mechanisms to reduce GABA inhibition onto 
pyramidal cells. Alterations in GABA neurotransmission by PV interneurons are shown by 
decreased expression of several gene products and are also associated with structural 
alterations in PV interneuron inputs. Structural alterations in PVCh cells include lower levels of 
GAT1 protein in the axon terminals and corresponding upregulation of α2-containing GABAARs 
at the AIS. Although the density of PVb cell inputs are unchanged in schizophrenia, alterations 
in PVb cells include reduced levels of PV and GAD67 protein in PVb boutons and compensatory 
downregulation of α1-containing GABAARs in the perisomatic compartment of pyramidal cells. 
Furthermore, lower cholecystokinin (CCK) and cannabinoid receptor 1 (CB1) transcript levels 
and lower CB1 protein in axon terminals reveal dysregulation of GABA neurotransmission in 
another subset of basket cells that also innervate the perisomatic region of pyramidal cells. 
Gene expression of neuropeptide somatostatin (SST) is also decreased in GABA interneurons 
along with postsynaptic α5-containing GABAARs that are localized in distal dendrites of 
pyramidal cells. However, gene expression of calretinin-containing GABA interneurons, that 
primarily innervate other GABA interneurons, appears to be unaltered in schizophrenia. 
Presumed alterations in thalamic and DA cell bodies and their inputs to the DLPFC are also 
depicted. Adapted from Lewis and Sweet (2009).  
 
1.4 DEVELOPMENTAL REFINEMENTS IN DLPFC DEEP LAYER 3 
MICROCIRCUITS DURING POSTNATAL MATURATION 
1.4.1 Protracted developmental maturation of pyramidal and GABA cells 
Pyramidal cells and GABA interneurons in DLPFC deep layer 3 microcircuits, the same 
microcircuit responsible for working memory function where pathological alterations are most 
pronounced in schizophrenia, undergo robust changes during postnatal development which is 
conserved across species. For example, dendritic spine density on DLPFC pyramidal cells 
undergoes significant pruning during postnatal development in both monkeys and humans 
(Anderson et al 1995, Petanjek et al 2011). The density of dendritic spines peaks in expression 
early in development during the perinatal period when there is exuberant spinogenesis, reaches 
its zenith during childhood, and then declines by ~50% during adolescence. Consistent with 
these observations, the density of asymmetric excitatory synapses (defined morphologically by 
the presence of a thick postsynaptic density) declines in a similar manner during postnatal 
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maturation in both monkeys and humans (Bourgeois et al 1994, Huttenlocher 1979, 
Huttenlocher & Dabholkar 1997).      
The elimination of supranumerary spines and synapses are determined by activity-
dependent stabilization mechanisms and various hypotheses for the selective elimination of 
excessive morphological structures have been proposed (Le Be & Markram 2006). One such 
hypothesis has proposed that the refinement of excitatory inputs to spines in an age-related 
fashion primarily involves elimination of mature synapses rather than nascent, immature 
synapses (Gonzalez-Burgos et al 2008). Whole-cell patch clamp recordings in in vitro slice 
preparations of monkey PFC have revealed that excitatory inputs to deep layer 3 pyramidal cells 
in young monkeys (3-months of age) had immature functional properties such as lower 
AMPA/NMDA receptor ratio and much longer duration of NMDA receptor-mediated excitatory 
synaptic currents. However, excitatory inputs to older monkeys (15-month of age) had mature 
functional properties that persisted throughout postnatal development (Gonzalez-Burgos et al 
2008). These findings led to the interpretation that the reorganization of excitatory connectivity 
involves the removal of mature synapses and that presynaptic factors or postsynaptic signals 
may tag mature synapses for pruning during postnatal development (Gonzalez-Burgos et al 
2008). Developmental changes may also include concomitant changes involving synapse-
specific stabilization following LTP and synapse-specific destabilization following LTD resulting 
in preservation of specific subpopulations of spines (Matsuzaki 2007, Zhou et al 2004). The 
rewiring of synaptic connections and activity-dependent stabilization of synapses may also be 
determined by molecular mechanisms involving actin cytoskeleton reorganization and related 
trafficking mechanisms (Calabrese et al 2006).  
These structural age-related changes in synaptic pruning is thought to underlie the 
decline in cortical gray matter thickness that takes place primarily during adolescence in 
humans and presumably to an exaggerated degree, in subjects with schizophrenia (Feinberg 
1982, Gogtay et al 2004). Structural comparisons across different populations of pyramidal cells 
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across laminar-location suggest that age-related developmental refinements are most striking in 
deep layer 3 pyramidal cells (Bourgeois et al 1994, Petanjek et al 2011) which might provide 
some insight into the laminar-specificity of spine alterations in schizophrenia. In schizophrenia, 
current theories postulate the idea that dysregulation of the molecular mechanisms associated 
with adolescence-related spine and synapse elimination may result in exaggerated pruning and 
lower spine density in the disease (Feinberg 1982, Hoffman & Dobscha 1989). Excessive 
synaptic pruning during postnatal development (particularly, during adolescence) has been 
linked to neurodevelopmental models of schizophrenia because it coincides with the emergence 
of the clinical symptoms of schizophrenia in early adulthood, suggesting that they may 
contribute to the pathophysiology of the disease (Lewis & Levitt 2002). Alternatively, the 
pathogenesis of schizophrenia may involve excessive production of immature axospinous 
synapses that are normally pruned.    
Consistent with the structural alterations in pyramidal cells during postnatal 
development, several components of GABA inhibition undergo marked changes in primate 
DLPFC during postnatal maturation in deep layer 3. In particular, the terminals from PV 
interneurons undergo significant changes in layer 3 of the monkey DLPFC during postnatal 
development. For example, the density of PV-immunoreactive boutons presumably from PVb 
cells increases linearly from the perinatal period through adolescence (Erickson & Lewis 2002). 
The density of PVCh axon cartridges immunoreactive for either PV or GAT1 exhibits a complex 
pattern of changes during the same period, increasing from birth to childhood and then declining 
progressively during adolescence (Cruz et al 2003). Consistent with these findings, recent work 
using multi-labeling confocal microscopy suggests that PV protein levels within existing boutons 
from PVb cells increases during postnatal development while the mean number of PVCh 
cartridges per pyramidal cell AIS declines during postnatal development (Fish et al 2013). 
Interestingly, density of ankyrin-G and βIV spectrin, structural proteins localized to the AIS, also 
declines progressively until 1 year of age (Cruz et al 2009). Non-fast spiking interneurons show 
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complex patterns of maturation during postnatal development in the primate DLPFC. The 
density of CCK basket cells, particularly in the superficial layers, is high at birth and declines 
during the perinatal and childhood periods (Oeth & Lewis 1993). Similarly, SST mRNA declines 
from the perinatal period through childhood in monkey DLPFC during postnatal development 
(Hoftman et al 2015). These findings indicate cell-type specific mechanisms of GABA 
interneuron maturation during postnatal development in the monkey DLPFC.     
At the postsynaptic level, GABAAR subunits also have distinctive developmental 
trajectories that vary across laminar location. Previous studies in total tissue homogenates have 
shown that the expression of α1, β2, δ, γ1, and γ3 GABAAR subunits increase whereas α2, α4, 
and β3 GABAAR subunits decrease in primate DLPFC during postnatal development (Duncan et 
al 2010, Fillman et al 2010, Le Magueresse & Monyer 2013, Maldonado-Aviles et al 2009). For 
example, expression of mRNAs encoding GABAA receptor α1 and α2 subunits in monkey 
DLPFC have revealed contrasting trajectories during postnatal maturation with striking changes 
between prepubertal and adult age groups (Hashimoto et al 2009). Importantly, given the 
differences in electrophysiological properties of different subunits, recent work examining 
GABAAR-mediated inhibitory postsynaptic currents (IPSCs) from pyramidal cells in DLPFC deep 
layer 3 found decreases in the decay of IPSCs by the prepubertal period, while the amplitude 
increased until peripuberty (Gonzalez-Burgos et al 2014, Hashimoto et al 2009). 
The myriad of molecular and structural changes in pyramidal cells and GABA 
interneurons during postnatal development, particularly in DLPFC deep layer 3, provides insight 
into understanding how circuit maturation might explain complex behaviors such as working 
memory. Previous work in humans, have revealed that working memory performance 
progressively improves through adolescence and this improvement is associated with increased 
participation of DLPFC circuity (Luna & Sweeney 2004). Similarly, studies in monkeys also 
suggest that the ability to perform working memory tasks first appears around 2-4 months of age 
and progressively increases to reach mature levels of performance around 3 years of age 
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(Goldman-Rakic 1987). The progressive improvement in working memory performance is 
predicated on greater activity of the PFC, since reversible cooling of the PFC has no effect on 
working memory performance during childhood (9-16 months of age), generates mild 
impairments during early adolescence (19-31 months of age), and significantly impedes 
performance in late adolescence (36 months of age) (Alexander 1982, Alexander & Goldman 
1978). These findings are corroborated by in vivo electrophysiology studies in monkeys showing 
enhanced firing during the delay period of working memory tasks, primarily mediated by deep 
layer 3 pyramidal cells (Goldman-Rakic 1995). Moreover, the proportion of PFC neurons 
exhibiting delay-related firing dramatically increases from the perinatal period to early 
adolescence (Goldman-Rakic 1987). 
1.4.2 Pyramidal cell and GABA interneuron circuitry in layer 3 is crucial for 
generating γ oscillations 
Neural oscillations are a cardinal feature of neural circuits and occur across a range of 
frequencies (Buzsaki & Draguhn 2004, Buzsaki & Schomburg 2015). Particularly, oscillations in 
the γ-frequency (30-80 Hz), which involves the synchronized activity of ensembles of pyramidal 
cells, is crucial for higher order cognitive processes (Bartos et al 2007, Fries 2009). In the 
human DLPFC, γ-frequency activity is induced during the delay period of working memory tasks 
(Tallon-Baudry et al 1998) and power of γ synchrony increases in proportion to working memory 
load (Howard et al 2003). Subjects with schizophrenia exhibit decreased power of frontal lobe γ-
frequency oscillations in EEG studies (Cho et al 2006, Minzenberg et al 2010) and also show 
alterations in phase-locking of γ-frequency oscillations at the onset of stimuli during cognitive 
tasks (Spencer et al 2003). These disrupted pathophysiological processes appear to be present 
throughout the duration of the disease and are even found in medication-naïve patients 
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(Minzenberg et al 2010) suggesting that it is not a manifestation of illness duration or medication 
use.  
Interestingly, the genesis of γ-frequency oscillations appears to show laminar-specificity 
as well, with electrophysiological studies proposing that γ-frequency oscillations principally 
originate in layer 3 in monkey association cortices (Buffalo et al 2011, Quilichini et al 2010) 
suggesting a dependency on recurrent connectivity in layer 3 between pyramidal cells and 
GABA interneurons. Indeed, according to the Pyramidal Interneuron Network Gamma (PING) 
model, the generation of γ-frequency oscillations is inextricably linked to the crosstalk between 
pyramidal cells and GABA interneurons via recurrent synaptic connections (Whittington et al 
2000). As per the PING model, GABA interneurons are recruited by phasic monosynaptic 
excitatory inputs from pyramidal cells, which synchronize the activity of pyramidal cells by 
feedback inhibition (Gonzalez-Burgos & Lewis 2012, Pouille & Scanziani 2001).   
Among the various subpopulations of GABA interneurons, PV interneurons appear to be 
particularly well suited to mediate feedback inhibition to synchronize the activity of neural 
ensembles as discussed above. Experimental studies in rodents using optogenetic stimulation 
corroborate the importance of PV interneurons in generating γ-frequency oscillations, rendering 
the interpretation that pyramidal neuron connections to PV interneurons in deep layer 3 may be 
particularly important (Cardin et al 2009, Sohal et al 2009). PV interneurons are thought to 
partake in the PING model because they are rapidly recruited by excitatory synaptic inputs, 
generate synchronous high frequency train of action potentials, and discharge single action 
potentials phase locked to fast network oscillations (Armstrong & Soltesz 2012, Bartos et al 
2007, Isaacson & Scanziani 2011). Therefore, local circuit abnormalities involving pyramidal 
cells and GABA interneurons (especially PV cells) in deep layer 3, essential for the generation 
of γ-frequency oscillations, support the logic that impairments in this cortical microcircuit may 
contribute to the neural substrate for working memory impairments in schizophrenia. 
 43 
1.5 GOALS AND RELEVANCE OF THIS DISSERTATION 
Understanding how dysfunction in DLPFC cortical circuits in deep layer 3 might give rise 
to the pathophysiology of altered γ-frequency oscillations and working memory deficits require 
an interrogation of the mechanisms by which these neuropathological alterations may arise, but 
also the normal developmental trajectories of these vulnerable microcircuits.  First, although 
previous studies have elucidated plausible molecular mechanisms that can produce dendritic 
spine deficits in subjects with schizophrenia, little is known about the cell-type specific 
alterations in signal transduction cascades in deep layer 3 pyramidal cells and a few questions 
remain unanswered. Therefore, based on previous studies, are CDC42-related gene alterations 
specific to deep layer 3 or pyramidal cells in this location (Chapter 2)? Are there additional 
CDC42 signaling pathway components that are perturbed in subjects with schizophrenia?  
Second, the deficit in dendritic spines should be associated with fewer excitatory afferents. 
Thus, are the dendritic spine deficits in DLPFC deep layer 3 pyramidal cells associated with 
fewer axospinous inputs from particular sources (Chapter 3)? In other words, are particular 
subpopulations of dendritic spines vulnerable in schizophrenia? Third, the presence and timing 
of the activity of pyramidal neurons, is regulated by inhibitory inputs mediated by GABAARs of 
varying subunit compositions that confer distinct functional properties to the receptor and 
influence the kinetics of GABA neurotransmission. Therefore, we sought to determine if the 
developmental trajectories of GABAAR subunit expression in primate DLPFC deep layer 3 
pyramidal neurons are protracted, subunit- and layer-specific (Chapter 4)? The developmental 
shifts in the expression of these subunits may modulate the characteristics of pyramidal cell 
firing and the maturation of behaviors such as working memory that depend on pyramidal cell 
activity. Understanding the normal maturation of cortical circuits in the monkey DLPFC is of 
paramount importance because aberrations in these circuits might underlie the core cognitive 
impairments in schizophrenia.    
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Therefore, the purpose of this dissertation is to ascertain the molecular (Chapter 2) and 
morphological (Chapter 3) alterations pertinent to dendritic spine pathology in deep layer 3 in 
subjects with schizophrenia and elucidate the developmental refinements (Chapter 4) in deep 
layer 3 pyramidal cells that are critical for the functional maturation of the DLPFC. Chapter 5 
concludes with a summary of the findings and proposed interpretation to our findings.    
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2.0  ALTERED EXPRESSION OF CDC42 SIGNALING PATHWAY COMPONENTS IN 
CORTICAL LAYER 3 PYRAMIDAL CELLS IN SCHIZOPHRENIA 
Adapted from: Datta D, Arion D, Corradi JP and Lewis DA (2015). Altered expression of CDC42 
signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia. Biological 
Psychiatry 78 (11): 775-785. 
2.1 INTRODUCTION 
Cognitive deficits, such as impairments in working memory, represent a core feature of 
schizophrenia (Kahn & Keefe 2013) and these impairments appear to reflect altered circuitry in 
the dorsolateral prefrontal cortex (DLPFC;(Weinberger 1987)). In particular, convergent lines of 
evidence from postmortem (Kristiansen et al 2007), neuroimaging (Merritt et al 2013) and 
pharmacological studies (Javitt & Zukin 1991) implicate aberrant glutamate neurotransmission 
in cortical dysfunction in schizophrenia (Coyle 2004, Konradi & Heckers 2003, Moghaddam 
2004). Pyramidal cells, the principal source of cortical glutamate neurotransmission, exhibit 
lower dendritic spine density (Garey et al 1998, Glantz & Lewis 2000, Konopaske et al 2014, 
Sweet et al 2009), shorter dendritic arbors (Glantz & Lewis 2000) and smaller somal volumes 
(Arnold et al 1995, Pierri et al 2001, Rajkowska et al 1998, Sweet et al 2003) in subjects with 
schizophrenia. These morphological aberrations appear to have laminar specificity as smaller 
pyramidal cell volumes and lower dendritic spine density were observed in deep layer 3 but not 
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in layers 5 or 6 (Kolluri et al 2005, Rajkowska et al 1998, Sweet et al 2004). None of these 
findings appeared to be attributable to antipsychotic medications or other co-morbid factors or 
potential confounds (Glausier & Lewis 2013) and therefore likely reflect the underlying disease 
process.   
Previous postmortem studies suggest that these morphological alterations in layer 3 
pyramidal cells may be the consequence of disturbed expression of genes that regulate the 
actin cytoskeleton (Hill et al 2006, Ide & Lewis 2010), which plays a critical role in dendritic 
spine formation and maintenance (Bonhoeffer & Yuste 2002, Koleske 2013, Negishi & Katoh 
2005, Tada & Sheng 2006). For example, transcript levels of the Rho GTPase cell division cycle 
42 (CDC42) are lower in DLPFC gray matter in subjects with schizophrenia and are positively 
correlated with layer 3 spine density measures (Hill et al 2006). The specificity of the spine 
density decrement on layer 3 pyramidal neurons may reflect the laminar-specific expression of 
certain molecules that interact with CDC42. Indeed, CDC42 effector proteins (CDC42EPs) are 
preferentially expressed in layers 2-3 of the human DLPFC (Arion et al 2007), and CDC42EP3 
messenger RNA (mRNA) expression was reported to be upregulated in schizophrenia (Ide & 
Lewis 2010). The combination of lower CDC42 and elevated CDC42EP3 was hypothesized to 
alter the integrity of the barrier formed by the septin family of proteins in the spine neck (Joberty 
et al 2001), rendering it less permeable to the influx of postsynaptic molecules that are 
necessary for spine plasticity in response to glutamate stimulation (Ide & Lewis 2010).    
These previous studies did not examine CDC42-related gene expression specifically in deep 
layer 3 or in pyramidal cells in this location. In addition, they did not address how altered CDC42 
signaling could disrupt the regulation of the assembly and disassembly of actin filaments 
through cofilin, a family of actin-binding proteins (Figure 5A). The activity of cofilin is 
downstream of a signaling pathway that involves the interaction between CDC42 and the p21-
activated serine/threonine protein kinases (PAK) family of proteins (Edwards et al 1999, 
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Hotulainen & Hoogenraad 2010). These proteins are activated upon binding of the guanosine 
triphosphate (GTP)-bound forms of CDC42 and activate (among other targets) the LIM domain-
containing serine/threonine protein kinases (LIMK1 and LIMK2) (Manser et al 1994, Parrini et al 
2002) which in turn regulate the actin-depolymerizing activity of cofilin (Chen et al 2006, 
Hotulainen et al 2005, Sumi et al 2001). Additionally, the activity of CDC42 is regulated by 
guanine nucleotide dissociation inhibitors such as ARHGDIA (Figure 5A), a class of molecules 
that inhibit the substitution of guanosine diphosphate (GDP) for GTP, suppressing GTPase 
activity (Newey et al 2005). Multiple regulators in the CDC42-PAK-LIMK pathway appear to be 
crucial for the actin cytoskeleton to maintain the stability of spine structure.  
To determine if alterations in the CDC42-PAK-LIMK signaling pathway could contribute to 
the spine deficits on deep layer 3 pyramidal cells in schizophrenia, we conducted targeted gene 
expression analyses at laminar and cellular levels of specificity. We used laser microdissection 
to collect samples of DLPFC deep layer 3 from 56 matched pairs of schizophrenia and 
comparison subjects, and of individual deep layer 3 pyramidal cells in a subset of these 
subjects, and we measured the expression levels of CDC42-related mRNAs in these samples 
using reverse transcriptase quantitative polymerase chain reaction (qPCR) and microarray, 
respectively. 
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Figure 5. Schematic diagrams of cell division cycle 42 (CDC42)-CDC42 effector protein (CDC42EP) 
and CDC42-p21-activated serine/threonine protein kinases (PAK)-LIM domain-containing 
serine/threonine protein kinases (LIMK) signaling pathways and their proposed roles in spine 
deficits in schizophrenia. 
 (A) CDC42 signaling pathways that regulate the contribution of F-actin to dendritic spine 
structure. The activity of CDC42 is inhibited by ARHGDIA, a guanine nucleotide dissociation 
inhibitor that suppresses intrinsic GTPase activity. For the CDC42-CDC42EP pathway, 
activated CDC42 inhibits CDC42EPs, which dissociate the complex of septin filaments 
 49 
consolidated by SEPT7 in the spine neck. This opening of the septin barrier permits an influx of 
molecules from the parent dendrite that facilitate F-actin mediated growth of spines in response 
to excitatory inputs. For the CDC42-PAK-LIMK pathway, CDC42 activates PAK, which in turn 
activate LIMK. Activation of this cascade inhibits the cofilin family of actin depolymerizing 
proteins that regulate the turnover of F-actin required for structural stability of spines. Arrows 
indicate activation and blunted lines indicate inhibition of each target. (B) Subjects with 
schizophrenia exhibit up- or down-regulation for multiple components of the CDC42-CDC42EP 
and CDC42-PAK-LIMK pathways in DLPFC deep layer 3 pyramidal cells. Solid short arrows 
next to transcript indicates reported evidence in this paper; open short arrows indicate 
previously reported evidence (Ide & Lewis 2010, Rubio et al 2012). (C) Predicted functional 
consequences in schizophrenia of altered CDC42 signaling pathways in DLPFC deep layer 3 
pyramidal neurons. Higher levels of ARHGDIA would directly inhibit the activation of CDC42 
holding it in an inactive GDP-bound state. In the CDC42-CDC42EP pathway, the effect of higher 
levels of ARHGDIA would be amplified by the combination of lower levels of CDC42 and higher 
levels of CDC42EPs, impairing the transient opening of the septin barrier in spine necks in 
response to excitatory inputs, and thereby suppressing the influx of molecules into the spine 
head required for spine growth and maintenance (Ide & Lewis 2010). In the CDC42-PAK-LIMK 
pathway, the combination of higher levels of ARHGDIA mRNA, lower levels of CDC42 mRNAs 
and lower levels of PAK mRNAs (given the much higher expression levels of PAK1 than PAK3, 
the down-regulation of PAK1 and PAK2 is predicted to have the dominant effect) would all 
converge to increase phosphorylation (inactivation) of cofilin family proteins and suppress actin 
depolymerization, resulting in F-actin destabilization and spine loss. The up-regulated levels of 
LIMK1/2 and PAK3 may represent compensatory, but inadequate, responses to mitigate the 
negative impact on F-actin dynamics of the upstream molecular pathology in this pathway. 
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2.2 MATERIALS AND METHODS 
2.2.1 Human subjects 
Human brain specimens (N=112) were obtained during routine autopsies conducted at 
the Allegheny County Medical Examiner’s Office (Pittsburgh, PA, USA) following consent 
obtained from the next-of-kin. An independent committee of experienced research clinicians 
made consensus DSM-IV (Psychiatric Association 1994) diagnoses or confirmed the absence of 
a psychiatric diagnosis for each using structured interviews with family members and review of 
prior medical records (Volk et al 2010). To control for experimental variance, each subject with 
schizophrenia (N=34) or schizoaffective disorder (N=22) was matched to one healthy 
comparison subject for sex and as closely as possible for age (Appendix A; see Supplemental 
Table S1 for details on individual subjects). As in prior studies (Curley et al 2011, Eggan et al 
2012, Hashimoto et al 2008b, Hashimoto et al 2003, Kimoto et al 2014), we consider 
schizoaffective disorder to be a variant of schizophrenia based on the DSM-IV requirement for 
the class A criteria of schizophrenia to be present, in the absence of mood symptoms. Samples 
from both subjects in a pair were processed together throughout all stages of the study. Subject 
groups (Table 1) did not differ in mean age, postmortem interval (PMI), RNA integrity number 
(RIN), tissue storage time at -80°C or race. Brain pH significantly differed between groups 
(t=2.51; df=55, p=0.015), although the mean difference between groups was very small (0.1 pH 
unit) and the biological significance, if any, of this difference is unclear. Every subject had RIN ≥ 
7.0 indicating an excellent quality of total RNA. All procedures were approved by the University 
of Pittsburgh’s Committee for the Oversight of Research Involving the Dead and Institutional 
Review Board for Biomedical Research. 
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Table 1. Characteristics of human subjects 
 
 
 
 
*Age, PMI, RIN and Brain pH are represented as mean ± SD. M, Male; F, Female; W, White; B, 
Black.  
 
For the schizophrenia subject groups, the table indicates the number of subjects for the 
potential confounding variables such as, diagnosis of schizoaffective disorder; history of 
substance dependence or abuse; nicotine use at the time of death (ATOD); use of 
antipsychotics, antidepressants, or Benzo/VPA ATOD; or death by suicide. Benzo/VPA, 
benzodiazepines or valproic acid.  
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2.2.2 Laser microdissection procedure 
We conducted two studies at different levels of resolution: 1) cortical layer-specific 
measures of gene expression in strips of tissue containing only DLPFC deep layer 3 (N=56 
pairs; Table 1) and 2) cell-type specific measures of gene expression in DLPFC deep layer 3 
pyramidal cells (N=36 pairs; Table 1).  
For both studies, the right hemisphere of each brain was blocked coronally, frozen and 
stored at -80°C (Volk et al 2000). Cryostat sections (12 μm) were cut and thaw-mounted onto 
glass PEN membrane slides (Leica Microsystems, Bannockburn, IL) that had been UV-treated 
at 254nm for 30 minutes. The sections were dried and stored at -80 °C. On the day of the 
microdissection, sections were stained for Nissl substance with thionin (Figure 6A). Using a 
Leica microdissection system (LMD 6500; 5x objective), DLPFC layer 3 was identified in 
portions of the section cut perpendicular to the pial surface. For the laminar microdissections, 
strips (~10 million μm2) containing deep layer 3 (defined as the zone from the layer 3-4 border to 
35% of the distance from the pial surface to the layer 6-white matter border) in DLPFC area 9 
were collected from each subject using a 5x objective (Figure 6B). In nearby tissue sections, 
individual deep layer 3 pyramidal cells (~200 pyramidal cells per subject), identified based on 
their characteristic somal morphology and the presence of a prominent apical dendrite directed 
radially toward the pia mater (Figure 6C, D), were captured using a 40x objective as previously 
described (Arion et al 2015). 
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Figure 6. Laser microdissection approach. 
 (A) Nissl stain of human DLPFC showing the location (dashed rectangle) of deep layer 3 which 
was sampled. Numbers indicate cortical layers and WM indicates white matter. Calibration bar 
equals 300 μm. (B) Nissl stained section after removal of strip of deep layer 3 by laser 
microdissection. Calibration bar equals 700 μm. (C and D) Representative images of individual 
deep layer 3 pyramidal cells being captured by laser microdissection in DLPFC deep layer 3. 
Calibration bar equals 30 μm.  
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2.2.3 qPCR analyses 
For each sample, RNA was extracted and purified using the QIAGEN RNeasy Plus 
Micro Kit (QIAGEN Inc, Valencia, California). Total RNA was converted to complementary DNA 
using the qScriptTM cDNA SuperMix (Quanta Biosciences, Gaithersburg, MD). Forward and 
reverse primers were designed for each target mRNA to generate PCR amplicons of 85-120 
base pairs. The specificity and efficiency of qPCR amplification for each target mRNA was 
demonstrated by: 1) high amplification efficiency (>92%) across a wide range of cDNA dilutions 
(Appendix A; Supplemental Table S3) and 2) single products demonstrated in dissociation 
curve analysis.  
Three internal reference transcripts (Beta-Actin [ACTB], Cyclophilin A [PPIA] and 
guanine nucleotide binding protein [GNAS]), selected based on their stable expression across 
the subjects in this cohort regardless of diagnosis (Volk et al 2014), were used to normalize 
data. Transcript expression levels of CDC42-related mRNAs (ARHGDIA, CDC42, CDC42EP4, 
PAK1, PAK2, PAK3, LIMK1 and LIMK2) were quantified using qPCR using Power SYBR green 
dye (Applied Biosystems, Foster City, CA) and ViiATM 7 Real-Time PCR system (Life 
Technologies, Carlsbad, CA). The cDNA samples from three matched pairs of schizophrenia 
and control subjects were processed together on the same 384-well qPCR plate with four 
replicates per primer set. 
2.2.4 Microarray analyses 
We used a microarray approach to quantify cellular expression of CDC42-related 
mRNAs in deep layer 3 pyramidal cells as previously described (Arion et al 2015). For 
transcriptome analysis, the RNA was extracted using the QIAGEN RNeasy Plus Micro Kit. The 
extracted RNA was transcribed into cDNA and subjected to a single round of amplification using 
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the Ovation Pico WTA System (Nugen Technologies, San Carlos, CA). After amplification, the 
cDNA was labeled using the Encore Biotin module and loaded on an Affymetric GeneChip® HT 
HG-U133+ PM Array Plate designed to assess expression levels of transcripts in the human 
genome (Affymetrix, Santa Clara, CA). 
2.2.5 Antipsychotic-exposed monkeys 
Experimentally naïve, male, young adult, long-tailed macaque monkeys (Macaca 
fascicularis) received twice daily oral doses of olanzapine, haloperidol or placebo (n=6 monkeys 
per group) for 17-27 months (Dorph-Petersen et al 2005). The doses of each antipsychotic 
medications produced trough serum levels known to be in the therapeutic range for the 
treatment of schizophrenia (Volk et al 2012). One monkey from each of the three groups was 
euthanized on the same day (Hashimoto et al 2008a), pyramidal cells were captured (Datta et al 
2015), and subjected to microarray analysis (Appendix A in Supplement 1). 
2.2.6 Data analysis and statistics 
qPCR analyses. The comparative threshold cycle (CT) method was used in which 
transcript levels are normalized to the geometric mean of the three reference genes (ACTB, 
PPIA and GNAS). The difference in cycle threshold for each transcript was assessed by 
deducting the mean cycle threshold for the three reference genes from the cycle threshold of 
the target transcript. Because the difference in cycle threshold (dCT) represents the log2-
transformed expression ratio of each target transcript to the geometric mean of the three 
reference genes, the relative expression ratio of each target transcript is determined as 2-dCT 
(Volk et al 2010). We performed two analyses of covariance (ANCOVA) models on the 
expression ratio data for each transcript. Because subjects were selected and processed as 
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pairs, the first paired ANCOVA model included mRNA level as the dependent variable; 
diagnostic group as the main effect; subject pair as a blocking factor; and tissue storage time, 
brain pH and RIN as covariates. Subject pairing may be considered an attempt to balance 
diagnostic groups for sex and age, and to account for the parallel processing of tissue samples 
from a pair, and thus to not be a true statistical paired design. Consequently, a second unpaired 
ANCOVA model was performed that included all covariates (i.e., age, sex, postmortem interval, 
storage time, RIN and pH). All statistical tests were conducted with α-level= 0.05. 
We also assessed the potential influence of other factors that are frequently co-morbid 
with the diagnosis of schizophrenia using ANCOVA models. For these analyses, we compared 
subjects with schizophrenia using each variable (sex; diagnosis of schizoaffective disorder; 
history of substance dependence or abuse; nicotine use at the time of death; use of 
antipsychotics, antidepressants, or benzodiazepines and/or sodium valproate at the time of 
death; or death by suicide) as the main effect and age, tissue storage time, brain pH, PMI, and 
RIN as covariates. 
Reported ANCOVA statistics include only those covariates that were statistically 
significant. As a result, the reported degrees of freedom vary across analyses. 
Microarray analyses. The probe sets were filtered and paired t-tests were performed using the 
Random Intercept Model with Bayesian Information Criterion variable selection (Wang et al 
2012). Differentially expressed gene discovery was conducted using meta-analysis and an 
adaptively weighted (AW) Fisher’s method (Li & Tseng 2011) was applied. Meta-analyzed p-
values from AW were then adjusted by the Benjamini-Hochberg procedure for multiple 
comparisons to control false discovery rate (Arion et al 2015, Benjamini & Hochberg 1995). 
Antipsychotic-exposed monkey analyses. An ANCOVA model with the level of pre-specified 
mRNAs as the dependent variable, treatment group as the main effect, and triad as a blocking 
factor was employed. For each transcript of interest, the values of all probe sets targeting that 
transcript were averaged within each animal. 
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2.3 RESULTS 
2.3.1 Expression of CDC42-related mRNAs in DLPFC deep layer 3 
In subjects with schizophrenia, mean mRNA levels of ARHGDIA, a common upstream 
regulator of pathways related to CDC42 signaling (Figure 5B), were higher in tissue 
homogenates of DLPFC deep layer 3 from the 56 subject pairs (+9.6%; paired: F1,55=6.02, 
p=0.017; unpaired: F1,108=1.99, p=0.161; Figure 7A) and in deep layer 3 pyramidal cells from 
the 36 subject pairs (+14.5%; p=0.041; Figure 7B). Although mean CDC42 mRNA levels were 
not significantly lower (-3.8%; paired: F1,55=1.43, p=0.237; unpaired: F1,110=0.29, p=0.585; 
Figure 7C) in the deep layer 3 tissue homogenates, they were significantly lower (-14.7%; 
p<0.001; Figure 7D) in DLPFC deep layer 3 pyramidal cells. Consistent with prior studies (Ide & 
Lewis 2010) of the CDC42-CDC42EP filament pathway (Figure 5B), mean CDC42EP4 
transcript levels were significantly higher in the subjects with schizophrenia in DLPFC deep 
layer 3 tissue homogenates (+30.2%; paired: F1,54=7.85, p=0.007; unpaired: F1,108=13.76, 
p<0.001; Figure 7E) and pyramidal cells (+39.4%; p=0.003; Figure 7F).  
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Figure 7. Expression levels of CDC42 signaling pathway components in DLPFC deep layer 3. 
(A,B) Rho GDP dissociation inhibitor encoded by ARHGDIA (C,D) Cell division cycle 42 
(CDC42), (E,F) CDC42 Effector Protein 4 (CDC42EP4) mRNA levels in DLPFC deep layer 3 
tissue homogenates (A,C,E) and DLPFC deep layer 3 pyramidal cells (B,D,F) from 
schizophrenia and comparison subjects. Scatter plots show the transcript levels for each 
matched pair of a comparison and schizophrenia subject. Values above the unity line reflect 
pairs in which transcript levels are higher in the schizophrenia subject relative to the comparison 
subject. Values below the unity line reflect pairs in which transcript levels are lower in the 
schizophrenia subject relative to the comparison subject. 
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To interrogate the integrity of the CDC42-PAK-LIMK signaling pathway that regulates the 
assembly and disassembly of actin filaments through cofilin, we evaluated the expression level 
of several members of this pathway (Figure 5B). Mean transcript levels for PAK1 did not differ 
between groups in tissue homogenates of DLPFC deep layer 3 (paired: F1,55=0.08, p=0.774; 
unpaired: F1,110=0.04, p=0.841; Figure 8A) but were significantly lower in pyramidal cell 
samples from schizophrenia subjects (-11.6%; p=0.002, Figure 8B). In contrast, in the subjects 
with schizophrenia mean transcript levels were higher for PAK2 in tissue homogenates of 
DLPFC deep layer 3 (+21.4%; paired: F1,54=9.14, p=0.004; unpaired: F1,108=12.80, p=0.001; 
Figure 8C) but were significantly lower in deep layer 3 pyramidal cells (-21.5%; p=0.013, Figure 
8D). This discrepancy between layer-specific and cell type-specific measures for PAK2 could 
represent opposing patterns of change in pyramidal cells relative to other cell types (i.e., 
interneurons and glial cells) in the illness. Furthermore, the difference in sample size between 
qPCR (N=56 pairs) and microarray (N=36 pairs) analyses do not account for the marked 
difference in expression as the mean transcript levels were higher for PAK2 (+24.2%) in tissue 
homogenates from the same 36 pairs used for microarray analyses. Mean transcript levels for 
PAK3 were significantly higher in both tissue homogenates of DLPFC deep layer 3 (+18.6%; 
paired: F1,54=13.03, p=0.001; unpaired: F1,107=7.33, p=0.008; Figure 8E) and pyramidal cells 
(+15.8%; p=0.0027; Figure 8F). Finally, in the subjects with schizophrenia mean transcript 
levels for LIMK1 were modestly higher in deep layer 3 tissue homogenates (+9.9%; paired: 
F1,55=3.70, p=0.060; unpaired: F1,109=3.63, p=0.059; Figure 8G) and were significantly higher in 
pyramidal cells (+22.7%; p=0.031; Figure 8H). Consistent with these changes, mean transcript 
levels for LIMK2 were significantly higher in both deep layer 3 tissue homogenates (+63.4%; 
paired: F1,55=29.53, p<0.001; unpaired: F1,108=27.95, p<0.001; Figure 8I) and pyramidal cells 
(+22.2%; p=0.030; Figure 8J). 
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Figure 8. Expression levels of CDC42 signaling pathway components in DLPFC deep layer 3.  
(A,B) p21 protein (CDC42/RAC)-activated kinase 1 (PAK1), (C,D) p21 protein (CDC42/RAC)-
activated kinase 2 (PAK2), (E,F) p21 protein (CDC42/RAC)-activated kinase 3 (PAK3), (G,H) 
LIM domain kinase 1 (LIMK1), (I,J) LIM domain kinase 2 (LIMK2) mRNA levels in DLPFC deep 
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layer 3 tissue homogenates (A,C,E,G,I) and DLPFC deep layer 3 pyramidal cells (B,D,F,H,J) 
from schizophrenia and comparison subjects. Scatter plots show the transcript levels for each 
matched pair of a comparison and schizophrenia subject. Values above the unity line reflect 
pairs in which transcript levels are higher in the schizophrenia subject relative to the comparison 
subject. Values below the unity line reflect pairs in which transcript levels are lower in the 
schizophrenia subject relative to the comparison subject. 
2.3.2 Effects of psychotropic medications and other confounding variables 
For the transcripts that were significantly altered in the same direction in both the deep 
layer 3 tissue homogenates and pyramidal cell samples from the subjects with schizophrenia, 
we evaluated the effect of potential confounding variables in the qPCR data. In the 56 
schizophrenia subjects, levels of ARHGDIA (Figure 9A), CDC42EP4 (Figure 9B), LIMK2 
(Figure 9C) mRNAs did not differ as a function of sex, diagnosis of schizoaffective disorder; 
history of substance dependence or abuse; nicotine use at the time of death; use of 
antipsychotics, antidepressants, or benzodiazepines and/or sodium valproate at the time of 
death; or death by suicide (all F1,48≤2.39; all p≥0.13). Similar results (all F1,48≤1.78; all p≥0.19) 
were found for the other transcripts (i.e., PAK2, PAK3) that were significantly altered by RT-
PCR. 
To interrogate the potential effect of long-term exposure to typical or atypical 
antipsychotics, we also evaluated CDC42-related mRNAs in DLPFC deep layer 3 pyramidal 
cells from monkeys chronically exposed to olanzapine, haloperidol or placebo. Levels of 
CDC42-related mRNAs did not significantly differ among these three groups of monkeys (Table 
2). Serum levels of antipsychotic medications were not significantly correlated with any gene 
expression measures (all lrl < 0.75; all p > 0.10).   
 
 62 
 
 
Figure 9. Effects of co-morbid factors on CDC42 signaling pathway components.  
The effect of co-morbid factors on (A) Rho GDP dissociation inhibitor encoded by ARHGDIA (B) 
CDC42 Effector protein 4 and (C) LIM domain kinase 2 mRNA expression levels in subjects with 
schizophrenia in DLPFC deep layer 3 tissue homogenates. For each panel, the circles 
represent mRNA expression levels for individual schizophrenia subjects by qPCR and the bars 
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represent mean mRNA levels for the indicated group. Numbers at the bottom of bars indicate 
the number of subjects with schizophrenia per group. None of these confounding variables were 
significant for any of the transcripts (all F1,48≤2.39, all p≥0.13). Two subjects had an 
undetermined manner of death and were not included in the death by suicide analysis. Six 
subjects had unknown nicotine use at the time of death and were not included in the nicotine 
analysis. Benzo/VPA, benzodiazepines or valproic acid. 
 
 
 
Table 2. Summary of differences by transcript in antipsychotic-exposed monkeys 
 
 
 
ANCOVA, analysis of covariance 
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2.4 DISCUSSION 
In this study, we found that subjects with schizophrenia exhibit altered gene expression, 
both up- and down-regulation, for components of the CDC42-PAK-LIMK pathway in DLPFC 
deep layer 3 tissue homogenates and pyramidal cells (Figure 5B, right side). In addition, we 
confirmed and extended to the cell type-specific level, earlier findings of altered expression in 
the CDC42-CDC42EP pathway (Figure 5B, left side). The levels of some transcripts (i.e., 
CDC42EP4, ARHGDIA, PAK3, LIMK1 and LIMK2) were significantly altered in schizophrenia, 
with the same direction and similar magnitude of difference from comparison subjects, in layer 3 
and pyramidal cell samples, as measured with qPCR and microarray analyses, respectively. In 
contrast, the levels of other transcripts (i.e., CDC42, PAK1) were significantly altered only in 
deep layer 3 pyramidal cell samples, but showed the same direction of change in the layer 3 
tissue homogenates, suggesting that these alterations are specific to or at least enriched in, 
pyramidal cells. These transcript alterations may reflect the disease process in schizophrenia 
because none of these changes were attributable to antipsychotic medications or other factors 
frequently co-morbid with schizophrenia. Our findings support the notion that altered signaling in 
the CDC42-PAK-LIMK pathway could perturb the regulation of the assembly and disassembly of 
actin filaments through cofilin, and in concert with alterations in the CDC42-CDC42EP pathway, 
could contribute to the lower density of dendritic spines that is most pronounced in deep layer 3 
pyramidal cells in the DLPFC of subjects with schizophrenia. 
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2.4.1 Differences in layer-specific vs. cell type-specific pathology in 
schizophrenia 
The assessment of molecular pathology at both laminar and cellular levels of resolution 
revealed differences in gene expression in schizophrenia that might be cell type-specific. For 
example, disease-related differences in the levels of CDC42 and PAK1 mRNAs detected in 
DLPFC deep layer 3 pyramidal neurons, but not in tissue homogenates from the same laminar 
location in the same subjects, support the idea that these findings are pyramidal cell-specific. 
Measures of gene expression in gray matter or even a specific cortical layer may obscure 
findings that are cell type-specific. Consistent with this idea, recent transcriptome analyses 
revealed substantial differential expression in schizophrenia of transcripts related to 
mitochondrial function in deep layer 3 pyramidal neurons and of transcripts related to the 
ubiquitin-proteasome system in layer 5 pyramidal cells (Arion et al 2014), alterations that were 
not detected in layer-specific transcriptome studies conducted in the DLPFC (Arion et al 2007). 
Similarly, previous studies in total gray matter tissue homogenates revealed a modest reduction 
(-6%) in levels of GABAA α1 subunit mRNA (Hoftman et al 2015), whereas dual-label in situ 
hybridization studies showed that mean GABAA α1 subunit mRNA expression was significantly 
40% lower in deep layer 3 pyramidal cells, but was not altered in interneurons in the same layer 
(Glausier & Lewis 2011). Additionally, findings using laser microdissection to dissect neuronal 
populations in the thalamus from subjects with schizophrenia revealed lower expression of 
transcripts encoding glutamate receptor subunits and components of the postsynaptic scaffold 
in relay neurons, but not in a mixed population of glial cells and interneurons (Sodhi et al 
2011).Thus, gene expression analyses at the level of individual cell types reveal distinctive 
alterations that are essential to understanding molecular pathology in the context of the neural 
circuits formed by different classes of neurons. 
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2.4.2 Contribution of CDC42-related signaling to dendritic spine abnormalities in 
DLPFC layer 3 pyramidal cells 
Signaling through CDC42 pathways regulates the polymerization of the actin 
cytoskeleton and thus is essential for the maturation of filopodia into spines and for the 
maintenance of a normal complement of dendritic spines. The combined findings of the present 
and prior studies suggest at least three different patterns of molecular disturbances in CDC42 
signaling that could contribute to spine deficits preferentially on deep layer 3 pyramidal cells in 
schizophrenia.  
First, our findings highlight a schizophrenia-related alteration in a regulatory component 
of the Rho family of GTPases, including CDC42. Similar to other members of this family, CDC42 
cycles between an active-GTP bound state and an inactive GDP-bound state (Luo 2000). The 
activity of these GTPases is regulated by guanine nucleotide dissociation inhibitors, such as 
ARHGDIA, which interacts with CDC42 (Gorvel et al 1998), suppresses the exchange of GDP 
for GTP and renders CDC42 inactive (Hoffman et al 2000). Our findings of higher expression 
levels of ARHGDIA in deep layer 3 pyramidal cells (Figure 5B) suggest that CDC42 is more 
likely to be held in an inactive-GDP bound state in subjects with schizophrenia. In combination 
with lower levels of CDC42 (Figure 5B), the capacity of both the CDC42-CDC42EP and 
CDC42-PAK-LIMK signaling pathways to modulate the actin filaments that form the structural 
framework of dendritic spines would be predicted to be impaired in deep layer 3 pyramidal 
neurons in schizophrenia (Figure 5C). 
Second, the prominence of dendritic spine abnormalities in deep layer 3 pyramidal 
neurons of subjects with schizophrenia has been proposed to be the consequence of altered 
signaling through molecules that are expressed in a layer-specific fashion (Ide & Lewis 2010). 
For example, CDC42 effector protein (CDC42EP) mRNAs are preferentially expressed in layer 
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3 of the human DLPFC (Arion et al 2007). We previously demonstrated upregulation of 
CDC42EP3 in layer 3 of subjects with schizophrenia (Ide & Lewis 2010), and we showed in the 
present study that CDC42EP4 is upregulated in layer 3 pyramidal cells.  According to the 
previously proposed model for the CDC42-CDC42EP pathway (Figure 5A), the transient 
activation of CDC42 that normally occurs in individual spines after glutamate stimulation 
disrupts the CDC42EP-mediated assembly of the septin barrier consolidated by SEPT7 in the 
spine neck, enabling entrance into the spine head of the postsynaptic molecules, second 
messengers and cytoskeleton proteins necessary for F-actin mediated growth of spines and 
synaptic potentiation (Ide & Lewis 2010). In schizophrenia, the effect of higher levels of 
ARHGDIA would be amplified by the combination of lower levels of CDC42 and higher levels of 
CDC42EPs (Figure 5B) which impairs the opening of the septin barrier in response to 
glutamate stimulation, and thereby inhibits the influx of molecules into the spine head required 
for spine growth and maintenance, contributing ultimately to spine loss (Figure 5C). 
Third, in this study we identified altered expression of several genes in the CDC42-PAK-
LIMK pathway. In this pathway, activated, GTP-bound CDC42 activates the PAK proteins which 
in turn activate LIMK proteins. This signaling cascade inhibits the cofilin family of actin 
depolymerizing proteins that regulate the assembly and disassembly of F-actin required for 
structural stability of spines (Chia et al 2013, Ouyang et al 2005, Scott & Olson 2007, Sumi et al 
1999) (Figure 5A). Our findings from deep layer 3 pyramidal cells indicate that schizophrenia is 
associated with lower expression of PAK1/2 proteins (Figure 5B) which would further reduce 
activity in the CDC42-PAK-LIMK pathway due to the combination of elevated expression of 
ARHGDIA and lower expression of CDC42 and contribute to spine deficits. Consistent with this 
interpretation, down-regulation of CDC42 and PAK1 proteins results in impaired long-term 
maintenance of spines (Murakoshi et al 2011), and over-expression in vitro of dominant 
negative forms of PAK1 reduces spine density (Hayashi et al 2007, Zhang et al 2005). A more 
recent study demonstrated that pharmacological manipulation of downstream signaling 
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components of the actin cytoskeleton such as the PAK proteins ameliorated synaptic deficits 
induced by DISC1 knockdown. Although this finding suggests that PAK proteins might serve 
therapeutic targets, future experiments need to delineate the pattern of alterations in multiple 
signaling cascades in subjects with schizophrenia that can converge on these downstream 
signaling components (Hayashi-Takagi et al 2014). In contrast, we found higher expression 
levels of LIMK1/2 and PAK3 in deep layer 3 pyramidal cells. We interpret this finding as a 
compensatory, but inadequate, response to the multiple upstream alterations that increase 
phosphorylation (inactivation) of cofilin family proteins and suppress actin depolymerization, 
resulting in F-actin destabilization and a reduction in spine number on deep layer 3 pyramidal 
cells (Figure 5C).  
In concert, these findings are consistent with other data suggesting that alterations in 
deep layer 3 pyramidal cells are “upstream” in the disease process of schizophrenia (Arion et al 
2014, Lewis et al 2012) or perhaps even directly related to genetic risk for the illness. For 
example, recent findings highlight the CDC42-PAK-LIMK regulatory network as a pathogenetic 
factor in actin cytoskeleton dysregulation in schizophrenia (Zhao et al 2015). In addition, de 
novo mutations in proteins that regulate actin filament dynamics are preferentially found in 
individuals with schizophrenia (Fromer et al 2014), and copy number variations at the 15q11.2 
locus implicate genes such as CYFIP1 that regulate dendritic complexity and spine actin 
dynamics (Pathania et al 2014, Yoon et al 2014).  
2.4.3 Conclusion 
In concert with previous findings of alterations in other mediators (e.g., RhoA, Duo, 
Reelin, DISC1) of spine morphogenesis in schizophrenia (Arnsten et al 2012, Brandon & Sawa 
2011, Erdely et al 2006, Guillozet-Bongaarts et al 2014, Hill et al 2006, Ide & Lewis 2010, 
Lipska et al 2006a, Lipska et al 2006b, Mirnics et al 2001, Rubio et al 2012), the findings of the 
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present study suggest that aberrant CDC42 signaling through two different pathways might 
represent a molecular pathology that converges on dendritic spine deficits specifically in deep 
layer 3 pyramidal cells (Glantz & Lewis 2000, Kolluri et al 2005) in subjects with schizophrenia. 
These observations support the notion that the actin cytoskeleton is dysregulated in 
schizophrenia. Because both spines and the axon terminals that innervate them are rich in 
actin, this dysregulation could result in lower excitatory drive to DLPFC deep layer 3 pyramidal 
cells (Lewis et al 2012) and a reduced need for energy production in these neurons (Arion et al 
2014). 
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3.0  IDENTITY OF INPUTS TO DENDRITIC SPINES ON DEEP LAYER 3 
PYRAMIDAL CELLS IN THE DORSOLATERAL PREFRONTAL CORTEX IN 
SCHIZOPHRENIA 
3.1 INTRODUCTION 
Cognitive impairments, including deficits in working memory, represent a core feature of 
schizophrenia (Kahn & Keefe 2013). Working memory is dependent on the sustained, 
synchronized firing of pyramidal cells in deep layer 3 of the dorsolateral prefrontal cortex 
(DLPFC), through recurrent excitatory interactions between spatially segregated clusters of cells 
(Goldman-Rakic 1995). Alterations in the circuitry of the DLPFC, such as morphological 
perturbations to pyramidal cells in deep layer 3, appear to contribute to the pathophysiology of 
working memory deficits in schizophrenia (Lewis et al 2012). For example, the density of 
dendritic spines, the principal site of excitatory inputs to pyramidal cells, is lower on the basilar 
dendrites of DLPFC deep layer 3 pyramidal cells in schizophrenia subjects (Garey et al 1998, 
Glantz & Lewis 2000, Konopaske et al 2014). These morphological alterations appear to be 
layer-specific as spine density in DLPFC layer 5 and 6 pyramidal cells did not differ between 
subject groups (Kolluri et al 2005). Consistent with these observations, the somal volume of 
deep layer 3 pyramidal cells in the DLPFC and other cortical areas, which correlates with the 
size of the dendritic tree and axonal arbor of a cell, is modestly reduced in subjects with 
schizophrenia, but showed no difference between subject groups in layer 5 (Pierri et al 2001, 
Rajkowska et al 1998, Sweet et al 2004). These layer-specific structural changes do not appear 
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to be attributable to antipsychotic medication history and are thought to reflect the disease 
process (Pierri et al 2001, Sweet et al 2009).  
The layer-specificity of the morphological alterations in pyramidal cells in schizophrenia, 
such as lower dendritic spine density, raises questions about how this might arise. One 
possibility is that the spine deficits in DLPFC deep layer 3 pyramidal cells are the result of an 
intrinsic abnormality in pyramidal cells which prevents the maintenance of a normal repertoire of 
excitatory inputs (Glausier & Lewis 2013, Lewis & Gonzalez-Burgos 2006). Consistent with this 
idea, altered gene expression of certain proteins that are crucial in modulating dendritic spine 
structure and plasticity have been reported in layer-specific and cell type-specific studies in 
DLPFC deep layer 3 in schizophrenia and the mRNA expression levels of these genes correlate 
with spine density measures in deep layer 3 pyramidal cells (Datta et al 2015, Hill et al 2006, Ide 
& Lewis 2010). Furthermore, dysregulation of the molecular mechanisms that are necessary for 
the formation and maintenance of dendritic spines is also associated with cognitive, 
psychomotor and social impairments in transgenic mouse models, reminiscent of schizophrenia-
like symptoms (Cahill et al 2009, Kim et al 2013, Kim et al 2015). However, an alternative 
possibility is that the reduction in excitatory inputs to DLPFC deep layer 3 pyramidal cells in 
schizophrenia is a consequence of a layer-specific reduction in the number of afferents.  
Although dendritic spines receive excitatory synaptic inputs primarily from corticocortical 
glutamate axon terminals, 15-30% of dendritic spines also receive synaptic input from GABA 
axon terminals (Beaulieu et al 1992, Jones & Powell 1969, Kubota et al 2007, van Versendaal 
et al 2012). Interestingly, the magnitude of reduction in dendritic spine density in schizophrenia 
parallels the proportion of dually innervated dendritic spines that receive both Gray’s Type I 
(asymmetrical; putatively excitatory) and type II (symmetrical; putatively inhibitory) synapses 
(Glantz & Lewis 2000, Gray 1959, Knott et al 2002, Kubota et al 2007, van Versendaal et al 
2012). In addition, in layer 3 of the monkey PFC area 9, a large fraction (44%) of PV-
immunoreactive (IR) axon terminals exclusively formed type II synapses onto dendritic spines 
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(Melchitzky et al 1999), the same layer where alterations in PV-basket interneurons are 
particularly pronounced in schizophrenia (Curley et al 2011, Glausier et al 2014, Hashimoto et al 
2008, Hashimoto et al 2003). In a recent study, activation of GABAARs on individual dendritic 
spines by uncaging of caged GABA that mimics IPSCs or tonic application of GABAAR agonist 
muscimol, suppressed increases in cytosolic Ca2+ and was found to promote spine shrinkage 
and elimination by a mechanism that involved the actin cytoskeleton depolymerizing factor 
cofilin/ADF (Hayama et al 2013), a downstream target of the CDC42-PAK-LIMK pathway that is 
disrupted in schizophrenia (Chapter 2) (Datta et al 2015). Moreover, GABA inputs onto spines 
have significantly higher turnover rates than GABA inputs onto the dendritic shaft, suggesting 
that inhibitory inputs onto spines are dynamically regulated by activity in local circuits (Chen et 
al 2012, Knott et al 2002). Therefore, GABA interneurons appear to be primed to gate the 
postsynaptic activity in individual dendritic spines and directly modulate excitatory synaptic 
activity within dendrites (Chiu et al 2013). However, previous studies in postmortem tissue in 
subjects with schizophrenia in the DLPFC have not investigated the possibility of deficits in the 
proportion of dual-innervated spines.  
In order to determine if a subpopulation of spines are preferentially affected in 
schizophrenia, we sought to examine if dendritic spine pathology in schizophrenia reflects fewer 
1) dual-innervated dendritic spines receiving an inhibitory synapse and corticocortical input, 
and/or 2) dendritic spines receiving only a corticocortical input. To distinguish between these 
possibilities, we used recent advances in multi-label fluorescence immunohistochemistry and 
spinning disk confocal microscopy in postmortem human tissue (Fish et al 2008, Rocco et al 
2015), to quantify the relative density of the various subpopulations of spines. These analyses 
were conducted in deep layer 3 and 4 of DLPFC area 9 in tissue sections from 20 matched 
pairs of schizophrenia and healthy comparison subjects and provide the first quantitative 
assessment of dendritic spine subpopulations in schizophrenia. 
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3.2 MATERIALS AND METHODS 
3.2.1 Human Subjects 
 Brain specimens (N=40) were obtained during routine autopsies conducted at the 
Allegheny County Office of the Medical Examiner (Pittsburgh, Pennsylvania) after consent for 
donation was obtained from next of kin. An independent committee of experienced research 
clinicians made consensus DSM-IV diagnoses for each subject using structured interviews with 
family members and review of medical records. The absence of psychiatric diagnoses was 
confirmed in comparison subjects using the same approach. In order to control for experimental 
variance, subjects with schizophrenia or schizoaffective disorder (N=20) were matched 
individually to one healthy comparison subject for sex and as closely as possible for other 
covariates. All tissue samples from subjects in a pair were processed together throughout all 
stages of the study. The mean age, postmortem interval and tissue freezer storage time did not 
differ between subject groups (Table 3). All procedures were approved by the University of 
Pittsburgh’s Committee for the Oversight of Research Involving the Dead and Institutional 
Review Board for Biomedical Research.  
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Table 3. Characteristics of human subjects 
 
*Age, PMI, and Storage Time are represented as mean ± SD. M, Male; F, Female; W, White; B, 
Black.  
 
3.2.2 Immunohistochemistry 
 The left hemisphere of each brain from each subject was blocked coronally at 
~1.0-2.0 cm intervals, fixed in cold 4% paraformaldehyde for 48 hours and immersed in a series 
of graded sucrose solutions. Blocks of tissue containing the superior frontal gyrus were 
sectioned coronally using a 40 μm block advance on a cryostat and stored in cryoprotectant 
solution at - 30°C until the day of the immunohistochemistry protocol. Two sections from DLPFC 
area 9 from each subject, spaced ~400 μm apart were used for the experiment, after 
identification of regions from Nissl-stained adjacent sections. Briefly, antigen retrieval methods 
were used to enhance immunoreactivity signal (Jiao et al 1999) by immersing sections in 0.01M 
sodium citrate solution (pH8.5) at 80°C in a water bath for 75 minutes, cooled to room 
temperature, rinsed in 0.1M phosphate buffer (pH7.4) and incubated in fresh 1% NaBH4 
(sodium borohydride) in 0.1M PBS for 30 minutes. After numerous rinses over 30 minutes, 
sections were permeabilized with 0.3% Triton X-100 in PBS for 30 minutes at room 
temperature, incubated in blocking solution containing 20% donkey serum, 1% bovine serum 
 75 
albumin (BSA), 0.1% lysine and 0.1% glycine in PBS for 2 hours, and then incubated in 
scintillation vials for approximately 72 hours at 4°C in PBS containing 2% donkey serum and the 
following primary antibodies: vesicular glutamate transporter 1(Vglut1; guinea pig, 1:200, 
Cat#AB5905, Millipore, Billerica, MA, USA), spinophilin (rabbit, 1:1000, Cat#AB5669, Millipore, 
Billerica, MA, USA) and gephyrin (goat, 1:100, Cat#Sc6411, Santa Cruz Biotechnology, Dallas, 
TX, USA). Following brief rinses in PBS for 2 hours, the sections were then incubated in 
secondary antibodies (Donkey) conjugated to Alexa 488, and 647 (1:500, Invitrogen, Grand 
Island, NY, USA) or biotin (1:200, Fitzgerald, Acton, MA) for 24 hours. Sections were then 
incubated in streptavidin 405 (1:200, Invitrogen, Grand Island, NY, USA) for 24 hours. Finally, 
after rinses (4x30 min), sections were mounted using Prolong Gold Antifade reagent (Life 
technologies, Carlsbad, CA, USA) and #1.5 cover glass to minimize spherical aberration when 
using high-NA objectives. All slides were then coded to obscure diagnosis and subject number, 
and stored at 4°C until imaging. 
3.2.3 Antibody Characterization 
 The polyclonal guinea pig anti-Vglut1 antibody directed against the C-terminus 
(amino acids 530-560), recognized a single band at the expected size of 60 kDa by western blot 
(Fremeau et al 2001) and preadsorption with immunogen peptide abolished immunolabeling 
(reported by manufacturer). The polyclonal rabbit anti-spinophilin antibody directed against a 
synthetic peptide (amino acids 286-390) recognized a single band of ~140 kDa by western blot 
and in primary neuronal cultures labeled only dendritic spines (Amateau & McCarthy 2002). The 
polyclonal goat anti-gephyrin antibody directed against the C-terminus of the protein (amino 
acids 710-760; clone R-20) labeled a single band of the appropriate molecular weight in western 
blots of mouse and rat brain tissue (reported by manufacturer). Secondary antibody specificity 
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was verified by omitting the primary antibody in pilot studies and has been shown to produce 
minimum cross-reactivity by the manufacturers.   
3.2.4 Microscopy and sampling 
 Images were acquired on an Olympus (Center Valley, PA, USA) IX81 inverted 
microscope equipped with an Olympus spinning disk confocal unit, a Hammamatsu ORCA-
Flash4.0 V2 digital CMOS camera (Bridgewater, NJ, USA), and a high-precision BioPrecision2 
XYZ motorized stage with linear XYZ encoders (Ludl Electronic Products Ltd, Hawthorne, NJ, 
USA) using a 60x 1.40 NA SC oil immersion objective. All equipment was controlled by 
Slidebook 5.0 (Intelligent Imaging Innovations Inc., Denver, CO, USA) and Slidebook 6.0 
(Intelligent Imaging Innovations Inc., Denver, CO, USA) was used for post-image processing. 
We generated three dimensional (3D) image stacks (2D images sequentially captured at 
defined 0.25 μm Z-step) that were 1024x1024 pixels over 25% of the total thickness of the 
tissue section starting at the coverslip. Data was collected using optimal exposure settings for 
every channel, yielding greatest dynamic range of the camera and negligible saturated pixels.  
All images were acquired in deep layer 3 and 4 defined as extending between 35-60% of 
the distance from the pial surface to the layer 6-white matter border and was performed blinded 
to subject diagnosis. Using systematic random sampling, image stacks were sampled using a 
200 x 200 μm2 sampling grid. We imaged a total of 15 sites within deep layer 3 and 4. 
Moreover, a potential confound of quantitative fluorescence measures in human cortex is 
lipofuscin autofluorescence, and this was circumvented by taking advantage of recently 
developed methods (Rocco et al 2015). To eliminate this confound, lipofuscin was imaged using 
a customized fifth channel (excitation wavelength: 405nm; emission wavelength: 647nm) at 
constant exposure time across all sections and all object masks that overlapped with a 
lipofuscin mask were removed from analysis.  
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3.2.5 Image Processing 
 Each image stack is normalized for exposure time in each channel, and cropped 
to remove the top 10% of z-planes due to variability in the tissue surface as a result of the 
sectioning process on the cryostat. Preceding segmentation, the data set is deconvolved using 
AutoQuant Adaptive Blind Deconvolution algorithm (Media Cybernetics, Rockville, MD) as 
previously described (Rocco et al 2015). The deconvolution process combines statistical 
techniques of maximum likelihood estimation and a constrained iterative deconvolution 
algorithm to help increase signal-to-noise ratio by increasing the clarity of the data via improving 
resolving power. For data segmentation, a Gaussian channel was made for every deconvolved 
channel by calculating a difference of Gaussians using sigma values of 0.7 and 2 as described 
previously (Rocco et al 2015). Following deconvolution, a custom threshold/morphological 
segmentation algorithm is used to create object masks of labeled immunoreactive puncta, 
identified by morphological size ranging from 0.03 to 0.50 μm3, which is appropriate for pre- and 
postsynaptic proteins as visualized by fluorescence microscopy (Fish et al 2008, Fish et al 
2011). The segmentation protocol uses the Ridler-Calvard method to establish an initial binary 
threshold value for the iterative segmentation process, adjusted for every channel for each 
channel in each image stack as described previously (Fish et al 2008). Multiple iterations with 
subsequent threshold settings increasing by 50 gray levels are used for threshold segmentation 
in order to reach the maximum pixel intensity value in MATLAB (Natick, MA, USA). The 
combination of varying intensity thresholds in conjunction with morphological size gating is well 
suited for selection of objects without uniform and/or high fluorescence intensities, which can 
occur when proteins differ in their content within synaptic structures, because of disease states.   
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3.2.6 Definition of spine subtypes 
 We used mask operations in Slidebook to identify subtypes of dendritic spines 
based on the degree of overlap between voxels of different object masks in a multistep process. 
Spinophilin is a protein phosphatase 1-binding protein that is highly concentrated within 
dendritic spines in the postsynaptic density in the primate cortex (Allen et al 1997, Muly et al 
2004), but the labeling is not exclusive to dendritic spines, with minor yet significant labeling of 
dendrites, shafts and glial cells (Muly et al 2004, Tang et al 2004). Presynaptic excitatory 
boutons were labeled using Vglut1, which specifically labels corticocortical boutons (Fremeau et 
al 2004, Fremeau et al 2001). Postsynaptic labeling for GABA synapses was labeled using 
gephyrin, which contributes to the multimeric scaffolds for the clustering of inhibitory receptors 
(Tyagarajan & Fritschy 2014). Figure 10 shows confocal micrograph captured at 1024X1024 
pixels showing immunoreactivity (IR) for Vglut1, spinophilin and gephyrin at 60X in the human 
DLPFC.   
 Dendritic spines receiving corticocortical input were defined as a spinophilin 
object mask that overlapped a Vglut1 object mask (Vglut1+/spinophilin+). Dual-innervated 
spines receiving corticocortical inputs were defined as spinophilin object masks that overlapped 
with gephyrin objects masks and Vglut1 objects masks (Vglut1+/spinophilin+/gephyrin+). Figure 
11 shows examples of different subpopulations of dendritic spines based on overlap between 
masked objects as described above. Figure 12 shows an example of masks generated for each 
channel using the methods described above.  
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Figure 10. Triple-labeled human DLPFC tissue to assess dendritic spine subtypes. 
Cryostat sections (40 μm) from schizophrenia and matched comparison subjects (2 
sections/subject) were labeled for (A) Vglut1 (blue), (B) spinophilin (red) and (C) gephyrin 
(green) followed by post-image processing. (D) Custom filter settings were used to identify 
lipofuscin, a lipid-containing residue of lysosomal digestion, which is often associated as a 
potential confound in human postmortem tissue by presenting autofluorescent signal much 
greater than background.  (E) Merged image showing Vglut1-IR, Spinophilin-IR and Gephyrin-IR 
puncta in human DLPFC deep layer 3. Bar = 20 μm. 
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Figure 11. Identification of dendritic spine subtypes in human DLPFC. 
(A1-D1) Dendritic spines (closed arrowheads) receiving a corticocortical input were 
defined as a spinophilin object mask that overlapped a Vglut1 object mask 
(Vglut1+/spinophilin+). (A2-D2) Dual-innervated spines receiving an inhibitory synapse 
and a corticocortical input (open arrowheads) were identified by spinophilin object 
masks that overlapped with gephyrin objects masks and Vglut1 objects masks 
(Vglut1+/spinophilin+/gephyrin+). Bar = 1 μm. 
 
3.2.7 Statistical Analyses      
 We used two analyses of covariance (ANCOVA) models, paired and unpaired, to test 
the effects of diagnostic group on puncta density. The paired ANCOVA used puncta density as 
the dependent variable, diagnostic group as the main effect, subject pair as a blocking factor, 
and PMI, storage time and age as covariates. Subject pairing may be considered an attempt to 
account for the parallel processing of tissue samples from a pair and to balance diagnostic 
groups for sex, age and PMI and not a true statistical paired design. As a result, we also used a 
second model without subject pair as a blocking factor that included age, sex, PMI, storage 
time, and brain pH as covariates.  
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All statistical tests were conducted with α=0.05. Reported ANCOVA statistics include 
only those covariates that were statistically significant. Therefore, the reported degrees of 
freedom vary across analyses.   
 
Figure 12. Generation of Vglut1-IR, gephyrin-IR and spinophilin-IR object masks. 
Images of human DLPFC deep layer 3 and 4 labeled for Vglut1, gephyrin and spinophilin. 
Single channel images of (A) Vglut1, (B) gephyrin, (C) spinophilin, and (D) lipofuscin 
autofluorescence. (E) Merged image of A, B, and C. (F) Object masks corresponding to A, B, 
and C. Bar = 10 μm. 
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3.3 RESULTS 
3.3.1 Density of Vglut1-IR puncta and gephyrin-IR puncta is unchanged in 
schizophrenia 
We determined the density of Vglut1-IR and gephyrin-IR puncta in 20 pairs of 
comparison and schizophrenia subjects in layers deep 3 and 4. The density of Vglut1-IR puncta 
was not significantly different (-3.5%; paired: F1,19=0.438, p=0.516; unpaired: F1,38=0.536, 
p=0.468; Figure 13A) in DLPFC deep layer 3 and 4 of schizophrenia (0.033 ± 0.0048 
objects/µm3) relative to comparison (0.034 ± 0.0056 objects/µm3) subjects. Likewise, the density 
of gephyrin-IR puncta was not significantly different (-2.9%; paired: F1,19=0.224, p=0.641; 
unpaired: F1,38=0.174, p=0.679; Figure 13B) in DLPFC deep layer 3 and 4 of schizophrenia 
(0.0061 ± 0.0011 objects/µm3) relative to comparison (0.0063 ± 0.0016 objects/µm3) subjects.  
3.3.2 Density of dendritic spines receiving corticocortical input is unchanged in 
schizophrenia 
In order to interrogate the subpopulation of spines that receive only a corticocortical 
input, the predominant form of excitatory afferents in the cortex, we determined the density of 
spinophilin object masks that overlapped with a Vglut1 object mask. The density of 
Vglut1+/spinophilin+ puncta was not significantly different (1.9%; paired: F1,19=0.105, p=0.750; 
unpaired: F1,38=0.133, p=0.718; Figure 14A) in layers deep 3 and 4 of schizophrenia (0.019 ± 
0.0033 objects/µm3) relative to comparison (0.019 ± 0.0031 objects/µm3) subjects.   
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3.3.3 Density of dual-innervated dendritic spines receiving an inhibitory synapse 
and a corticocortical input is unchanged in schizophrenia  
The density of Vglut1+/spinophilin+/gephyrin+ puncta was unchanged (-6.5%; paired: 
F1,19=0.416, p=0.527; unpaired: F1,38=0.398, p=0.532; Figure 14B) in schizophrenia (0.0002 ± 
0.00007 objects/µm3) relative to comparison (0.0002 ± 0.00008 objects/µm3) subjects.  
 
Figure 13. Vglut1-IR and gephyrin-IR puncta density are unaltered in DLPFC deep layer 3 and 4 of 
subjects with schizophrenia. 
(A) Mean density of Vglut1-IR puncta. (B) Mean density of gephyrin-IR puncta. Each data point 
represents a schizophrenia and matched comparison subject pair. Data points below the unity 
line reflect pairs in which the measure is lower for the schizophrenia subject. F-statistics and p-
values are provided for both paired and unpaired ANCOVA analyses. 
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Figure 14. Vglut1+/spinophilin+ and Vglut1+/spinophilin+/gephyrin+ puncta density in DLPFC 
deep layer 3 and 4 between diagnostic groups. 
(A) Mean density of Vglut1+/spinophilin+ puncta. (B) Mean density of 
Vglut1+/spinophilin+/gephyrin+ puncta. Each data point represents a schizophrenia and 
matched comparison subject pair. Data points below the unity line reflect pairs in which the 
measure is lower for the schizophrenia subject. F-statistics and p-values are provided for both 
paired and unpaired ANCOVA analyses. 
3.4 DISCUSSION 
  
In the present study, we sought to determine whether dendritic spine pathology in 
DLPFC reflects 1) a subpopulation of dual-innervated dendritic spines receiving an inhibitory 
synapse and a corticocortical input, and/or 2) dendritic spines that only receive a corticocortical 
input. In the DLPFC of subjects with schizophrenia, methodological limitations have precluded 
the assessment of neuropathological alterations in postmortem tissue with a high degree of 
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spatial resolution required to detect relatively small synaptic structures, and accurately quantify 
synapse-specific changes in these identified structures. To the best of our knowledge, the 
current study provides the first examination of dendritic spine subtypes in postmortem tissue in 
subjects with schizophrenia. We report that the density of dual-innervated dendritic spines 
receiving an inhibitory synapse and corticocortical input and density of putative dendritic spines 
only receiving a corticocortical input is unaltered in DLPFC layers deep 3 and 4 in the illness.  
Furthermore, we provide evidence that neither the density of Vglut1-IR nor gephyrin-IR puncta 
density is altered in DLPFC deep layer 3 and 4 in schizophrenia. 
3.4.1 Subpopulation of dendritic spines receiving thalamocortical input may be 
decreased in schizophrenia  
 Excitatory synaptic input onto dendritic spines is mediated by corticocortical or 
thalamocortical afferents. Corticocortical inputs include local and long-range association 
projections, whereas thalamocortical inputs to the DLPFC originate in the mediodorsal (MD) 
nucleus of the thalamus and densely arborize in deep layer 3 and 4 (Giguere & Goldman-Rakic 
1988). Although the subpopulation of dendritic spines receiving corticocortical inputs are 
unaltered in the disease, one possible interpretation of our findings is that reduced 
thalamocortical activity and/or inputs to DLPFC deep layer 3 and 4 lead to dendritic spine 
destabilization and loss of the spines targeted by these afferents. The thalamus is necessary for 
gating information between cortical areas, and in particular, the temporal synchronization of 
neuron ensembles in the PFC for cognitive processes (Saalmann & Kastner 2011). 
Interestingly, numerous studies have reported reduced activity of the MD thalamus, aberrant 
thalamocortical oscillations and thalamocortical dysconnectivity in subjects with schizophrenia 
(Minzenberg et al 2009, Woodward et al 2012). In fact, recent studies using diffusion tensor 
imaging and probabilistic tractography have shown reduced thalamic connectivity to the PFC in 
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schizophrenia, which was correlated with behavioral performance during working memory tasks 
(Marenco et al 2012). Importantly, selectively decreasing neural activity in the MD of mice 
performing cognitive tasks using the DREADD (designer receptor exclusively activated by a 
designer drug) pharmacogenetic approach, resulted in reduced beta-band synchronization 
between MD and PFC, and impairments in PFC-dependent learning and working memory tasks 
(Parnaudeau et al 2013). Thus, these studies suggest that diminished activity of the MD 
thalamus and disrupted MD-PFC functional connectivity might serve a critical role in the 
pathophysiology of the disease. 
Several studies have interrogated the neuronal number and volume of the MD thalamus 
in postmortem tissue and the magnitude of reported differences vary considerably across 
studies. Initial studies by some groups reported decrease in volume and total neuron number of 
the MD thalamus (Byne et al 2002, Pakkenberg 1990, Young et al 2000), although follow-up 
studies overcoming methodological shortcomings showed no difference (Cullen et al 2003, 
Dorph-Petersen et al 2004). The discrepancy in the postmortem findings might be explained by 
size of subject cohorts and demographic, clinical and tissue characteristics of subjects 
examined, specific study of one or both hemispheres, and technical limitations in determining 
the anatomical boundaries of thalamic nuclei. However, in spite of the ambiguous anatomical 
findings in the MD thalamus in schizophrenia, axonal arborization from the MD thalamus to the 
PFC might still be reduced. Supporting this idea, a previous study from our group showed a 
marked decrement in the density of PV-IR varicosities in DLPFC area 9, specifically in the 
termination zone of axonal projections from the MD thalamus within deep layer 3 and 4 (Lewis 
et al 2001). Experiments conducted in macaque monkeys using immunocytochemical labeling 
for PV, have shown robust labeling in thalamic relay nuclei that project to the cortex (Jones 
1998), and EM studies have shown that PV-IR terminals from MD thalamus constitute ~50% of 
total PV terminals in the middle cortical layers, and form Gray’s Type I synapses (Melchitzky et 
al 1999).  
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The findings from the Lewis et al. 2001 study raise two interpretations: 1) Reduced PV-
containing inputs from the MD thalamus and/or 2) reduced PV-basket cell boutons in DLPFC 
deep layer 3 and 4. A recent study demonstrated that the density of PV-basket cell inputs in the 
DLPFC is unchanged in schizophrenia (Glausier et al 2014). Although not definitive, these 
observations raise the idea that the decrement in the density of PV-IR varicosities in the DLPFC 
middle layers reflects fewer projections from the MD thalamus. As a result, decreased 
thalamocortical connectivity in the DLPFC in schizophrenia might contribute to the loss of spines 
within DLPFC deep layer 3 and 4 microcircuits.  However, this needs to be tested using a multi-
label fluorescence immunohistochemistry approach in DLPFC deep layer 3 and 4, using a 
combination of pre- and postsynaptic proteins to identify thalamocortical inputs onto dendritic 
spines.        
3.4.2 Is there a redistribution of excitatory inputs from the dendritic spine to the 
dendritic shaft in schizophrenia? 
An alternative explanation for a marked decrement in dendritic spine density observed 
previously, without a parallel change in corticocortical inputs (density of Vglut1-IR puncta) in the 
DLPFC as found in this study, is that excitatory inputs are relocalized onto the dendritic shaft as 
a consequence of a structural loss in spines. Various mechanistic studies exploring the 
functional consequences of dendritic spine loss, suggest that a decrement in dendritic spine 
density might cause a redistribution of excitatory synapses from dendritic spines to the dendritic 
shaft. For example, overexpression of Nr4a1, an activity-inducible gene encoding a nuclear 
receptor, produced a marked decrement in dendritic spine density without reducing excitatory 
synaptic transmission (AMPAR- and NMDAR-mediated EPSCs), which was produced by a 
redistribution of excitatory synapses onto the dendritic shaft in the absence of spines (Chen et al 
2014). The downregulation of dendritic spines was mediated by the ability of Nr4a1 to alter gene 
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transcription of components of the actin cytoskeleton regulatory pathways, causing a 
reorganization of F-actin within dendritic spines (Chen et al 2014). Similarly, knockdown of 
hevin, an astrocyte-secreted synaptogenic protein that specifically induces thalamocortical 
synaptic connectivity without affecting corticocortical connectivity, produced a redistribution of 
excitatory synapses from dendritic spines to the shaft, resulting in no overall change in 
asymmetric synapse density compared to wild-type mice (Risher et al 2014). In the CA1 region 
of the hippocampus, chronic blockade of AMPARs resulted in a loss in dendritic spines but a 
concomitant 5-fold upregulation in the number of asymmetric shaft synapses, with a 
corresponding increase in mEPSC amplitude, but no change in mEPSC frequency or 
AMPA/NMDA ratio (Mateos et al 2007). The relocalization of excitatory synapses from spines to 
shafts is consistent with previous studies showing that PSDs can dynamically redistribute to the 
dendritic shaft, following spine retraction (Woods et al 2011). In fact, our findings showing no 
change in the density of Vglut1-IR puncta density is consistent with observations made in the 
auditory cortex in deep layer 3 in schizophrenia, where dendritic spine deficits have been 
reported (Moyer et al 2013). Taken together, these findings suggest a plausible explanation of 
how deficits in dendritic spines in schizophrenia might be associated with a spatial 
reorganization of excitatory inputs from the spines to the shaft. However, future studies using 
EM in postmortem tissue in schizophrenia, need to elucidate if such a phenomenon truly occurs 
and if the proportion of asymmetric excitatory synapses on dendritic shafts of DLPFC deep layer 
3 pyramidal cells is higher in schizophrenia. Alternatively, attempts to explore intracellular filling 
of pyramidal cells in postmortem human tissue might be considered, although the scope of this 
approach is currently extremely limited (Benavides-Piccione et al 2013).  
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3.4.3 Limitations of this study 
 An important limitation of the current study is that by assessing dendritic spines using 
confocal microscopy, we cannot truly differentiate among the cellular source of the counted 
spines. Based on our previous results, the density of dendritic spines emanating from the basilar 
dendrites of deep layer 3 pyramidal cells were lower in the illness, however, dendritic spine 
density on the basilar dendrites of layer 5 and 6 pyramidal cells were unaltered (Glantz & Lewis 
2000, Kolluri et al 2005). By imaging in a particular layer of the cortex (deep layer 3 and 4), we 
do not know if the counted spines are located on the basilar dendrites of pyramidal cells whose 
cell bodies are located in deep layer 3, or if these are the spines located on the apical dendrites 
of layer 5 or 6 pyramidal cells. 
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4.0  DEVELOPMENTAL EXPRESSION PATTERNS OF GABAA RECEPTOR SUBUNITS IN 
LAYER 3 AND 5 PYRAMIDAL CELLS OF MONKEY PREFRONTAL CORTEX 
Adapted from: Datta D, Arion D, Lewis DA (2015). Developmental expression patterns of 
GABAA receptor subunits in layer 3 and 5 pyramidal cells of monkey prefrontal cortex. Cerebral 
Cortex 25 (8): 2295-2305. 
4.1 INTRODUCTION 
 
The primate dorsolateral prefrontal cortex (DLPFC) plays a critical role in cognition, 
particularly in tasks involving spatial working memory, the ability to transiently maintain and 
manipulate a limited amount of spatial information in order to guide thought or behavior. In both 
monkeys and humans, performance on spatial working memory tasks progressively improves 
from early childhood through adolescence, with mature levels of performance not achieved until 
late adolescence or early adulthood (Diamond 2002, Goldman 1971, Luna et al 2010). This age-
related improvement in performance appears to reflect the maturation of the functional 
architecture of the DLPFC, and consequently its increased participation in the neural circuits 
that mediate spatial working memory (Alexander 1982, Alexander & Goldman 1978).  
Within DLPFC circuitry, pyramidal cells in layer 3 appear to be preferentially involved in 
mediating working memory. For example, neural activity during the delay period of spatial 
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working memory tasks is most pronounced in the supragranular layers of the monkey DLPFC, 
with the greatest activity in layer 3 pyramidal cells (Friedman & Goldman-Rakic 1994, 
Sawaguchi et al 1990). In addition, reciprocal connections among populations of spatially-
segregated clusters of layer 3 pyramidal cells are thought to provide the anatomical substrate 
for the recurrent excitation that sustains the firing of these neurons during the delay period of 
working memory tasks, serving as the cellular basis for keeping information “on-line” (Arnsten et 
al 2012, Goldman-Rakic 1995).  
The time course of spatial working memory maturation is correlated with a 
developmental increase in the proportion of DLPFC neurons that exhibit delay period firing 
(Alexander 1982). This age-related change in neural activity patterns is associated with 
developmental refinements in structural markers of excitatory inputs to layer 3 pyramidal cells. 
For example, in layer 3 of both monkey and human DLPFC, the density of pyramidal neuron 
dendritic spines, the site of most excitatory synapses, and the density of axospinous synapses 
increase markedly during early postnatal life, remain at a plateau during childhood, and then 
decrease by 40-50% during adolescence (Anderson et al 1995, Bourgeois et al 1994, 
Huttenlocher 1979, Petanjek et al 2011).  
Importantly, the activity of layer 3 pyramidal neurons during working memory tasks is 
also spatially tuned by inhibitory inputs. For example, interneurons in the monkey DLPFC 
demonstrate delay period activity that is isodirectionally tuned to nearby pyramidal neurons 
(Rao et al 1999). Furthermore, pharmacological blockade with GABA antagonists in the DLPFC 
disrupts both the spatial tuning of pyramidal neurons and behavioral performance during 
working memory tasks (Constantinidis et al 2002, Rao et al 2000). Consistent with this role of 
inhibition in spatial working memory, the axon terminals of the subset of GABA neurons (basket 
and chandelier cells) that express the calcium-binding protein parvalbumin also undergo 
substantial developmental refinements in layer 3 of monkey DLPFC. For example, parvalbumin 
protein levels in the axon terminals of basket neurons progressively increase during postnatal 
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development, whereas the density of chandelier neuron axon terminals decreases (Cruz et al 
2003, Erickson & Lewis 2002, Fish et al 2013). Basket and chandelier neurons, and other 
classes of GABA neurons, selectively target different domains on pyramidal cells and regulate 
their activity through GABAA receptors with different subunit compositions (Farrant & Kaila 2007, 
Farrant & Nusser 2005, Jacob et al 2008). Moreover, the subunit composition of GABAA 
receptors contributes to the specificity of their electrophysiological properties. For example, α1-
containing GABAA receptors generate currents with a much faster decay time relative to α2- or 
α5-containing GABAA receptors (Farrant & Nusser 2005). Thus, different GABAA receptor 
subunits appear to play specialized roles in regulating the activity of layer 3 pyramidal cells, and 
changes in the expression of these subunits with age may contribute to the maturation of spatial 
working memory performance.  
Consequently, we sought to determine whether the expression of different GABAA 
receptor subunits in layer 3 pyramidal neurons have distinctive developmental trajectories, 
whether these trajectories differ from those of major markers (AMPA Glur1 and NMDA Grin1 
subunits) of excitatory neurotransmission, and whether these developmental changes are 
specific to layer 3 pyramidal cells.  In order to address these questions we used laser 
microdissection techniques to capture individual layer 3 pyramidal cells from the DLPFC of 
monkeys ranging in age from postnatal one week to 11.5 years and quantified the expression 
levels of the transcripts of interest by qPCR. Identical studies were conducted in layer 5 
pyramidal cells which differ from layer 3 pyramidal cells based on their birth date, source of 
afferents, principal projection targets (Jones 1984) and role in working memory circuitry 
(Arnsten et al 2012). Moreover, available evidence indicates that recurrent excitatory 
connections between layer 3 and 5 pyramidal cells (Kritzer & Goldman-Rakic 1995) might be 
critical for the persistent firing of these cells that is required to sustain mental representation in 
the absence of ongoing sensory input (Arnsten et al 2012). 
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4.2 MATERIALS AND METHODS 
4.2.1 Animals 
We used 26 rhesus (Macacca mulatta) monkeys ranging in age from one week to 
11.5 years (Appendix B; Supplemental Table 1). All monkeys were female except for 
one adult male. Monkeys younger than 6 months of age were housed with their 
mothers; juveniles 6-24 months were housed in groups; and those older than 24 months 
were housed either in pairs, or in single cages, in the same social setting as previously 
described (Erickson & Lewis 2002). All housing and experimental procedures were 
conducted in accordance with guidelines set by the U.S. Department of Agriculture and 
the National Institutes of Health Guide for the Care and Use of Laboratory Animals and 
with approval of the University of Pittsburgh’s Institutional Animal Care and Use 
Committee.  
Eleven monkeys were perfused transcardially with ice-cold artificial cerebrospinal 
fluid (ACSF) under deep anesthesia with ketamine and pentobarbital (Gonzalez-Burgos 
et al 2008); in two of these monkeys, a small tissue block was surgically excised from 
the rostral third of the principal sulcus in the left hemisphere for electrophysiology 
studies 2-4 weeks prior to perfusion. The remaining 15 monkeys, all experimentally 
naïve, were deeply anesthetized with ketamine and pentobarbital. After the monkey was 
deeply anesthetized, a scalpel and heavy duty scissors were used to quickly remove the 
head. Rongeurs were then used to remove the top of the skull and fine scissors used to 
resect the dura. The brain was then removed intact. Standard coronal blocks (~5 mm 
thick) were cut from the right hemisphere, placed on 2”x3” glass slides and immersed in 
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isopentane chilled on dry ice.  Each frozen block was then placed in an appropriately 
labeled bag and stored in a -80°C freezer.  
Monkeys were divided into the following four age groups based on the previously 
identified inflection points in the developmental trajectories of excitatory inputs to layer 3 
pyramidal cells in monkey DLPFC (Anderson et al 1995, Bourgeois et al 1994): 1) 
perinatal (n = 6), monkeys from 0.1 to 1.5 months of age, within the period of a rapid 
increase in density of excitatory synapses and spines; 2) prepubertal (n = 7), monkeys 
from 3 to 9 months of age, within the period when the density of excitatory synapses 
and spines is at a plateau; 3) peripubertal (n = 7), monkeys from 16 to 32 months of 
age, within the period of excitatory synapse and spine pruning; 4) adult (n = 6), 
monkeys from 45 to 138 months of age, during the period when excitatory synapse and 
spine density are at stable adult levels. 
4.2.2 Laser microdissection analyses 
Cryostat sections (12 μm) were cut from coronal blocks containing DLPFC areas 
9 and 46 (Figure 15A-C), thaw-mounted onto glass polyethylene naphthalate 
membrane slides (Leica Microsystems, Bannockburn, IL) that had been previously UV-
treated at 254 nm for 30 minutes, dried briefly, and stored at −80°C. On the day of the 
microdissection, slides were immersed in an ethanol–acetic acid fixation solution, 
stained with thionin, dehydrated through 100% ethanol, and air dried. Using a Leica 
microdissection system (LMD 6500;  X40 objective; power, 15; aperture, 9; speed, 12; 
balance, 14; and offset, 180), individual pyramidal neurons in deep layer 3 or layer 5 
were captured as previously described (Arion & Lewis 2011). Approximately 150 Nissl-
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stained pyramidal cells from each of layer 3 and 5 were collected from each of three 
different slides per animal. Pyramidal cells were identified based on their characteristic 
somal morphology and the presence of a prominent apical dendrite directed radially 
towards the pia mater (Figure 15D-E). The pyramidal cells from a given layer for each 
monkey were pooled together in 0.5-mL microtube caps (Ambion/Applied Biosystems, 
Foster City, CA), resulting in a sample of approximately 450 pyramidal cells per layer 
per subject, and lysed by vortexing for 30 seconds in 200 μL of RLT Buffer Plus 
(QIAGEN, Valencia, CA). The RNA was purified using the RNeasy Plus Micro kit 
(QIAGEN). 
In order to validate the cell type specificity of the dissected neurons, and the 
absence of glial or GABA cell contamination, we obtained LMD samples of Nissl-stained 
1) pyramidal neurons identified using the criteria described, 2) non-pyramidal neurons 
(presumably interneurons), and 3) glial cells from the same tissue sections. The cDNA 
from each sample was used to quantify levels of specific markers of interneurons 
(glutamic acid decarboxylase 67, GAD67) and glial cells (myelin basic protein, MBP) by 
qPCR. In pyramidal cells, expression levels of GAD67 were only 3.3% of those in 
interneurons and MBP only 0.6% of those in glial cells. In concert, these findings 
demonstrate that our dissection method results in the selective collection of pyramidal 
neurons without contamination by other cortical cell types. 
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Figure 15. Dissection of individual pyramidal cells in different laminar locations from monkey 
DLPFC. 
(A) Schematic drawing of the lateral view of the macaque monkey brain showing the 
approximate location (dotted black lines) of DLPFC sections used in the study. PS indicates 
principal sulcus and CS indicates cingulate sulcus. (B) Schematic drawing of a representative 
coronal section of monkey DLPFC, at the rostral-caudal level shown in panel A, showing the 
location of areas 9 and 46. Box indicates the portion of the section shown in panel C. (C) 
Thionin-stained coronal section showing the locations where pyramidal cells were captured in 
layer 3 and layer 5. (D) Digitally optimized representative image of a pyramidal cell in layer 3. 
(E) The same pyramidal cell in the process of being captured by laser microdissection. 
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4.2.3 Quantitative real-time polymerase chain reaction 
Total RNA was converted to complementary DNA using the qScriptTM cDNA SuperMix 
(Quanta Biosciences, Gaithersburg, MD). Priming was performed with a mix of poly dT and 
random hexamers, according to the manufacturer’s recommendations. The efficiency for each 
primer set was between 90% and 100%, and the amplified product resulted in a specific single 
amplicon in dissociation curve analysis (Appendix B; Supplemental Table 2). Given the 
limitations on the number of cells that could be captured, and the resulting limits on the amount 
of available cDNA from each sample, we were able to profile a total of 8 transcripts of interest 
(and two reference genes) from each sample. We determined transcript levels of the major 
postsynaptic GABAA receptor subunits (α1, α2, α5, β2, γ2 and δ) and of critical subunits for 
AMPA (Glur1) and NMDA (Grin1) glutamate receptors. 
Samples from both layers of a given subject were always assayed on the same plate. 
For each sample, amplified product differences for each transcript were measured with 4 
replicates using SYBR Green chemistry-based detection (Mimmack et al 2004).  β-Actin and 
cyclophilin A were used as endogenous reference genes to normalize the expression levels of 
transcripts, as these two transcripts have been previously shown to have stable levels of 
expression across development in monkey DLPFC (Hoftman et al 2015, Volk et al 2012). The 
qPCR reactions were carried out in StepOnePlus thermal cycler (Applied Biosystems) using the 
StepOnePlus software with the automatic baseline and threshold detection options selected. 
These data were exported to Microsoft Excel (Microsoft, Redmond, Washington) and delta cycle 
thresholds (dCTs) were calculated for each sample by using the geometric mean of the two 
endogenous reference genes as the normalization factor (i.e., cycle threshold [CT] for each 
transcript in a sample minus the geometric mean of β-actin and cyclophilin A CTs for the same 
sample). Since the dCT represents the log2-transformed expression ratio of each transcript of 
interest to the geometric mean of the two reference genes we calculated the more intuitive 
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expression ratio (i.e., expression ratio=2−dCTs) of each transcript and reported the results as 
expression ratios (Hashimoto et al 2008, Volk et al 2010).  
4.2.4 Statistical Analyses 
To assess the effect of age on transcript levels, we conducted both Pearson regression 
analyses for individual animal data and analyses of variance (ANOVA) for age group data for 
each transcript in layer 3 and layer 5 pyramidal cells. We also determined the mean and 
standard deviation of the expression ratios for each age group. Tukey’s post hoc test was used 
for comparisons between age groups with α=0.05. The reported p values for both the regression 
analyses and the ANOVAs were corrected for multiple comparisons (8 transcripts per layer 
times 2 layers equals 16 comparisons) using the Holm’s simultaneous inference procedure 
(Volk et al 2000). 
4.3 RESULTS 
4.3.1 Postnatal expression of GABAA receptor subunit mRNAs in pyramidal cells  
 In monkey DLPFC, the levels of GABAA receptor α1 subunit mRNA significantly 
increased with age in both layer 3 (r=0.93, p<0.001) and layer 5 (r=0.94, p<0.001) pyramidal 
neurons (Fig. 16A). From the youngest (three animals one week of age) to oldest (three 
animals over eight years of age) monkeys (Appendix B; Supplemental Table 1), mean levels 
of the α1 subunit mRNA increased by 137% in layer 3 and by 199% in layer 5 (Table 4). 
Analysis by age group also revealed significant differences in mRNA levels in both layer 3 
(F3,22=21.9, p<0.001) and layer 5 (F3,22=26.5, p<0.001) pyramidal neurons, with post hoc 
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analyses revealing significant (p<0.05) increases in expression of α1 subunit mRNA between 
the perinatal to peripubertal age groups in layer 3 and between the perinatal to prepubertal and 
the prepubertal to peripubertal age groups in layer 5 (Fig. 16B). In addition, GABAA α1 subunit 
mRNA levels were higher in layer 3 than in layer 5 pyramidal cells in every animal, with 
expression levels approximately 2-fold higher in layer 3 in each age group.  
In contrast, expression levels of the GABAA α2 subunit mRNA selectively decreased 
across postnatal development in layer 3 pyramidal cells (r= -0.92, p<0.001), and did not change 
with age in layer 5 pyramidal neurons (Fig. 16C). From the youngest (three animals one week 
of age) to oldest (three animals over eight years of age) monkeys, mean levels of the α2 subunit 
mRNA decreased by 61% in layer 3 (Table 4). Analysis by age group also revealed significant 
differences in mRNA levels in layer 3 (F3,22=61.5, p<0.001), with  post hoc analyses revealing 
significant (p<0.05) decreases in α2 subunit expression between each pair of adjacent age 
groups (Fig. 16D). Although the level of GABAA α2 subunit mRNA was higher in layer 3 than 
layer 5 in every age group, this difference declined from approximately 4-fold higher in layer 3 in 
the perinatal age group to less than 2-fold in the adult age group. 
In contrast to the developmental trajectories exhibited by α1 and α2 subunits, expression 
of α5 subunit mRNA significantly decreased in both layer 3 (r= -0.83, p<0.001) and layer 5 (r= -
0.70, p<0.001) pyramidal neurons (Fig. 16E). From the youngest (three animals one week of 
age) to oldest (three animals over eight years of age) monkeys, mean levels of the α5 subunit 
mRNA decreased by 74% in layer 3 and by 50% in layer 5 (Table 4). Analysis by age group 
also revealed significant differences in mRNA levels in both layer 3 (F3,22=41.1, p<0.001) and 
layer 5 (F3,22=13.5, p<0.001) pyramidal neurons, with post hoc analyses showing significant 
(p<0.05) decreases in α5 subunit expression between the perinatal to prepubertal and 
prepubertal to adult age groups in layer 3 pyramidal cells and between the perinatal to 
prepubertal age group in layer 5 pyramidal cells (Fig. 16F). The laminar pattern of GABAA α5 
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subunit mRNA expression also differed from α1 and α2 subunits as α5 levels were 
approximately 2-fold higher in layer 5 than layer 3 pyramidal cells across all age groups. 
The GABAA β2 subunit, which preferentially assembles with the α1 subunit (Farrant & 
Nusser 2005), showed a developmental pattern of expression similar to that of the α1 subunit. 
Transcript levels of β2 significantly increased in both layer 3 (r=0.64, p<0.001) and layer 5 
(r=0.68, p<0.001) pyramidal cells (Fig. 16G). From the youngest (three animals one week of 
age) to oldest (three animals over eight years of age) monkeys, mean levels of the β2 subunit 
mRNA increased by 47% in layer 3 and by 89% in layer 5 (Table 4). Analysis by age group also 
revealed significant differences in mRNA levels in both layer 3 (F3,22=6.4, p=0.003) and layer 5 
(F3,22=7.5, p=0.001) (Fig. 16H) pyramidal neurons, with post hoc analyses revealing significant 
(p<0.05) increases in β2 subunit  expression between the perinatal to peripubertal age groups in 
layer 3 and between the perinatal to prepubertal age groups in layer 5 pyramidal neurons (Fig. 
16H). Similar to the α1 subunit, laminar analyses showed that the expression of GABAA β2 
subunit was approximately 2-fold higher in layer 3 than layer 5 pyramidal cells in every age 
group. 
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Figure 16. Developmental trajectories of GABAA receptor α1, α2, α5 and β2 subunit mRNAs in 
layer 3 and 5 pyramidal cells in monkey DLPFC. 
The left panels show the expression ratios for each transcript in individual subjects for layer 3 (white 
circles) or layer 5 (black circles) pyramidal cells. The Pearson’s correlation coefficient (r) and 
corresponding p-value are indicated for each panel on the left. The right panels show the mean (SD) 
expression ratios for each age group; age groups not sharing the same letter are significantly different 
(p<0.05). (A, B) GABAA α1 subunit mRNA expression increased throughout postnatal development. (C, 
D) GABAA α2 subunit mRNA expression decreased selectively in layer 3 pyramidal cells from perinatal to 
adult. (E, F) GABAA α5 subunit mRNA expression decreased in both layers throughout development. (G, 
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H) GABAA β2 subunit mRNA expression increased in both layers during development, paralleling the 
trajectory of GABAA α1 subunit mRNA. 
In postsynaptic locations, most α1-, α2- and α5-containing GABAA receptors also contain 
a γ2 subunit (Farrant & Nusser 2005, Jacob et al 2008). Expression of GABAA receptor γ2 
subunit mRNA significantly increased in both layer 3 (r=0.89, p<0.001) and layer 5 (r=0.94, 
p<0.001) pyramidal neurons (Fig. 17A). From the youngest (three animals one week of age) to 
oldest (three animals over eight years of age) monkeys, mean levels of the γ2 subunit mRNA 
increased by 92% in layer 3 and by 163% in layer 5 (Table 4). Analysis by age group also 
revealed significant differences in mRNA levels in both layer 3 (F3,22=18.5, p<0.001) and layer 5 
(F3,22=31.7, p<0.001) pyramidal neurons, with post hoc analyses revealing significant (p<0.05) 
increases in γ2 subunit expression between the perinatal to peripubertal and peripubertal to 
adult age groups in both layer 3 and layer 5 pyramidal cells (Fig. 17B). The magnitude of 
expression of the γ2 subunit was similar between layers with a slightly higher expression in 
layer 3 pyramidal cells at all developmental age groups.  
 Cortical GABAA receptors containing δ subunits are localized extrasynaptically, 
have a high affinity for GABA, and mediate tonic inhibition, defined as the constant activation of 
extrasynaptic receptors that, by increasing input conductance, reduces the probability of 
generating an action potential (Farrant & Nusser 2005, Nusser et al 1998, Wei et al 2003). Our 
results showed that the expression of the GABAA receptor δ subunit mRNA significantly 
increased in layer 5 (r=0.91, p<0.001) pyramidal cells, but did not change in layer 3 pyramidal 
cells across postnatal development (Fig. 17C). From the youngest (three animals one week of 
age) to oldest (three animals over eight years of age) monkeys, mean levels of the δ subunit 
mRNA increased by 193% in layer 5 (Table 4). Analysis by age group revealed significant 
differences in mRNA levels in layer 5 (F3,22=24.7, p<0.001) pyramidal neurons, with post hoc 
analyses revealing significant (p<0.05) increases between the perinatal to prepubertal and 
prepubertal to adult age groups (Fig. 17D). Expression level of the δ subunit was approximately 
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4-fold higher during the perinatal period in layer 3 compared to layer 5 pyramidal cells, with the 
levels of expression becoming similar in both layers in the adult age group. 
 
Figure 17. Developmental trajectories of GABAA receptor γ2 and δ subunit mRNAs in layer 3 and 
layer 5 pyramidal cells in monkey DLPFC. 
The left panels show the expression ratios for each transcript in individual subjects for layer 3 (white 
circles) or layer 5 (black circles) pyramidal cells. The Pearson’s correlation coefficient (r) and 
corresponding p-value are indicated for each panel on the left. The right panels show the mean (SD) 
expression ratios for each age group; age groups not sharing the same letter are significantly different 
(p<0.05). (A, B) GABAA γ2 subunit mRNA expression increased throughout postnatal development in 
both layers. (C, D) GABAA δ receptor subunit mRNA expression increased selectively in layer 5 pyramidal 
cells although the magnitude of expression was higher in layer 3 pyramidal cells. 
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4.3.2 Postnatal expression of glutamate AMPA and NMDA receptor subunit 
mRNAs in pyramidal cells 
 In order to determine the specificity of these developmental changes in 
expression of GABAA receptor subunits, we also evaluated the expression patterns for two 
glutamate receptor subunits that are critical mediators of excitatory neurotransmission (Cull-
Candy et al 2001, Traynelis et al 2010). Expression of AMPA receptor Glur1 subunit mRNA 
significantly decreased in layer 3 (r= -0.62, p<0.001) pyramidal cells, and did not change in layer 
5 pyramidal cells (Fig. 18A). From the youngest (three animals one week of age) to oldest 
(three animals over eight years of age) monkeys, mean levels of the AMPA Glur1 subunit 
mRNA decreased by 37% in layer 3 (Table 4). Analysis by age group revealed significant 
differences in mRNA levels in layer 3 (F3,22=7.2, p=0.002) pyramidal cells, with post hoc 
analyses revealing significant (p<0.05), albeit modest, decreases in AMPA Glur1 subunit 
expression between the perinatal to peripubertal age group in layer 3 pyramidal cells (Fig. 18B). 
Expression levels of the AMPA Glur1 subunit in layer 5 pyramidal cells were almost 2-fold 
higher in layer 5 compared to layer 3 pyramidal cells in every animal across all ages.   
 The developmental trajectory of the obligatory subunit for NMDA receptors, Grin1 
(Monyer et al 1992, Schorge & Colquhoun 2003, Ulbrich & Isacoff 2008), did not show any 
significant changes in either layer 3 or layer 5 pyramidal cells during postnatal development 
(Fig. 18 C, D). The expression of the NMDA Grin1 subunit was higher in layer 3 than layer 5 
pyramidal cells across all age groups (perinatal=26.6%; prepubertal=46.7%; 
peripubertal=36.2%; adult=22.9%). 
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Figure 18. Developmental trajectories of glutamate receptor subunits AMPA Glur1 and NMDA 
Grin1 mRNAs in layers 3 and 5 pyramidal cells of monkey. 
The left panels show the expression ratios for each transcript in individual subjects for layer 3 
(white circles) or layer 5 (black circles) pyramidal cells. The Pearson’s correlation coefficient (r) 
and corresponding p-value are indicated for each panel on the left. The right panels show the 
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mean (SD) expression ratios for each age group; age groups not sharing the same letter are 
significantly different (p<0.05). (A, B) AMPA Glur1 subunit mRNA expression decreased 
between the perinatal and peripubertal age groups during development in layer 3 pyramidal 
cells. (C, D) NMDA Grin1 subunit mRNA expression was largely unchanged throughout 
development. 
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Table 4. Summary of differences, by layer, magnitude, and time of maturation, of the developmental trajectories for GABA and glutamate 
receptor subunits in layers 3 and 5 pyramidal cells of the monkey DLPFC. 
Maximal % change from 
youngest to oldest 
Period when adult level of 
expression achieved
Maximal % change from 
youngest to oldest
Period when adult level of 
expression achieved
GABAA α1 137% Adult 199% Peripubertal L3>L5
GABAA α2 -61% Adult - Perinatal L3>L5
GABAA α5 -74% Peripubertal -50% Prepubertal L5>L3
GABAA β2 47% Peripubertal 89% Prepubertal L3>L5
GABAA γ2 92% Adult 163% Adult L3>L5
GABAA δ - Perinatal 193% Adult L3>L5
AMPA Glur1 -37% Peripubertal - Perinatal L5>L3
NMDA Grin1 - Perinatal - Perinatal L3>L5
Transcript Magnitude of expression
Layer 3 Layer 5
 
The youngest age group comprises of three animals of one week of age and the oldest animals comprises of three 
animals that were over eight years of age. 
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4.4 DISCUSSION 
In this study, we used a cell type-specific approach to determine if the expression of 
GABAA receptor subunits specifically in layer 3 pyramidal neurons in monkey DLPFC exhibit 
distinctive developmental trajectories, whether these trajectories differ from those of excitatory 
receptor subunits in these neurons, and whether these developmental patterns of receptor 
transcript expression differ from those in layer 5 pyramidal cells.   
Expression levels of all six GABAA receptor subunits studied changed over a protracted 
period of postnatal development. Some transcripts (e.g. GABAA receptor α1 subunit) in layer 3 
pyramidal neurons progressively increased from birth until the adult age group, whereas others 
(e.g. GABAA receptor α2 subunit) declined across the same developmental period. In contrast, 
postnatal developmental changes in both glutamate receptor subunits were modest, with adult 
levels reached early in life. Some transcripts exhibited a similar direction of developmental 
change in both layer 3 and 5 pyramidal cells (e.g., GABAA α5 decreased in both layers and 
GABAA β2 increased in both layers), whereas others (e.g., GABAA receptor α2 and δ subunits 
and AMPA Glur1) changed with age only in one layer. Transcripts also differed in terms of 
whether expression levels were consistently higher in layer 3 (e.g. GABAA receptor γ2 subunit) 
or layer 5 (e.g. glutamate AMPA receptor Glur1 subunit) pyramidal cells.  
Our focus on gene expression patterns in a specific population of neurons may be 
particularly informative since measures of transcript levels in total gray matter may be diluted by 
other cell types. For example, previous studies of total gray matter suggested a less robust 
increase in GABAA α1 subunit levels during development (Hoftman et al 2015) than those 
observed in layer 3 and 5 pyramidal cells in the present study. Moreover, the collection of the 
same number of neurons per subject also excludes the potential confound of gray matter 
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measures that age-related differences in transcript levels reflect changes in neuron number or 
density rather than changes in gene expression. 
4.4.1 Relationships among developmental trajectories of GABA receptor 
subunits 
The postsynaptic influence of GABA released into the synaptic cleft is determined, in 
part, by the subunit composition of the GABAA receptor to which it binds. The majority of GABAA 
receptors assemble according to a 2α:2β:γ stoichiometry (Farrant & Kaila 2007, Luscher et al 
2011, Olsen & Sieghart 2009). The resulting receptor heterogeneity is associated with 
differences in two key parameters of synaptic transmission: the duration of inhibitory 
postsynaptic currents (IPSCs) and the nature of inhibition (i.e., phasic versus tonic). Because 
GABAA receptor α subunits contribute to differences in the decay rate of IPSCs, the 
developmental trajectories reported here may underlie important changes in the functional 
properties of DLPFC circuitry. For example, the decay time of GABA-activated currents is 6-fold 
faster when mediated by α1- than by α2 or α5-containing receptors (Farrant & Nusser 2005, 
Lavoie et al 1997, McClellan & Twyman 1999). Thus, the progressive increase in expression of 
GABAA α1 subunit and decrease in expression of α2 and α5 receptor subunits in layer 3 
pyramidal cells across postnatal development is likely to substantially decrease the duration of 
IPSCs in these neurons with age. Consistent with this interpretation, the decay time constant of 
IPSCs in layer 3 pyramidal cells of monkey DLFPC was reported to decline significantly by 
approximately 25% between 16 and 44 months of age (Hashimoto et al 2009). A similar 
correlation between developmental changes in tissue levels of α GABAA receptor subunits and 
of IPSC decay time has been observed in rodent neocortex and hippocampus (Bosman et al 
2002, Cohen et al 2000), although these changes are completed much earlier in rodents (Le 
Magueresse & Monyer 2013).  
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Whether these findings reflect a switch in the α subunit composition of GABAA receptors 
at particular synaptic sites or a change in the number of GABAA receptors containing a 
particular α subunit at different synaptic locations remains an important question for future 
studies. In either case, the apparent increase in the relative numbers of receptors containing 
fast versus slow decay kinetics may contribute to the substrate for developmental changes in 
cortical network oscillations. For example, gamma band (30-80 Hz) oscillations require a fast 
decay of GABA currents, such as that associated with the GABAA α1 subunit, in order for 
ensembles of pyramidal cells to be quickly released from synchronous inhibition in order to fire 
at a fast frequency (Bartos et al 2007). The developmental increase in the relative abundance of 
GABAA α1 subunits that confer fast IPSC decay properties shown here may increase the 
capacity of prefrontal networks to generate gamma oscillations. In addition, our finding that the 
increase in the relative ratio of α1 to α2 or α5 subunit expression is more prominent in layer 3 
than in layer 5 pyramidal cells is particularly interesting given recent findings that gamma 
oscillations originate principally in layer 3 of adult monkey association cortices (Buffalo et al 
2011). Because prefrontal gamma oscillation power increases in proportion to working memory 
load (Howard et al 2003, Roux et al 2012, Tallon-Baudry et al 1999), our findings may represent 
an important factor in the postnatal developmental increase in the power of gamma oscillations 
in humans (Uhlhaas et al 2009) and in working memory performance from 3 months of age to 
adulthood in monkeys (Alexander & Goldman 1978, Goldman 1971). 
It is important to note that the subcellular location of the receptors affected by the 
opposed developmental trajectories of GABAA α1 and α2 subunits in layer 3 pyramidal cells and 
the expression levels of the cognate proteins cannot be determined from the present study. 
However, in adult animals, α1-containing receptors predominate postsynaptic to PV basket cell 
inputs, whereas α2-containing receptors predominate postsynaptic to PV chandelier cell inputs 
(Klausberger et al 2002, Nusser et al 1996). Previous studies using electron microscopy 
revealed that the overall density of symmetric GABAergic synapses does not change during 
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postnatal development in monkey DLPFC (Bourgeois et al 1994). However, recent work using 
quantitative, multi-label, confocal microscopy suggests that the pruning of axon terminals may 
be a cell type- and membrane domain-specific phenomenon which is not detectable when all 
GABAergic terminals are assessed without regard to cell type (Fish et al 2013). For example, 
the mean number of chandelier cell boutons per pyramidal neuron axon initial segment was 
significantly lower in adult compared with 3-month-old monkeys, whereas the density of basket 
cell boutons did not differ (Fish et al 2013). In contrast, the levels of parvalbumin protein in 
basket cell axon terminals were approximately two-fold higher in adult relative to 3-month-old 
animals, whereas no age-related differences were found for parvalbumin protein levels in 
chandelier cell axon terminals (Fish et al 2013). Although speculative, these findings raise the 
possibility that the GABAA receptors postsynaptic to these two types of GABA axon terminals 
may also exhibit distinctive types of developmental changes in response to the changes in their 
presynaptic inputs. For example, due to the developmental pruning of chandelier cell terminals, 
the number of GABAA α2-containing postsynaptic receptors may similarly decline, leading to a 
progressively lower demand for expression of α2 mRNA. Similarly, based on findings that 
parvalbumin levels are correlated with the probability of GABA release (Eggermann & Jonas 
2012), the parallel increase in parvalbumin protein levels in basket cell terminals and the 
number of postsynaptic GABAA α1-containing receptors suggested by the current findings would 
provide a synergistic mechanism for increasing the strength of inhibitory inputs from 
parvalbumin basket cell inputs and thus a greater capacity to generate gamma oscillations with 
age.   
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4.4.2 Comparison of perisomatic and dendritic inhibition in pyramidal cells 
during postnatal development 
In contrast to the perisomatic location of GABAA α1 and α2 subunits, GABAA receptors 
containing α5 subunits are localized on pyramidal cell apical dendrites (Ali & Thomson 2008) 
postsynaptic to GABA inputs from the Martinotti class of GABA neurons that express the 
neuropeptide somatostatin (SST) (Kawaguchi & Kubota 1996, Melchitzky & Lewis 2008). The 
SST-containing interneurons are low threshold-spiking cells that form electrically-coupled 
networks which oscillate at theta frequency (4-8 Hz) (Beierlein et al 2000, Gibson et al 2005). 
Moreover, these inputs are critical mediators of dendritic inhibition which controls the local 
integration of inputs and mediates strong disynaptic inhibition in cortical circuits (Kapfer et al 
2007, Murayama et al 2009, Silberberg & Markram 2007). Our findings of a developmental 
decline in expression of the GABAA α5 subunit in both layer 3 and layer 5 pyramidal cells 
suggests that dendritic inhibition decreases progressively during postnatal maturation in the 
primate DLPFC (Caraiscos et al 2004). Expression of the mRNA for SST, which inhibits 
pyramidal neurons (Boehm & Betz 1997), also decreases significantly during postnatal 
development in the human PFC (Fung et al 2010). Although the developmental trajectories of 
molecules regulating GABA release from SST terminals and of SST receptors in pyramidal 
neurons remain unknown, the available data suggest that both presynaptic (Fung et al 2010) 
and postsynaptic components of dendritic inhibition onto layer 3 and 5 pyramidal cells decrease 
during maturation of the DLPFC. Thus, our results may provide the substrate for a progressive 
developmental shift from dendritic inhibition to perisomatic inhibition as the principal means to 
modulate pyramidal cell output. Alternatively, the apparent decrease in dendritic inhibition could 
parallel the decrease in density of dendritic spines and excitatory axospinous synapses during 
postnatal development (Anderson et al 1995, Bourgeois et al 1994, Petanjek et al 2011). This 
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notion is supported by recent findings suggesting that a significant proportion of dendrite-
targeting GABA synapses are made onto individual spines to focally regulate Ca2+ signals and 
that GABA inputs onto spines have high rates of turnover in vivo (Chen et al 2012, Chiu et al 
2013, Kubota et al 2007, van Versendaal et al 2012). Hence, the progressive decline in dendritic 
inhibition during postnatal development could be a response to the pruning of dendritic spines in 
apical dendrites.      
4.4.3 Contrasting development of markers of phasic versus tonic inhibition of 
pyramidal cells  
The γ2 subunit co-assembles with α1 and β2 subunits to form ~60% of GABAA receptors 
in the adult cortex (Mohler 2006). Our data indicate that these three subunits all increase in a 
similar fashion across postnatal development, suggesting a progressive increase in phasic 
inhibition with age in both layer 3 and 5 pyramidal neurons. In contrast, expression of the 
GABAA δ receptor subunit increased exclusively in layer 5 pyramidal cells during postnatal 
development, consistent with the findings of a prior in situ hybridization study showing a 
selective increase in GABAA δ receptor subunit expression in layer 5 relative to layer 3 
(Maldonado-Aviles et al 2009). Interestingly, the γ2 to δ subunit ratio increased by 49% from the 
youngest (three animals one week of age) to the oldest animals (three animals over 8 years of 
age) in layer 3 pyramidal cells and decreased by 10% in layer 5 pyramidal cells. These 
comparisons suggest that the ratio of phasic to tonic inhibition becomes increasingly different 
between layer 3 and 5 pyramidal cells across postnatal development. The laminar-specific 
pattern of changes in the nature of GABA inhibition suggest that phasic inhibition predominates 
over tonic inhibition with age in layer 3 pyramidal cells during circuit maturation while the ratio of 
phasic to tonic inhibition remains unchanged in layer 5 pyramidal cells.  
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4.4.4 Development trajectories of molecular markers of inhibition versus 
excitation of DLPFC pyramidal neurons 
Our experiments revealed marked differences in the magnitude of developmental 
changes in GABAA and glutamate receptor subunits in monkey DLPFC. In contrast to the robust 
developmental changes in GABAA receptor subunits, the developmental trajectories for the 
AMPA Glur1 and NMDA Grin1 subunits were relatively flat in both layers 3 and 5 pyramidal 
cells. Among other possibilities, the difference in trajectories may contribute to the molecular 
substrate for electrophysiological findings that excitatory postsynaptic currents (EPSCs) in layer 
3 pyramidal cells of monkey DLPFC achieve mature properties much earlier in postnatal 
development than do IPSCs (Gonzalez-Burgos et al 2008, Hashimoto et al 2009). 
4.4.5 Conclusion 
In aggregate, the developmental trajectories of transcripts critical in mediating GABA 
neurotransmission in pyramidal cells in the DLPFC support a dynamic and complex process of 
circuit maturation. Our findings suggest that the molecular determinants of GABA 
neurotransmission have distinctive developmental trajectories that differ in magnitude and 
direction of change, whereas the molecular determinants of glutamate neurotransmission are 
relatively stable and achieve adult expression levels early in development. As a result, the 
components of GABA neurotransmission in DLPFC circuitry may have distinctive 
developmentally sensitive periods during which environmental events may have a particular 
strength in either enriching or impairing circuit development.  
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5.0  GENERAL DISCUSSION 
In this dissertation, we provide evidence for pyramidal cell type-specific molecular 
disturbances and synapse-specific structural impairments in DLPFC deep layer 3, and cell type-
specific and layer-specific nature of postnatal developmental refinements in pyramidal cells in 
the DLPFC, within the circuitry that subserves γ-frequency oscillations and working memory. In 
order to understand layer-specific and cell type-specific molecular mechanisms that are 
perturbed in schizophrenia, we investigated dysregulation of the actin cytoskeleton required for 
dendritic spine formation and maintenance and examined the integrity of the CDC42-PAK-LIMK 
signaling pathway using laser microdissection in DLPFC deep layer 3 (Chapter 2). In order to 
reveal synapse-specific structural impairments in DLPFC deep layer 3, we conducted studies to 
determine if a subpopulation of dendritic spines is preferentially affected in schizophrenia using 
triple-label fluorescence immunohistochemistry and spinning-disk confocal microscopy 
(Chapter 3). Finally, in order to understand cell type-specific and layer-specific postnatal 
developmental refinements in pyramidal cells in the DLPFC, we examined the developmental 
trajectories of GABAAR subunit expression in layer 3 and 5 pyramidal cells using laser 
microdissection in the monkey DLPFC (Chapter 4).  
We reported upregulation and downregulation of mRNA levels for various components of 
the CDC42-PAK-LIMK signaling pathway that were not attributable to psychotropic medications 
or other comorbid factors, suggesting that cell type-specific impairments in the actin 
cytoskeleton may substantially contribute to dendritic spine deficits in DLPFC deep layer 3 
pyramidal cells (Chapter 2). We report that the density of putative dual-innervated dendritic 
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spines receiving an inhibitory synapse and corticocortical input, and dendritic spines receiving a 
corticocortical input are unaltered in the illness, although other subpopulations of spines 
receiving thalamocortical input may be affected (Chapter 3). We also found that the 
developmental trajectories of GABAAR subunit expression in primate DLPFC deep layer 3 
pyramidal neurons are protracted, subunit- and layer-specific and posited that the molecular 
maturation of GABA synapses may account, at least in part, for the maturation of synchronized 
pyramidal cell firing which is crucial for γ-frequency oscillations (30-80 Hz) and emergent 
properties such as working memory (Chapter 4).  
In the following discussion, I will consider these topics and present a plausible cascade 
of events that might explain local-circuit abnormalities observed in the DLPFC and systems-
level alterations in different neurotransmitter systems observed in the illness. I will also weigh in 
on alternative hypotheses that have been postulated for the disease process and mechanisms 
that can produce the reported data not addressed in the individual chapters. Lastly, I will offer 
some insight into future directions that are vital in establishing cause-consequence-
compensation relationships in the pathogenesis of schizophrenia and speculate on the scope of 
innovative therapeutic strategies.           
5.1 DECIPHERING THE DISEASE PROCESS IN SCHIZOPHRENIA 
 A fundamental challenge with making deductions from observed alterations in 
postmortem tissue in subjects with schizophrenia is knowing whether the observed changes 
represent a 1) Cause, an upstream primary problem related to the pathogenesis of the illness; 
2) Consequence, a downstream detrimental manifestation of a cause; 3) Compensation, a 
response to the pathophysiology induced by pathological alterations; 4) Confound, an artifact of 
technical limitations; 5) Comorbidity, an outcome of factors frequently associated with the 
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disease process (Lewis & Gonzalez-Burgos 2008). Determining in which category a particular 
alteration lies is imperative for clarifying what cellular and molecular disturbances are most 
proximal to the pathophysiology of specific clinical symptoms (e.g., γ-frequency oscillations and 
working memory deficits).        
5.1.1 Molecular evidence for a cell-autonomous intrinsic deficit in DLPFC deep 
layer 3 pyramidal cells: Dysregulation of the actin cytoskeleton 
Given the critical importance of dendritic spine structural stability and functional integrity 
in mediating neural plasticity, a major unmet need in basic neuroscience is explicating the 
cellular and molecular mechanisms that establish dendritic stability and illuminating how these 
are perturbed in disease. The actin cytoskeleton provides essential structural support for 
maintaining F-actin configuration and dynamic remodeling of spine shape. The morphological 
properties of dendritic spines are determined by an intricate balance between actin 
polymerization and depolymerization (Honkura et al 2008, Okamoto et al 2004). In particular, 
the cofilin/ADF family is particularly important in establishing the equilibrium for G-actin and F-
actin concentration by disassembling actin filaments to generate new barbed ends for F-actin 
assembly (Carlier et al 1997, dos Remedios et al 2003). In this dissertation, we have identified 
alterations in the expression of numerous molecular regulators of the actin cytoskeleton in a 
layer-specific and cell type-specific manner in DLPFC deep layer 3 in individuals with 
schizophrenia that might be a critical “upstream” cause in the pathogenesis of schizophrenia. 
Our results suggest that altered signaling through CDC42-PAK-LIMK pathway might be 
expected to reduce F-actin turnover in spines through cofilin/ADF and decrease dendritic spine 
density. Moreover, we confirmed and extended to the cell type-specific level earlier findings of 
disruptions in the CDC42-CDC42EP pathway. We have argued that morphological alterations 
such as lower dendritic spine density is most pronounced in DLPFC deep layer 3, because of a 
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cell-autonomous intrinsic abnormality in DLPFC deep layer 3 pyramidal cells, reflected by 
impairments in genes related to the actin cytoskeleton that are specifically dysregulated in 
DLPFC deep layer 3 pyramidal cells. Although alterations of CDC42 signaling pathway 
components are expected to significantly destabilize actin filament dynamics, in the following 
section, I will provide other plausible mechanisms that might impair the function of the actin 
cytoskeleton in pyramidal cells and merit further interrogation in schizophrenia.   
5.1.2 Role of other actin cytoskeleton signaling proteins in F-actin regulation 
Changes in the expression of several additional cytoskeleton regulatory molecules occur 
following changes in neuronal activity to modulate the dynamic equilibrium between F-actin and 
G-actin. For example, inhibition of RhoA target, Rho-associated protein kinase (ROCK) can 
suppress spine loss resulting from enhanced RhoA signaling (Xing et al 2012). Other molecules 
such as Drebrin, myristoylated alanine-rich C-kinase substrate (MARCKS) and β-adducin have 
important roles in dendritic spine morphogenesis and transition of immature spines to more 
stable structures (Koleske 2013). In addition, brain-derived neurotrophic factor (BDNF) and its 
postsynaptic partner TrkB receptors have also been documented to be crucial for spine 
enlargement and stabilization by inactivating cofilin/ADF (Baquet et al 2004, Gorski et al 2003, 
Rex et al 2007) and both BDNF and TrkB mRNA are lower in the DLPFC of subjects with 
schizophrenia (Hashimoto et al 2005, Weickert et al 2003). Another mechanism which can 
attenuate the activity of cofilin/ADF in dendritic spines involves synaptic GTPase activating 
protein (synGAP), an inhibitor of the Rho GTPase RAC and important molecule for trafficking of 
glutamate receptors (Carlisle et al 2008). For example, heterozygous or homozygous deletion of 
synGAP in rodents was sufficient to cause altered activity-dependent phosphorylation of 
cofilin/ADF, resulting in an excess of mushroom-shaped spines (Carlisle et al 2008). Finally, F-
actin binding proteins such as cortactin that are activated by tyrosine protein kinase Abl-related 
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gene (ARG), can stabilize newly generated F-actin filaments by stimulating nucleation of the 
ARP2/3 complex (MacGrath & Koleske 2012). Selective inactivation of the ARP2/3 complex in 
vivo in forebrain excitatory cells leads to a decrement in spine and synapse density reinforcing 
its central role in orchestrating actin nucleation for long-term spine stability (Kim et al 2013, Kim 
et al 2015). The ARP2/3 complex has emerged as an important molecular hub, acting 
downstream of multiple genes implicated in the pathogenesis of schizophrenia and might be an 
important candidate for future examination (Figure 19) (Clement et al 2012, De Rubeis et al 
2013, Hayashi-Takagi et al 2010, Russell et al 2014). 
 
Figure 19. Model for molecular mechanisms that determine F-actin polymerization through ARP2/3 
complex. 
The activity of the ARP2/3 complex is regulated by several nucleation-promotion factors (NPFs) such as 
the Wiskott-Aldrich syndrome (WASP) proteins, WASP family Verprolin-homologous (WAVE) proteins 
and cortactin that act downstream of Rho GTPases such as CDC42 and RAC1, and tyrosine protein 
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kinase such as ARG, respectively. The ARP2/3 complex may represent a common final output for actin 
cytoskeleton regulatory pathways and binds to the sides of existing actin filaments to induce actin 
nucleation, resulting in the formation of branched actin filament networks. The ARP2/3 complex is 
comprised of seven subunits (actin binding proteins, ARP2 and ARP3; ATP-binding proteins, ARPC1, 
ARPC2, ARPC3, ARPC4, ARPC5) that are activated downstream of known risk genes for schizophrenia. 
Although beyond the purview of this dissertation, our preliminary findings suggest a marked decrement in 
6 out of 7 subunits of the ARP2/3 complex (unpublished data) in DLPFC deep layer 3 pyramidal cells in 
schizophrenia. We are currently in the process of determining what upstream mechanism (CDC42-N-
WASP, ARG-cortactin and RAC1-WAVE) might produce the downregulation of the ARP2/3 complex in 
schizophrenia. 
 
5.1.3 Synaptic scaffolding proteins contribute to dendritic spine and synapse 
maintenance 
The structural support required for the long-term maintenance of dendritic spines and the 
actin cytoskeleton is also provided by various scaffolding proteins and stabilizing mechanisms 
provided by cell-adhesion molecules. For example, Shank/Homer/PSD95 complexes interact 
with NMDARs to recruit IP3 receptors and F-actin to excitatory synapses within dendritic spines, 
and modulate spine enlargement necessary for dendritic spine stabilization (Naisbitt et al 1999, 
Sala et al 2001). Knock-out Shank mice have diminished basal synaptic transmission, 
decreased dendritic spine density and social behavioral impairments (Hung et al 2008, Wohr et 
al 2011), and mutations in the promoter of the Shank1 gene have been associated with working 
memory deficits in subjects with schizophrenia (Lennertz et al 2012). Furthermore, cadherin-
catenin, neurexin/neuroligin and ephrin receptor bidirectional adhesion signaling complexes are 
functionally coupled to the actin cytoskeleton to promote structural stabilization necessary for 
spine and synapse maintenance (Arikkath & Reichardt 2008, Craig & Kang 2007, Elia et al 
2006, Ethell et al 2001, Penzes et al 2003). In addition, these scaffolding proteins and cell-
adhesion complexes might serve as an important activity-dependent molecular control for 
concurrent spine maturation and pruning during neural circuit refinement, particularly during 
adolescence when the symptoms of schizophrenia emerge (Bian et al 2015). 
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5.1.4 Potential genetic basis for actin cytoskeleton impairments in schizophrenia 
Several lines of evidence suggest that the neuropathological alterations observed in 
schizophrenia may be a product of genetic predispositions that impair the regulation of actin 
filament dynamics and the capacity to maintain a normal complement of excitatory inputs 
(Fromer et al 2014, Kirov et al 2012, Roussos et al 2012, Schizophrenia Working Group of the 
Psychiatric Genomics 2014). Copy number variation studies, GWAS, and exome sequencing 
studies have particularly identified enrichment in signaling complexes formed by the activity-
regulated cytoskeleton-associated scaffold protein (ARC) of the postsynaptic density, PSD 
protein complex and NMDAR-signaling, which are central elements to regulating synaptic 
strength at glutamatergic synapses, and are thought to be associated with increased risk for 
developing schizophrenia (Crowley et al 2013, Kirov et al 2012, Purcell et al 2014, Stefansson 
et al 2008, Timms et al 2013). In addition, de novo mutations in schizophrenia are over-
represented among loci encoding cytoskeleton-associated proteins that modulate actin filament 
dynamics and actin bundle assembly, and could contribute to the pathogenesis of the illness 
(Fromer et al 2014). The robust consistency of these genetic findings converge upon a 
constrained set of signaling pathways related to the regulation of synaptic plasticity, particularly 
on glutamatergic synapses. As the burgeoning body of literature establishing an etiological 
genetic basis for impairments in actin cytoskeleton pathways and glutamate postsynaptic 
proteins continues to grow, it is plausible that a genetic liability might provide a potential cause 
for a proximal deficit in dendritic spines in schizophrenia, which may be moderated by cell type-
specific gene expression patterns.   
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5.1.5 F-actin interaction with presynaptic active zone proteins      
The impairments in actin cytoskeleton signaling pathways in schizophrenia raise the 
possibility that destabilization of F-actin localized within presynaptic boutons and postsynaptic 
specializations could result in reduced excitatory drive to DLPFC deep layer 3 pyramidal cells. 
An emerging idea in the field proposes that the F-actin meshwork within presynaptic 
compartments of axonal boutons might serve as an important scaffold to organize the 
neurotransmitter release machinery, establish protein regulators at active zones, and enable 
presynaptic vesicle docking and endocytosis (Chia et al 2012, Dillon & Goda 2005, Zhang & 
Benson 2001). For example, in addition to their normative functions in controlling postsynaptic 
dendritic spine structures, the LIMK proteins are thought to also perform an important role in the 
presynaptic compartment. The LIMK proteins have been localized in the presynaptic 
compartment of the neuromuscular junction and loss of function of LIMK1 causes presynaptic 
motor neuron terminal degeneration, by acting downstream of the bone morphogenetic protein 
(BMP) receptor (Eaton & Davis 2005). Therefore, is a similar phenomenon for F-actin regulation 
of presynaptic compartments observed in the central nervous system? In fact, a recent report 
demonstrated that overexpression of neuregulin 1 during early postnatal development causes 
synaptic dysfunction and schizophrenia-like behavioral deficits (hyperactivity, impaired 
sensorimotor gating, social and cognitive deficits), by increasing levels of synaptic LIMK1 (Yin et 
al 2013a). Overexpression of neuregulin 1, similar to that observed in schizophrenia (Hashimoto 
et al 2004, Weickert et al 2012), produced glutamatergic hypofunction by seemingly 
suppressing presynaptic vesicle fusion at the active zone through a LIMK1-cofilin/ADF-mediated 
actin depolymerization mechanism (Yin et al 2013a). Moreover, the glutamatergic hypofunction 
phenotype produced in these mice was also paralleled by GABAergic hypofunction with a 
decrease in the amplitude of mIPSCs and expression of GABAA α1 receptors in pyramidal cells 
(Yin et al 2013a). Interestingly, dysfunction in the presynaptic neurotransmitter exocytic 
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machinery involving the soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
(SNARE) complex has been reported in postmortem studies in schizophrenia (Castillo et al 
2010, Ramos-Miguel et al 2015). Thus, it is plausible that impairments in the presynaptic 
release machinery might arise from molecular alterations in the actin cytoskeleton that disrupts 
F-actin organization within presynaptic compartments.     
In concert, it appears as though there is a great deal of functional redundancy for actin 
cytoskeleton signaling pathways which might be necessary for optimal control of actin filament 
dynamics required for spine morphogenesis and synaptic activity. At any rate, understanding 
the extent of neuropathological alterations in actin cytoskeleton signaling pathways in 
schizophrenia and the spatial and temporal relationship between different regulatory aspects of 
signal transduction should remain an ongoing area of scrutiny. 
5.2 ASSEMBLING A CASCADE OF ALTERATIONS IN THE PATHOPHYSIOLOGY 
OF SCHIZOPHRENIA 
Elucidating the neuropathological alterations in DLPFC circuits in postmortem tissue in 
subjects with schizophrenia could shed light on pathophysiological impairments such as lower γ-
frequency oscillations and working memory deficits. Numerous compelling hypotheses have 
been postulated, but understanding cause-consequence-compensation relationships for local 
circuit abnormalities and systems-level alterations in the illness, remains an ongoing challenge. 
As part of this section of the dissertation, I intend to summarize some of these hypotheses and 
provide some insight on how the findings presented in this dissertation may be integrated into 
the different models. Understanding the proximal pathology to the pathophysiology of working 
memory dysfunction can foster a better understanding of what animal models or model systems 
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might be beneficial in testing the efficacy of novel pharmacological compounds to ameliorate the 
symptoms of the illness.  
5.2.1 Proximal deficit in schizophrenia is reduced excitatory drive to DLPFC 
deep layer 3 pyramidal cells 
 A major idea in the field proposes that a cell-type autonomous intrinsic deficit in 
deep layer 3 pyramidal cells, resulting from dysregulation of the actin cytoskeleton, induces 
morphological impairments (fewer dendritic spines, reduced somal volumes, shorter dendritic 
arbors) to these cells (Lewis et al 2012, Lewis & Gonzalez-Burgos 2006). These cell type-
specific alterations may also be associated with hypofunctional NMDARs (and/or AMPAR 
signaling). These molecular and morphological alterations have been hypothesized to decrease 
excitatory drive to DLPFC deep layer 3 circuits and render DLPFC deep layer 3 pyramidal cells 
in a hypoactive state with a reduced need for mitochondria-mediated energy synthesis (Arion et 
al 2015, Gonzalez-Burgos et al 2015). Consistent with this idea, transcriptome analyses of deep 
layer 3 and 5 pyramidal cells have revealed marked dysfunction in mitochondrial and ubiquitin-
proteasome system signatures, respectively, suggesting that these cells are hypometabolic, and 
hence less active (Arion et al 2015). Moreover, many of these alterations were not present, or 
found to a lesser degree, in samples of DLPFC gray matter from the same subjects, suggesting 
that the pattern of pathology is pyramidal cell-specific (Arion et al 2015). Therefore, these 
observations invoke the idea that dendritic destabilization due to actin cytoskeleton impairments 
and a decrement in the number of spines to receive glutamate inputs, lead to mitochondrial 
dysfunction in DLPFC deep layer 3 pyramidal cells (Figure 20).   
The decrement in excitatory activity of pyramidal cells in DLPFC deep layer 3 may 
involve a myriad of homeostatic, compensatory responses to reduce feedback inhibition of 
these pyramidal cells to restore excitatory-inhibitory (E/I) balance in DLPFC microcircuits. The 
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stability and integrity of circuit activity is dependent on E/I balance in order to prevent runaway 
excitation or dying out of cortical activity. This balance is maintained through the scaling of 
excitatory and inhibitory strength by virtue of a process termed homeostatic synaptic plasticity 
(HSP) (Turrigiano 2008, Turrigiano et al 1998). A plethora of scaling factors has been implicated 
in recent years and the diverse HSP mechanisms involve alterations in neurotransmitter content 
and postsynaptic receptor number (Pozo & Goda 2010, Turrigiano 2011).  
In schizophrenia, an important HSP mechanism may involve the activity-dependent 
downregulation of phasic excitation of PV interneurons, in response to decreased network 
excitatory activity due to hypoactive DLPFC deep layer 3 pyramidal cells. Consistent with this 
idea, reduced excitatory drive to deep layer 3 pyramidal cells leads to decreased mRNA levels 
of neuronal activity-regulated pentraxin (NARP), an immediate early gene important in the 
formation of excitatory inputs onto PV (and possibly SST) interneurons, in the DLPFC in 
subjects with schizophrenia (Kimoto et al 2015). NARP is secreted in an activity-dependent 
fashion at presynaptic glutamatergic axon boutons and facilitates the clustering of GluR4-
containing AMPARs on PV interneurons (Chang et al 2010, Gu et al 2013). In fact, recent 
studies found that in mice with genetic deletion of the NARP gene and its associated receptor, 
there was a marked reduction in GluR4 AMPARs on PV interneurons, resulting in decreased 
feedback inhibition and disruptions in hippocampal rhythms and working memory (Pelkey et al 
2015). Importantly, in the schizophrenia specimens, NARP mRNA was positively correlated with 
GAD67 mRNA (Kimoto et al 2015). Interestingly, the GAD67 promoter contains a conserved 
binding site for Zif268 (Szabo et al 1996, Yanagawa et al 1997), an immediate early gene, and 
Zif268 activation is accompanied by increased GAD67 expression (Luo et al 2008). Levels of 
Zif268 are also lower in the DLPFC of subjects with schizophrenia and are positively associated 
with GAD67 mRNA levels in the same subjects (Kimoto et al 2014). Thus, reduced Zif268 in 
response to lower excitatory activity of DLPFC deep layer 3 pyramidal cells, might be a crucial 
factor that contributes to lower GAD67 levels, altered GABA synthesis and compromised 
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cognition in schizophrenia. Given the fact that GAD67 expression in PV interneurons are 
activity-dependent (Benson et al 1994, Lau & Murthy 2012), decreased excitatory drive to deep 
layer 3 pyramidal cells might lead to an activity-dependent reduction in the secretion of NARP, 
thereby contributing to lower excitatory drive onto PV interneurons and reduction in Zif268, and 
a concomitant activity-dependent downregulation in GAD67 and PV expression in schizophrenia 
(Curley et al 2011, Glausier et al 2014, Volk et al 2000, Volk et al 2012a).  
Supporting these findings, recent postmortem studies have also found elevated mRNA 
levels of the μ opioid receptor in schizophrenia (Volk et al 2012b). This receptor is intriguing for 
a couple of reasons: 1) Subcellular localization suggests that it is present in the perisomatic 
compartment and axon boutons of PV interneurons in the hippocampus (Drake & Milner 2002, 
McQuiston & Saggau 2003, Stumm et al 2004, Torres-Reveron et al 2009), 2) activation of the μ 
opioid receptor activates G protein-coupled inwardly rectifying K+ channels that hyperpolarize 
the membrane potential and dampen responsiveness to excitatory drive, suppressing GABA 
release (Capogna et al 1993, Glickfeld et al 2008, Wimpey & Chavkin 1991). In fact, activation 
of the μ opioid receptor has been shown to impair γ-frequency oscillations (Gulyas et al 2010, 
Whittington et al 1998). The homeostatic upregulation of the μ opioid receptor in subjects with 
schizophrenia is predicted to further suppress presynaptic GABA release into the synaptic cleft 
(Volk et al 2012b) and GABA neurotransmission is further decreased by lower levels of GABAA 
α1 receptors in pyramidal cells in the postsynaptic compartment (Beneyto et al 2011, Glausier & 
Lewis 2011). 
Consistent with these observations, recent studies suggest that the driving force for Cl- 
influx into pyramidal cells in deep layer 3 may be altered in schizophrenia. Although expression 
levels of the two transporters (N+-K+-Cl—co-transporter 1 (NKCC1) and K+-Cl—co-transporter 2 
(KCC2)) that primarily establish the Cl- equilibrium potential (Kahle et al 2008) are unaltered in 
schizophrenia (Arion & Lewis 2011), their activity may be altered, by virtue of existing in a 
hyper-phosphorylated state. Concordant with this interpretation, the expression levels of two 
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kinases, oxidative stress response kinase (OXSR1) and with no K (lysine) protein kinase 
(WNK3) is elevated in subjects with schizophrenia which is expected to decrease the activity of 
KCC2 and increase the activity of NKCC1, thereby increasing Cl- levels intracellularly in layer 3 
pyramidal cells (Arion & Lewis 2011). As a result, activation of GABAARs by GABA is expected 
to produce less influx of Cl-, diminishing the hyperpolarizing nature of GABA signaling.  
In concert, an array of pre- and postsynaptic alterations has been observed in GABA 
interneurons and these alterations are most pronounced in PV interneurons in DLPFC deep 
layer 3, the same laminar location where the molecular and morphological aberrations in 
pyramidal cells are most prominent.  Taken together, the most parsimonious interpretation for 
the constellation of findings related to GABA neurotransmission alterations in schizophrenia, 
suggest reduced feedback inhibition of postsynaptic pyramidal cells, in response to reduced 
excitatory drive to DLPFC deep layer 3 pyramidal cells (Figure 20), although other 
interpretations are plausible (discussed in section 5.3). Although the compensatory changes in 
GABA interneurons restores E/I balance at a new level, the diminished strength of excitation 
and inhibition is at an insufficient level to synthesize γ-frequency oscillations (30-80 Hz) to 
properly mediate cognitive control required for working memory function (Lewis et al 2012). 
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Figure 20. Altered E/I balance in schizophrenia. 
(A and B) Schematic showing copy number variations at risk alleles 15q11.2-13 (chromosome 
microdeletion) and 16p11.2 (chromosome microduplication), which implicate dysregulation of 
actin filament dynamics in the pathogenesis of schizophrenia. (C and D) Molecular alterations 
and predicted functional consequences of altered CDC42 signaling pathway components 
(CDC42-CDC42EP and CDC42-PAK-LIMK) in DLPFC deep layer 3 pyramidal cells in 
schizophrenia (see Figure 5 in Chapter 2).  The synergistic alterations in CDC42 signaling 
pathways is predicted to destabilize actin dynamics and produce spine deficits preferentially in 
DLPFC deep layer 3 pyramidal cells in schizophrenia. The size of molecules in schizophrenia 
relative to control subjects, reflect the pattern of changes observed in the illness. Arrows 
indicate activation, and blunted lines indicate inhibition of each target. (E and F) Schematic 
summarizing the organization of the DLPFC microcircuit between deep layer 3 pyramidal cells 
and GABA interneurons. Deep layer 3 pyramidal cells (green) are reciprocally connected to 
other pyramidal cells by local axon collaterals to mediate recurrent excitation and GABA (black) 
interneurons (primarily PV interneurons) to generate feedback inhibition. The integrity of these 
connections maintains normal γ-frequency oscillations (30-80 Hz) and E/I balance in healthy 
subjects. In schizophrenia, molecular alterations such as dysregulation of the actin cytoskeleton 
in deep layer 3 pyramidal cells is predicted to induce morphological perturbations such as lower 
dendritic spine density and somal volume. These alterations have been hypothesized to lower 
excitatory drive in the network and decrease the need for ATP production, resulting in a 
hypoactive circuit (light green). A primary upstream deficit in deep layer 3 pyramidal cells 
induces compensatory mechanisms [less presynaptic glutamatic acid decarboxylase (GAD67); 
lower number of postsynaptic GABAARs] to reduce feedback inhibition from local GABA 
interneurons (light grey). Adapted from Lewis et al (2012) (G and H) In concert, the changes at 
the gene, molecular and circuit level, result in a reset E/I balance in schizophrenia with 
diminished excitation and inhibition, precluding normal circuit operations required for the 
generation of network oscillations such as γ-frequency oscillations, thereby producing cognitive 
impairments. Heat maps are reproduced from Cho et al (2006). 
5.2.2 Reconciling DLPFC circuit changes with system-level alterations in 
schizophrenia 
One of the functional consequences of reduced excitatory drive in DLPFC deep layer 3 
might involve deficient excitatory output from the DLPFC. In addition to alterations in glutamate 
and GABA neurotransmission, alterations in dopamine neurotransmission have been well 
documented in schizophrenia. Traditionally, psychosis-related phenotypes were thought to be a 
consequence of excessive subcortical dopamine and the effectiveness of antipsychotic drugs is 
correlated to their inhibition of dopamine D2 receptors. However, a few studies have postulated 
that cognitive control impairments related to working memory might be associated with reduced 
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dopaminergic drive to the PFC (Davis et al 1991, Weinberger 1987). Elegant studies first 
conducted by Goldman-Rakic and later examined by other groups, demonstrated the 
importance of dopamine neurotransmission in regulating cognitive control (Sawaguchi 2001, 
Sawaguchi & Goldman-Rakic 1994), and in particular, in increasing the excitability of pyramidal 
cell ensembles in the DLPFC in layer 3, which might be important for sustaining the activity of 
DLPFC neuron activity during the delay-period of working memory tasks (Gonzalez-Burgos et al 
2002, Henze et al 2000, Urban et al 2002). Indeed, regional depletion of dopamine in the 
prefrontal cortex of monkeys produces cognitive deficits, suggesting that dopamine 
neurotransmission in the DLPFC is critical for cognitive function (Brozoski et al 1979). The 
postsynaptic compartment of dopamine signaling is mediated primarily through D1 receptors 
(D1Rs) in the DLPFC during working memory tasks and pharmacological antagonism of D1Rs 
impairs delay-period activity (Sawaguchi & Goldman-Rakic 1991, Williams & Goldman-Rakic 
1995). In essence, dopamine stimulation of D1Rs exhibits an inverted U-shaped influence on 
working memory, with blockade and excessive activity impairing spatial working memory, and 
optimal stimulation enhancing spatial tuning by suppressing delay-related firing in the cell’s non-
preferred orientation (Sawaguchi & Goldman-Rakic 1991, Vijayraghavan et al 2007, Zahrt et al 
1997). Studies in schizophrenia suggest a decrement in dopamine inputs in the DLPFC with a 
concomitant compensatory upregulation of D1 dopamine receptors revealed by in vivo imaging 
studies (Abi-Dargham et al 2002, Akil et al 1999).  
A current theory has proposed that hypoactive pyramidal cells and reduced excitatory 
drive to deep layer 3 pyramidal cells in schizophrenia, could explain a hypodopaminergic 
phenotype in the cortex and a hyperdopaminergic phenotype in subcortical areas  (Figure 21) 
(Lewis & Gonzalez-Burgos 2006). This is because tracing studies using high-resolution electron 
microscopy in rats have shown that PFC pyramidal cells innervate dopamine cells in the ventral 
tegmental area in the ventral mesencephalon, which furnish reciprocal projections back to the 
PFC and inhibit, through GABA interneurons, dopamine cells that project to the nucleus 
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accumbens in the striatum (Carr & Sesack 2000a, Carr & Sesack 2000b). If this circuit is 
conserved across species, a plausible hypothesis in schizophrenia is that reduced excitatory 
output of pyramidal cells in the cortex can produce decreased dopamine activity in the cortex 
through mesocortical loops and increased dopamine activity in the striatum through mesostriatal 
loops (Figure 21). Consistent with this hypothesis, recent in vivo studies in mice involving 
functional loss of the actin cytoskeleton in excitatory pyramidal cells of the forebrain 
recapitulated synaptic and behavioral phenotypes reminiscent of schizophrenia (Kim et al 2013, 
Kim et al 2015). Using a combination of optogenetics, viral anterograde and retrograde tract 
tracing, whole-cell patch clamp recording, the recent study involved conditional deletion of the 
ARP2/3 complex, and demonstrated spine loss and abnormal synaptic contacts in forebrain 
pyramidal cells (Kim et al 2015). This alteration resulted in increased stimulation of dopamine 
neurons in the ventral tegmental area and substantia nigra pars compacta (VTA/SNc), thereby 
producing elevated striatal dopamine and antipsychotic-responsive psychomotor disturbances in 
conjunction with behavioral abnormalities such as cognitive deficiencies, sociability deficits, 
reduced sensorimotor gating and locomotor hyperactivity (Kim et al 2015). Moreover, the study 
suggests that the increased dopamine subcortically maybe a consequence of a proximal 
alteration in pyramidal neurons in the PFC, since viral re-expression of the ARP2/3 complex in 
frontal cortical neurons lowered striatal dopamine and reduced hyperlocomotor activity (Kim et 
al 2015). In this context, the mechanistic manipulation has face validity since administration of 
antipsychotic drugs such as haloperidol and clozapine rescued the behavioral deficits, lending 
credence to the idea that actin cytoskeleton perturbations maybe the primary deficit in the 
pathogenesis of schizophrenia (Figure 21). This elegant proof-of-principle study raises several 
additional questions that need to be delineated: Can mouse models that produce aberrant actin 
cytoskeleton dynamics in PFC pyramidal cells recapitulate compensatory pre- and postsynaptic 
alterations in GABA neurotransmission, similar to those seen in schizophrenia? How do these 
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mechanistic alterations relate to other brain regions that are disrupted in schizophrenia such as 
the hippocampus? 
Dysregulation of the actin cytoskeleton in DLPFC deep layer 3 pyramidal cells and 
morphological impairments in dendritic spines is predicted to decrease excitatory drive to 
DLPFC deep layer 3 cortical circuits. The decrease in excitation is balanced by homeostatic 
compensatory mechanisms to decrease feedback inhibition by GABA interneurons, in order to 
restore E/I balance in DLPFC microcircuits. Hypofunctional DLPFC pyramidal cells in deep layer 
3 in schizophrenia lead to decreased output from the DLPFC layer 5 pyramidal cells, and 
Figure 21. Schematic depicting local-circuit and systems-level abnormalities in schizophrenia. 
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dysfunction of dopamine neurons located in the mesencephalon as a downstream 
consequence. Alterations in dopamine neurotransmission in schizophrenia include decreased 
activity of mesencephalic dopamine neurons projecting back to the cortex and increased 
activity, through disinhibition, of dopamine neurons projecting to the striatum. A 
hypodopaminergic phenotype in the cortex produces a compensatory, but functionally 
insufficient, upregulation of D1 receptors. Abbreviations: P, Pyramidal cells; GABA, γ-
Aminobutyric acid interneurons; DA, Dopamine cells. Figure adapted from Lewis and Gonzalez-
Burgos (2006). 
 
5.3 IS THE PROXIMAL DEFICIT IN SCHIZOPHRENIA IN GABA 
INTERNEURONS? 
An alternative hypothesis in the field posits that a proximal deficit in GABA interneurons 
might be an upstream event in the disease pathogenesis (Lisman et al 2008, Nakazawa et al 
2012). A myriad of cellular, molecular and structural alterations have been extensively 
characterized in GABAergic circuits in subjects with schizophrenia (reviewed in section 1.3.6, 
Figure 4). Particularly, extensive research has been focused on fast-spiking PV interneurons 
since these cells are critical in regulating the activity of pyramidal cells in layer 3 microcircuits 
and entrainment of DLPFC neural networks at γ-frequency oscillations (30-80 Hz) required for 
working memory (Cardin et al 2009, Sohal et al 2009). As a result, reduced GABA signaling 
from PV interneurons might contribute to the pathophysiology of lower prefrontal γ-frequency 
oscillation power during working memory tasks (Cho et al 2006, Howard et al 2003) and 
cognitive dysfunction in schizophrenia (Kahn & Keefe 2013). A number of sophisticated studies 
over the last decade have advocated different mechanisms by which PV interneurons might be 
dysfunctional in schizophrenia. The following sections will briefly discuss the various 
mechanisms by which this could occur. 
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5.3.1 Genetic liability for PV interneuron dysfunction 
The decrement in GAD67 mRNA observed in schizophrenia might be due to causes that 
regulate the GAD1 gene. Allelic variants in the GAD1 gene and epigenetic mechanisms 
involving chromatin structure perturbations have been associated with increased risk for 
schizophrenia and lower levels of GAD67 (Huang et al 2007, Straub et al 2007), suggesting that 
GAD67 changes may be developmentally controlled during the prenatal period. For example, 
using 3D genome architectures, it has been observed that the GAD1 gene contains promoter-
enhancer chromosomal loops that allow various distal regulatory elements to control GAD67 
transcription in an activity-dependent manner. In the prefrontal cortex in subjects with 
schizophrenia, this loop was disturbed, providing a plausible explanation for activity-dependent 
downregulation of GAD67 in the illness (Bharadwaj et al 2013). Consistent with these findings, 
increased numbers of GABA interneurons expressing the DNA methyltransferase 1 (DNMT1) 
mRNA with a concomitant downregulation of GAD67 and reelin mRNAs have been observed in 
the PFC in schizophrenia subjects, suggesting that hyper-methylation of gene promoters might 
lead to gene expression changes observed in the illness (Ruzicka et al 2007). In fact, the 
upregulation of DNMTs that are highly expressed in GABA interneurons might lead to gene 
silencing of various other GABA-related markers by interacting with CpG binding repressor 
proteins and histone deacetylases (HDACs) (Grayson & Guidotti 2013). Interestingly, a recent 
large-scale genomic study found enrichment for CNV’s related to GABA neurotransmission, 
although this was restricted to the GABAAR signaling complex, while replicating and extending 
the CNV enrichment for genes involved in glutamate neurotransmission in schizophrenia 
(Pocklington et al 2015).   
Decreased signaling through putative risk genes related to signal transduction pathways 
such as neuregulin 1 and ErbB4, which affect NMDAR signaling, have also been implicated in 
the pathogenesis of schizophrenia (Lewis & Moghaddam 2006). Recent interrogation of this 
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pathway, by conditional deletion of ErbB4 in PV interneurons, a tyrosine kinase receptor, has 
demonstrated cellular, physiological and behavioral deficits suggestive of schizophrenia (Allen 
et al 2008, Fazzari et al 2010, Neddens et al 2011, Sullivan et al 2012). These deficits included 
pre- and postsynaptic alterations in PV interneurons, decreased spine density of pyramidal cells 
and altered γ-frequency oscillations (Del Pino et al 2013, Yin et al 2013b). Although these 
studies provide an interesting mechanistic link to PV interneuron dysfunction in schizophrenia, 
caution must be used in extrapolating too much from these findings because total ErbB4 mRNA 
levels appear to be unaltered in schizophrenia, but the expression levels of two minor splice 
variants are significantly altered (Chung et al 2015, Law et al 2007). However, dysregulated 
splicing of ErbB4 variants might function as dominant negatives in relation to ErbB4 signal 
transduction, therefore altered ErbB4 splice variant expression might be simulated by deletion of 
ErbB4 in rodent models.   
5.3.2 NMDAR hypofunction in PV interneurons   
Although the exact causes of PV interneuron dysfunction in schizophrenia is still under 
scrutiny, a widely popular hypothesis posits that hypofunction of NMDAR-mediated signaling 
specifically within PV interneurons, might be a potential primary pathological mechanism in the 
disease process (Lisman et al 2008, Nakazawa et al 2012). Consistent with this idea, initial 
results showed that administration of NMDAR antagonists such as phencyclidine and ketamine 
to healthy adult subjects produced behavioral changes reminiscent of positive, negative and 
cognitive symptoms of schizophrenia (Javitt & Zukin 1991, Krystal et al 1994, Lahti et al 1995). 
Follow up studies involving in vivo electrophysiology in the rat PFC revealed that systemic 
administration of NMDAR antagonist decreased the activity of putative GABA interneurons, 
which at a delayed rate, increased the firing rate of pyramidal cells (Homayoun & Moghaddam 
2007). Importantly, these findings have been interpreted under the premise that PV cell 
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activation is more sensitive to NMDAR antagonists than pyramidal cells for their activation, by 
virtue of greater contribution of NMDARs at glutamate synapses onto PV interneurons, than 
pyramidal cells. As a result, these findings led to the speculation that disinhibition of pyramidal 
cells was mediated by preferential NMDAR hypofunction in PV GABA interneurons (Homayoun 
& Moghaddam 2007, Lisman et al 2008, Seamans 2008). Indeed, NMDAR antagonists in rodent 
studies produced a marked reduction of PV and GAD67 expression in PV interneurons similar 
to that seen in subjects with schizophrenia (Behrens et al 2007, Cochran et al 2003, Kinney et al 
2006). Moreover, conditional knockout of the GluN1 (NR1) subunit during early postnatal 
development in a majority of cortical and hippocampal GABA interneurons, presumably mostly 
PV interneurons, produced similar downregulation of PV and GAD67 protein levels (Belforte et 
al 2010). In fact, specific knockout of GluN1 subunit of the NMDAR in PV interneurons 
generates disruptions in cortical rhythms such as γ-frequency oscillations (Carlen et al 2012, 
Korotkova et al 2010) that are also perturbed in subjects with schizophrenia (Cho et al 2006).  
Despite these findings, there are certain fundamental challenges with the NMDAR 
hypofunction on PV interneuron hypothesis in schizophrenia: First, the relative contribution of 
NMDAR to EPSCs in fast-spiking interneurons compared with pyramidal cells is significantly 
smaller in several cortical regions including the PFC (Gittis et al 2010, Hull et al 2009, Lamsa et 
al 2007, Lu et al 2007, Rotaru et al 2011). In fact, the contribution of AMPAR to EPSCs in fast-
spiking interneurons was significantly larger than in pyramidal cells due to the contribution of 
GluA2-lacking rapidly deactivating AMPARs (Hull et al 2009, Rotaru et al 2011, Wang & Gao 
2010). The greater contribution of AMPARs to EPSCs in fast-spiking interneurons might prime 
these cells for fast synaptic activation in response to pyramidal cell activity for rapid 
depolarization and repolarization required for precise high-frequency firing, favoring the 
integration of coincident inputs necessary for the generation of γ-frequency oscillations 
(Galarreta & Hestrin 2001, Hu et al 2010). In addition, computational network models comparing 
fast AMPAR-mediated vs. slow NMDAR-mediated excitation of fast-spiking interneurons 
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suggest that AMPAR-mediated fast-spiking interneuron excitation is sufficient to support γ-
frequency oscillations (Rotaru et al 2011). Supporting these findings, GluA1- or GluA4-KO in PV 
interneurons in mice had a marked decrement in spiking, reduced temporal precision and lower 
power of γ-frequency oscillations by preventing rapid coupling of excitation with inhibitory output 
(Fuchs et al 2007). In fact, NMDAR antagonists enhance rather than decrease the power of γ-
frequency oscillations in rodent and human models (Hakami et al 2009, Hong et al 2010). 
Second, conditional deletion of GluN1 subunit expression in PV interneurons in adult animals 
produces marginal changes in glutamate neurotransmission and no change in PV and GAD67 
protein levels, consistent with the evidence that in adult mice NMDARs provide a minor 
contribution to PV interneuron EPSCs (Belforte et al 2010). Third, serial electron microscopy 
studies using quantitative postembedding immunogold techniques analyzing synapses on 
interneuron dendrites and pyramidal cell spines have found a significantly lower density of 
GluN1-containing NMDARs onto PV interneurons compared to pyramidal cells (Nyiri et al 2003). 
Similarly, in the adult human cortex, ~70% of PV interneurons lack detectable levels of NMDAR 
subunit mRNAs (Bitanihirwe et al 2009). Fourth, systemic NMDAR antagonist application to 
awake behaving monkeys does not produce disinhibition (Wang et al 2013). Moreover, repeated 
exposure to NMDAR antagonist dizocilpine maleate (MK-801) in rats during adulthood does not 
produce disinhibition of cortical circuits assessed by analyzing local field potentials (Thomases 
et al 2013). Fifth, the disinhibition produced as a result of NMDAR hypofunction in PV 
interneurons is predicted to result in a hyper-excitable circuit, however substantial evidence 
points to a decrease, rather than an increase in the activity of the DLPFC. In fact, a recent meta-
analysis of working memory in schizophrenia has “converged on hypoactivation of the 
dorsolateral prefrontal cortex as the most common finding” (Kern et al 2013), which is in striking 
contrast to the notion of disinhibited cortical circuits (Lisman et al 2008, Nakazawa et al 2012). 
In sum, these studies suggest that NMDAR hypofunction on PV interneurons as a proximal 
primary deficit and cortical disinhibition seem implausible and the effect of NMDAR antagonists 
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is unlikely to be mediated by NMDARs at glutamate synapses in mature cortical PV 
interneurons. 
5.3.3 Role of other mechanisms underlying reduced GABA neurotransmission 
Intrinsic abnormalities in interneurons may arise from alterations in gene products that 
are specifically expressed in these cells. Interneurons are known to depend on the expression 
of voltage-gated potassium channels for the accurate recognition of coincident excitatory 
synaptic inputs that may be critical for the synchronization of cortical networks. Intriguingly, PV 
interneurons exclusively express the Kv9.3 voltage-gated K+ channel modulatory α subunit, 
encoded by the KCNS3 gene (Georgiev et al 2012). These Kv9.3 subunits form heteromeric 
channels with Kv2.1 α subunits, encoded by the KCNB1 gene (Kerschensteiner & Stocker 1999, 
Patel et al 1997). In comparison to homomeric Kv2.1 channels, heteromeric Kv2.1/Kv.9.3 
channels have electrophysiological properties that are particularly suited for coincident input 
detection such as fast synaptic activation, slower deactivation, accelerated closed-state 
inactivation and a maximum of cumulative inactivation shifted towards higher frequencies 
(Kerschensteiner & Stocker 1999, Patel et al 1997). Recent studies using in situ hybridization 
have reported mRNA reductions in both KCNS3 and KCNB1, in the DLPFC of subjects with 
schizophrenia, signifying a decrement in heteromeric Kv2.1/Kv9.3 channels in PV interneurons 
(Georgiev et al 2014, Georgiev et al 2012). Furthermore, microarray analysis revealed 40% 
lower levels of KCNS3 mRNA specifically in PV interneurons captured by laser microdissection, 
further validating dysregulation of PV interneurons in schizophrenia (Georgiev et al 2014). 
Consistent with these results, another report suggests significant reductions in the mRNA and 
protein levels of Kv3.1b, the predominant splice variant of the Kv3.1 channel, which is involved 
in the repolarization of action potentials in neurons and contributes to the fast-spiking phenotype 
of PV interneurons (Yanagi et al 2014). In addition, murine models with disruptions in Kv3.1 and 
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Kv3.2 channels in fast-spiking PV interneurons exhibit alterations in firing patterns and 
synchrony for network oscillations (Joho et al 1999, Lau et al 2000). Genetic studies in 
schizophrenia have also revealed a SNP associated with KCNH2 gene, which encodes for 
another voltage-dependent K+ channel Kv11.1, specifically expressed in the primate brain 
(Huffaker et al 2009). As a result, reduction in the complement of Kv2.1/Kv9.3 and Kv3.1 
channels is expected to slow the time course of EPSPs in PV interneurons, impairing the ability 
of these cells to respond to temporally convergent excitatory inputs from DLPFC deep layer 3 
pyramidal cells. This is turn, will preclude the summation of EPSPs within narrow time windows 
required for synchronizing neural ensembles of pyramidal cells in the range of γ-frequency 
oscillations. 
Other current studies have established a connection between alterations in structural 
components of PV interneurons. PV cells are ensheathed by complex extracellular structures 
called perineuronal nets (PNNs) which consist of chondroitin sulfate proteoglycans and 
extracellular matrix components and these components are generated in an activity-dependent 
fashion (Dityatev et al 2007, Kwok et al 2011). PNNs act as cation sinks which promote the fast-
spiking phenotype of PV interneurons and are also implicated in establishing the opening and 
closing of critical periods during development to regulate synaptic plasticity (Morishita et al 
2015). Using Wisteria floribunda agglutinin which binds to the carbohydrate component of 
PNNs, the density of PNNs was reduced in the PFC in subjects with schizophrenia (Mauney et 
al 2013). In experimental rodent models, these PNN structures are also protective against 
oxidative stress (Cabungcal et al 2013), which might be crucial since redox dysregulation and 
oxidative stress has been implicated in the pathogenesis of schizophrenia (Do et al 2009). 
Consistent with reduced levels of cortical glutathione, an antioxidant, in subjects with 
schizophrenia (Gawryluk et al 2011), these studies provide a strong mechanistic basis for PV 
interneuron dysfunction involving PNN alterations. 
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Finally, deficits in GABA neurotransmission in schizophrenia might be a manifestation of 
impairments in GABA neuron ontogeny during gestation, which precludes normal phenotype 
specification and development. In contrast to pyramidal cells that undergo radial migration from 
the ventricular zone of the pallium during differentiation and maturation (Nadarajah et al 2001, 
Rakic 1995), GABA interneurons undergo tangential migration from the ventricular zone of the 
subpallium (Marin & Rubenstein 2001). The maturation of cortical neurons is adjusted by highly 
intricate extracellular signaling systems (e.g., netrin/DCC, Slit/Robo, Wnt3a) and transcription 
factor cascades (e.g., Pax6, Nkx2.1, Sox6, Lhx6, Dlx5/6, and Gsx1/2) that dictate fate 
specification (Hebert & Fishell 2008, Marin & Rubenstein 2001). Recent studies in postmortem 
tissue in the DLPFC in subjects with schizophrenia have found robust decreases in Lhx6 (Volk 
et al 2012a), which is necessary for the tangential migration of PV and SST interneurons, and 
mRNA levels of Lhx6 and GAD67 were correlated in the same subjects (Volk et al 2014). In fact, 
rodent studies using heterozygous Dlx5/6 mice, homeobox transcription factors that are critical 
for the maturation of PV interneurons, exhibit abnormal PV interneuron-specific intrinsic 
electrophysiological properties, decreased task-evoked γ-frequency oscillations, and 
compromised PFC-dependent cognitive flexibility following adolescence (Cho et al 2015a). 
These findings also demonstrate that stimulation at γ-frequency oscillations can restore 
cognitive flexibility in adult Dlx5/6+/- mice, proposing a potential causal link between disrupted 
ontogenetic factors and GABA interneuron dysfunction (Cho et al 2015a).    
Ultimately, the determination of which hypothesis provides the most persuasive 
explanation of pathophysiological relationships (e.g., alterations in γ-frequency oscillations) in 
the disease process requires mechanistic tests in tractable paradigms to evaluate cause-
consequence-compensation relationships. Given the heterogeneity of symptomatology in 
schizophrenia, it is also conceivable that a certain hypothesis (e.g., cell-autonomous intrinsic 
abnormality in DLPFC deep layer 3 pyramidal cells) may be more applicable to certain 
subpopulations of patients, whereas an alternative hypothesis (e.g., primary deficit in GABA 
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interneurons) may be more relevant to others. It is also imperative to understand how these 
hypotheses may shed light on developmental processes to see how they align with post-
adolescence onset of schizophrenia endophenotypes.     
 
5.4 DISSECTING THE MATURATION OF CORTICAL CIRCUITS THAT 
SUBSERVE WORKING MEMORY FUNCTION IN THE PRIMATE DLPFC 
A thorough understanding of normal brain maturation is critical for advancing our 
knowledge of neurodevelopmental disorders such as schizophrenia. Due to technical limitations, 
direct probing of the normal postnatal refinements of neural cortical circuits in humans in a cell-
specific manner is constrained. As a result, among the possible nonhuman primate models, the 
rhesus macaque (Macaca mulatta) has been extensively used as an experimental animal model 
to interrogate the fundamental neural mechanisms occurring throughout postnatal development. 
Moreover, due to their phylogenetic closeness to the human species, rhesus macaques provide 
an ideal species to investigate more complex cognitive functions and social behaviors. In 
comparison to rodents, rhesus macaques have an expanded PFC that continues to mature in a 
protracted fashion during postnatal development, similar to the human PFC (Nelson & Winslow 
2009). In addition, primates and rodents have marked differences in the gene composition of 
neural progenitor cells, anatomical characteristics and physiological properties of circuit 
assembly (Molnar & Clowry 2012, Rakic 2009).  
An important aspect of understanding the refinements in cortical circuits is to 
contextualize it in the framework for what the developmental trajectories of these circuits may 
tell us about vulnerabilities for the emergence of the various symptoms, cognition in particular, 
in schizophrenia. Over the last 3 decades, schizophrenia has been conceptualized as a disorder 
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of PFC cortical development and various hypotheses have been proposed to integrate aberrant 
developmental processes with the manifestation of clinical symptoms (Feinberg 1982, 
Keshavan et al 1994, Murray & Lewis 1987, Weinberger 1987). More recent theories have 
advocated that schizophrenia may be perceived as a “cognitive brain network disorder” with 
disruptions in integration across functionally similar brain regions, which might occur early in 
brain development (Dauvermann et al 2014). The sculpting of normative connectivity patterns 
during postnatal development is orchestrated by a myriad of intrinsic programming mechanisms 
that are temporally controlled by various guidance cues, signaling molecules, and activity-
dependent pruning processes (Schubert et al 2015). In fact, recent genomic studies provide the 
first evidence that gene networks that undergo de novo mutations in schizophrenia are highly 
co-expressed in the fetal prefrontal cortex and functionally participate in migration, 
transcriptional regulation, signaling and synaptic transmission during development (Gulsuner et 
al 2013). Given the fact that PFC circuits involve sensitive periods of increased vulnerability for 
the pathogenesis of the disease, such that specific elements of the circuitry are selectively 
vulnerable to environmental insults during specific epochs in postnatal development (Hoftman & 
Lewis 2011), even a slight perturbation to the delicate balance of the system might result in 
deleterious consequences and contribute to neurodevelopmental disorders such as 
schizophrenia. In the following section, I will contrast the maturation of GABA and glutamate 
neurotransmission during postnatal development in the monkey DLPFC and based on the 
inflection points of GABA and glutamate postsynaptic markers, I will shed light on what 
components of DLPFC circuitry may be particularly prone to environmental insults during 
specific sensitive periods.   
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5.4.1 Molecular postsynaptic features of GABA neurotransmission undergo 
protracted developmental changes 
In DLPFC area 9 and 46, using single-cell laser capture microdissection, in conjunction 
with qPCR gene expression profiling, we provide evidence showing that the expression of 
molecular postsynaptic determinants of GABA neurotransmission in pyramidal cells changes in 
a subunit- and layer-specific fashion during postnatal development. For example, in layer 3 
pyramidal cells in the monkey DLPFC, the expression of the GABAA α1 subunit progressively 
increases from the perinatal period to adulthood, which is paralleled by a decline in expression 
of the GABAA α2 subunit during the same developmental period, in the same cells. In contrast, 
in DLPFC layer 5 pyramidal cells, we observed a similar, yet modest, increase in the expression 
of the GABAA α1 subunit, but no change in expression for the GABAA α2 subunit during 
postnatal development. The developmental trajectories of other GABA-related transcripts critical 
in mediating GABA neurotransmission (e.g., GABAA α5, GABAA β2, GABAA γ2, GABAA δ) in 
pyramidal cells in the DLPFC have similar dynamic and complex patterns of change. The 
developmental trajectories for these transcripts are protracted, extending from birth through 
adolescence, and show different patterns of change depending on the laminar-location of the 
pyramidal cell.  
The developmental shifts in expression of GABAA receptor subunits may be particularly 
relevant for pyramidal cells in layer 3 that are part of the microcircuit that is crucial for the 
generation of γ-frequency oscillations. The progressive shift in the subunit composition to 
GABAA α1 subunit-containing receptors is predicted to result in faster inhibitory decay kinetics, 
which is particularly important since γ-frequency oscillations depend critically on the decay time 
course for inhibition (Bartos et al 2007, Buzsaki & Wang 2012). Consistent with these findings, 
recent studies investigating the functional development of GABA synapses using 
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electrophysiology in in vitro living slice preparations in monkey DLPFC layer 3 pyramidal cells 
during postnatal development, found that the decay of GABAAR-mediated inhibitory 
postsynaptic currents (GABAAR-IPSCs) decreased while the amplitude of GABAAR-IPSCs 
increased until the peripubertal period (Gonzalez-Burgos et al 2014). In particular, this 
progressive shift towards faster and stronger inhibitory currents may be necessary for fast-
spiking PV interneurons to temporally synchronize pyramidal cell ensembles through feedback 
inhibition, thereby providing the functional capacity to support γ-frequency oscillations (Bartos et 
al 2007, Buzsaki & Wang 2012). In fact, in rodent cortical and hippocampal pyramidal cells, a 
similar decrease in GABAAR-IPSCs has been attributed to a developmental upregulation of 
GABAA α1 subunit-containing receptors, although the maturation of circuits in primates occurs in 
a prolonged fashion compared to rodents (Bosman et al 2002, Cohen et al 2000, Pinto et al 
2010). Moreover, simulations in computational network models predicted that mature levels of γ-
band power are attained at late stages of development in the monkey DLPFC (Gonzalez-Burgos 
et al 2014). Therefore, both the molecular determinants of GABA neurotransmission and 
functional inhibitory synaptic properties of DLPFC layer 3 pyramidal cells, continue to 
progressively develop in a protracted manner during circuit maturation.  
The molecular and functional maturation of GABA synapses during postnatal 
development may have significant ramifications for emergent behaviors that depend on the 
circuitry of the DLPFC in primates, such as working memory. Behavioral performance involving 
working memory tasks first appears around 2-3 years of age and continues to improve during 
postnatal development and involves increased recruitment of activity in the DLPFC (Alexander 
1982, Alexander & Goldman 1978). Individuals who later go on to develop schizophrenia, fail to 
show this normal age-related improvement in working memory in late childhood and during 
adolescence, roughly between 7-15 years (Reichenberg et al 2010). Moreover, working memory 
load is proportional to PFC γ-frequency oscillations, in particular power of γ-frequency 
oscillations (Howard et al 2003). Subjects with schizophrenia fail to show bilateral increase in 
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the power of γ-frequency oscillations during working memory tasks (Cho et al 2006, Minzenberg 
et al 2010). Therefore, it is clear that the capacity for working memory is increasing during 
postnatal development, and working memory is dependent on γ-frequency oscillations. These 
findings highlight a critical question: How is the maturation of γ-frequency oscillations changing 
during postnatal development? Recent studies suggest that the power of 40 Hz auditory steady-
state responses progressively increases with age, reaching a peak during adolescence (Cho et 
al 2015b). In addition, γ-frequency oscillation synchrony using a Gestalt perception task in 
parietal regions, increased in a monotonic fashion from childhood to adulthood (Uhlhaas et al 
2009, Uhlhaas & Singer 2006, Uhlhaas & Singer 2010). Consistent with these findings, fMRI 
studies using blood oxygenation level-dependent (BOLD) signal which correlates positively with 
γ-frequency oscillation activity (Magri et al 2012, Niessing et al 2005), have observed that 
working memory performance and DLPFC activity continue to develop through late adolescence 
(Luna & Sweeney 2004, Scherf et al 2006). However, the development of functional oscillatory 
activity in the DLPFC has not been directly explored and remains an important question for 
future experiments.  
In aggregate, the findings presented in this dissertation might provide an important 
molecular substrate for the protracted maturation of GABA synapses required for sustaining γ-
frequency oscillations and the emergent property of working memory function during postnatal 
development. Since numerous environmental exposures from birth through adolescence have 
been associated with increased risk for schizophrenia (Hoftman & Lewis 2011, van Os et al 
2010), the trajectories for different GABA transcripts may be susceptible to the influence of 
unique environmental exposures which operate during specific sensitive periods, to affect 
specific components of cortical circuits. This might explain why the cumulative effect of multiple 
environmental insults (e.g., cannabis exposure, stress) can exacerbate the risk for the 
development of schizophrenia, since different environmental insults affect different components 
of neuronal circuits that are rapidly changing during postnatal maturation.   
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5.4.2 Molecular postsynaptic features of glutamate neurotransmission remain 
static 
In contrast to the dynamic and complex developmental trajectories of the molecular 
determinants of GABA neurotransmission, the postsynaptic molecular determinants of 
glutamate neurotransmission (AMPA GluA1 and NMDA GluN1, encoded by AMPA Glur1 and 
NMDA Grin1, respectively) revealed an intriguing pattern in pyramidal cells across laminar 
location. The expression level of the NMDA GluN1 subunit was consistently higher in layer 3 
pyramidal cells compared to layer 5 pyramidal cells, although the developmental trajectory is 
relatively stable and achieve adult levels of expression early during the perinatal period 
(Chapter 4). In contrast, the expression of the AMPA GluR1 subunit was consistently higher in 
layer 5 pyramidal cells compared to layer 3 pyramidal cells (Chapter 4). Together, the NMDA 
GluN1/AMPA GluA1 subunit ratio was at least >2-fold higher in layer 3 pyramidal cells 
compared to layer 5 pyramidal cells in the DLPFC of monkeys throughout postnatal 
development, at every age group. The mean NMDA GluN1/AMPA GluA1 subunit mRNA ratio 
increased by 67% from the perinatal (3 animals 1 week of age) to peripubertal monkeys (3 
animals ~32 months of age). Analysis by age group revealed significant differences in NMDA 
GluN1/AMPA GluA1 subunit mRNA ratio levels in layer 3 (F3,22=11.6, P<0.001) pyramidal cells, 
with post hoc analyses revealing significant (P<0.05) increases between perinatal to 
peripubertal age groups (Figure 22). However, NMDA GluN1/AMPA GluA1 subunit mRNA ratio 
levels in layer 5 (F3,22=2.0, P=0.141) showed no change during postnatal development (Figure 
22).   
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Figure 22. Developmental trajectories of glutamate receptor NMDA GluN1/AMPA GluA1 subunit 
mRNA ratio levels in layers 3 and 5 pyramidal cells of monkey DLPFC. 
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(A) Panel shows the expression for the NMDA GluN1/AMPA GluA1 subunit mRNA ratio in individual 
subjects for layer 3 (red circles) or layer 5 (blue circles) pyramidal cells. (B) Mean (SD) expression ratios 
for each age group; age groups not sharing the same letter are significantly different (P<0.05). 
This dichotomous relationship between the expression of the principal subunits of NMDA 
and AMPA receptors in layer 3 and 5 pyramidal cells is congruent with recent findings 
suggesting that the persistent firing from recurrent excitation within the network of DLPFC layer 
3 “Delay” cells is dependent on NMDA receptor stimulation (Wang et al 2013). DLPFC layer 3 
“Delay” cells are usually spatially tuned and maintain persistent firing during the delay period of 
working memory tasks, and convey information to “Response” cells primarily localized in layer 5 
which fire in anticipation of, during and after the motor response during working memory tasks 
(Arnsten et al 2012, Sawaguchi et al 1989). Iontophoresis of specific antagonists for GluN2A 
and GluN2B receptor subunits in monkeys performing spatial working memory tasks suggests 
that NMDA GluN2B subunits are critical for DLPFC layer 3 “Delay” cells, since persistent firing 
was eliminated by local GluN2B NMDAR blockade (Wang et al 2013). Similar to our findings 
suggesting that the molecular composition of AMPARs is higher in layer 5 “Response” cells, the 
data from Arnsten and colleagues also revealed that layer 5 “Response” cells are selectively 
sensitive to AMPAR blockade (Wang et al 2013). These findings were validated by 
immunoelectron microscopy studies showing that NMDA GluN2B subunits are found exclusively 
within the postsynaptic density of DLPFC layer 3 spinous synapses in adult monkeys (Wang et 
al 2013). 
The molecular and electrophysiological findings are consistent with an emerging notion 
from theoretical computation models with biophysically realistic simulations of activity in cortical 
neuronal networks, suggesting that spatial working memory is more stable, if network recurrent 
excitation between pyramidal cells is primarily mediated by slow voltage-gated NMDA receptors 
in DLPFC deep layer 3 microcircuits (Compte et al 2000, Lisman et al 1998, Wang 1999). 
NMDA receptor activation supports slow reverberating excitation and this pattern of excitation is 
crucial for the sustained firing of DLPFC deep layer 3 pyramidal neurons in the absence of 
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external stimulation (Compte et al 2000, Lisman et al 1998, Wang 1999, Wang 2001). In 
contrast, the decay of AMPA-receptor mediated EPSCs are three times faster than the decay of 
GABAA receptor mediated IPSCs (Aksay et al 2001, Hestrin 1993). As a result, a system with 
fast-positive and slow-negative feedback is dynamically unstable and can lead to network 
collapse. Thus, persistent activity mediated through NMDA-receptors might provide the 
necessary stability to sustain network oscillations in the γ-frequency range, which is generated 
in layer 3 association cortices (Buffalo et al 2011, Compte et al 2000, Quilichini et al 2010). 
These molecular findings are relatively consistent with functional development of 
glutamate synapses in monkey DLPFC deep layer 3 pyramidal cells. Whole-cell patch clamp 
recordings in in vitro slice preparations of monkey DLPFC have revealed that excitatory inputs 
to deep layer 3 pyramidal cells had mature functional properties by 15-months of age which 
persisted throughout postnatal development (Gonzalez-Burgos et al 2008). The molecular and 
functional maturation of glutamate synapses in monkey DLPFC deep layer 3 pyramidal cells 
differ starkly from the structural maturation of excitatory inputs. For example, previous studies 
have shown that the density of dendritic spines located on the basilar dendrites on layer 3 
pyramidal cells increase substantially during late gestation which reaches a plateau during late 
childhood, and then declines during adolescence (Anderson et al 1995). Similarly, in the human 
DLPFC, pyramidal neuron spine density undergoes a dramatic increase after birth to peak in 
childhood, and then declines during adolescence until the third decade of life (Petanjek et al 
2011). In sum, it appears as though the molecular and functional maturation of glutamate 
synapses in deep layer 3 pyramidal cells occur prior to the pruning of synapses during late 
adolescence. Importantly, based on the inflection points of the developmental trajectories of 
GABA and glutamate synapses, it seems as though the molecular and functional maturation of 
glutamate synapses in DLPFC deep layer 3 occurs significantly earlier than the molecular and 
functional maturation of GABA synapses (Figure 23). Although speculative, these contrasting 
patterns for GABA and glutamate neurotransmission suggest that glutamate synapses may not 
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be as susceptible as GABA synapses, to the influence of unique environmental exposures 
during specific sensitive periods. 
 
Figure 23. Developmental trajectories of GABA and glutamate postsynaptic markers in monkey 
DLPFC. 
(A) Subcellular organization of GABA and glutamate postsynaptic markers in pyramidal cells. 
(B) Schematic summary of developmental trajectories of GABAA receptor subunits and (C) 
glutamate receptor subunit in DLPFC deep layer 3 (solid lines) and layer 5 (dashed lines) 
pyramidal cells. The protracted maturation profile for GABA postsynaptic markers during 
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postnatal development might explain why various environmental insults operating during 
sensitive time windows, can act on different components of DLPFC circuitry and increase the 
risk for schizophrenia. In contrast, the maturation profile for glutamate postsynaptic markers is 
relatively stable and less susceptible to environmental insults.  
 
 
5.5 CONCLUDINGS REMARKS: THE NEXT FRONTIER IS UNDERSTANDING 
PATHOLOGY AT THE LEVEL OF SUBNETWORKS  
The different lines of evidence presented thus far, provide compelling evidence of a cell-
autonomous intrinsic abnormality in DLPFC deep layer 3 pyramidal cells that might be the 
primary deficit in the pathogenesis of schizophrenia. However, accumulating evidence supports 
the notion that even in an individual cortical layer, pyramidal cells are highly heterogeneous, 
have different local connection probabilities, distinct long-range projection targets, variability in 
intrinsic and functional properties, qualitative and quantitative differences in morphological 
properties and receive presynaptic inputs from different sources (Adesnik & Scanziani 2010, 
Beed et al 2010, Le Be et al 2007, Morishima & Kawaguchi 2006, Otsuka & Kawaguchi 2008). 
For example, using paired recordings and quantitative morphological analysis, recent evidence 
suggests that layer 5 forebrain corticopontine (CPn) projecting cells showed great reciprocal 
connectivity between each other, while avoiding corticostriatal (CCS) projecting cells (Morishima 
et al 2011). In contrast, in layer 5 of the visual cortex, the probability of feedforward connections 
from corticocortical cells to corticotectal cells is 4-fold higher than the probability of 
monosynaptic connections among corticocortical or corticotectal cells (Brown & Hestrin 2009). 
Therefore, it seems like different connectivity motif schemes may dictate the organization of 
subpopulations of excitatory cells depending on the brain region of interest. These connectivity 
motifs may be organized during neuronal differentiation as previous studies have shown that 
ontogenetic radially aligned sister excitatory cells have a propensity to be reciprocally connected 
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with each other rather than neighboring non-siblings, within a microcircuit of a functional cortical 
column (Yu et al 2009). Furthermore, a recent study puts forth the idea that genetically defined 
subpopulations of pyramidal cells share distinct neurogenesis and synaptogenesis time 
windows and are preferentially interconnected within a hippocampal microcircuit (dentate gyrus-
CA3 and CA3-CA1) (Deguchi et al 2011).    
Intriguingly, there is a growing consensus that pyramidal cells that can be subdivided 
into different subpopulations project to and are targeted by distinct subtypes of GABA 
interneurons, and may partake in separate information processing channels in neuronal 
networks (Bortone et al 2014, Krook-Magnuson et al 2012, Yoshimura & Callaway 2005). 
Supporting this idea, a recent study in the hippocampus using a combination of in vitro paired 
intracellular recordings, in vivo two-photon functional imaging in awake mice, and computational 
modeling showed that PVb cells evoked several times greater postsynaptic currents in CA1 
pyramidal cells located in the deep layers compared to the superficial layers of the stratum 
pyramidale (Lee et al 2014b). In addition, the study showed that PVb cells preferentially 
innervated pyramidal cells projecting to the amygdala but received excitatory innervation from 
pyramidal cells that projected to the cortex (Lee et al 2014b). Similarly, CCK basket cells 
selectively innervate calbindin expressing pyramidal cells in layer 2 of the medial entorhinal 
cortex that project to the contralateral entorhinal cortex, but avoid reelin expressing pyramidal 
cells that project to the ipsilateral dentate gyrus (Varga et al 2010). In the striatum, fast-spiking 
GABA interneurons, selectively target direct-pathway medium spiny neurons (MSNs) over 
indirect-pathway MSNs, providing a mechanism for pathway-specific regulation of striatal output 
pathways (Gittis et al 2010). Finally, in the visual cortex, corticocortical pyramidal cells receive 
~8-fold greater inputs onto their AIS from axoaxonic cells than corticothalamic cells (Farinas & 
DeFelipe 1991).  
This raises the question, is a similar phenomenon of GABA interneuron specialization 
observed in the PFC, such that certain subpopulations of GABA interneurons selectively 
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innervate subpopulations of pyramidal cells? Indeed, using optogenetic stimulation paradigms, 
an elegant recent study found that fast-spiking PV interneurons preferentially innervate layer 5 
thick-tufted, subcortically projecting type A cells, with prominent h-current, while avoiding thin-
tufted callosally projecting type B cells, lacking a prominent h-current (Lee et al 2014a). The 
specificity of PV interneuron innervation to pyramidal cell subpopulations may have important 
implications for the computational properties of these cells during network activity. These 
findings are consistent with previous studies showing that disynaptic inhibition occurs with a 
higher probability between thick-tufted layer 5 pyramidal cells that are reciprocally connected, 
than callosally projecting layer 5 pyramidal cells (Le Be et al 2007). However, these findings are 
not in agreement with other studies which suggest that GABA interneuron connectivity, primarily 
in layer 2/3 in the somatosensory and frontal cortex resembles a “blanket of inhibition” such that 
GABA interneurons contact nearby pyramidal cells very densely without any apparent specificity 
(Fino & Yuste 2011, Inan et al 2013, Packer & Yuste 2011). These differences may be 
explained by several plausible reasons including laminar-specificity, brain region under 
investigation and technical methods applied to assess connectivity patterns between GABA 
interneurons and pyramidal cells. Interestingly, a recent report postulates that rather than 
exerting homogeneous inhibition in a uniform manner in postsynaptic pyramidal cells, the 
strength of inhibition is matched in a heterogeneous fashion depending on the amount of 
excitation received by the postsynaptic pyramidal cell (Xue et al 2014). As a consequence, E/I 
balance ratios are equalized across pyramidal cells such that when excitation increases, 
inhibition increases proportionally through increased recruitment of inhibitory drive by 
independent adjustment of synapses, primarily from PV interneurons (Xue et al 2014). 
Moreover, it is also pertinent to mention that, connectivity patterns between molecularly defined 
subpopulations of GABA interneurons themselves show cell type-specificity. At least in the 
supragranular and infragranular layers of the visual and somatosensory cortex, PV interneurons 
strongly inhibit each other but provide little inhibition to other interneurons, whereas SST 
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interneurons inhibit all other interneuron subtypes but avoid one another and VIP interneurons 
selectively target only SST interneurons (Pfeffer et al 2013, Pi et al 2013).      
 
 
In sum, it appears as though pyramidal cells with distinct long-distance axonal projection 
patterns may have unique connectivity patterns, forming subnetworks within spatially 
intermingled cortical circuits. Intriguingly, GABA interneurons show domain specificity, selectivity 
in targeting the subcellular compartment along the somatodendritic arbor of pyramidal cells, and 
subnetwork specificity, by innervating specific subpopulations of pyramidal cells. Although, the 
functional implication of these selective innervation patterns to pyramidal cell subnetworks 
remains to be elucidated, this interneuron specialization represents an unrecognized form of 
GABA microcircuit specificity (Harris & Shepherd 2015, Krook-Magnuson et al 2012). As 
described above, in the context of the disease process of schizophrenia, GABA interneurons 
exhibit pre- and postsynaptic alterations to reduce feedback inhibition in response to reduce 
excitatory drive to DLPFC deep layer 3 pyramidal cells. However, based on emerging evidence, 
is it plausible that certain pyramidal cell subpopulations that receive preferential innervation from 
specific subtypes of GABA interneurons in the local microcircuit are preferentially affected in 
schizophrenia? Our nuanced understanding of cortical microcircuits from newer experimental 
approaches available primarily in rodents provides exciting opportunities for future investigation, 
with the underlying hope that advances in basic neuroscience may be applied to probing 
pathological disturbances in schizophrenia at even higher levels of spatial resolution. Ultimately, 
understanding such complex relationships within cortical microcircuits in schizophrenia might 
eventually facilitate in the discovery of novel therapeutic targets.   
 
 
155 
APPENDIX A 
Altered Expression of CDC42 Signaling Pathway Components in Cortical 
Layer 3 Pyramidal Cells in Schizophrenia 
Supplemental Information 
Antipsychotic-exposed Monkeys 
From each monkey in a triad, 150 individually-dissected pyramidal cells were 
collected from DLPFC deep layer 3. Total RNA was extracted (QIAGEN RNeasy 
microkit Plus), cDNA synthesized (QUANTA BioSciences qScriptTM cDNA SuperMix) 
and microarray analysis conducted using GeneChip® Rhesus Macaque Genome Array 
(Affymetrix, Santa Clara, CA) with all samples from a given triad processed together. All 
studies were carried out in accordance with the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals and were approved by the University of 
Pittsburgh Institutional Animal Care and Use Committee.  
Statistical Analysis 
Microarray Sample Probe Set Filtering and Correction for Multiple Comparisons 
A detailed description of the statistical analyses used for the microarray data is 
provided in Arion et al. 2014. Briefly, the Affymetrix CEL files were normalized and log2 
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transformed using RMA Express. Using a previously published method to filter the 
probe sets, the microarray dataset was filtered to 1) remove low expression probe sets 
by eliminating the lowest 40% mean intensities across all samples, and 2) remove non-
informative probe sets by eliminating probe sets with the lowest 40% standard deviation 
across all samples. The microarray data set was then analyzed using the Random 
Intercept Model with Bayesian Information Criterion variable selection (RIM-BIC). In 
order to combine the differential expression information for each transcript, an 
adaptively weighted Fisher’s method was used. The meta-analyzed p-values were then 
corrected for multiple comparisons using the Benjamini-Hochberg protocol to control 
false discovery rate. Finally, the potential influence of comorbid or confounding 
variables (sex, age, schizoaffective disorder diagnosis, suicide, RIN, PMI, pH, 
benzodiazepine or valproic acid use ATOD, antidepressant use ATOD and tobacco use 
ATOD) on differentially expressed probe sets was determined. 
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Table 5. Table S1. Demographic, postmortem, and clinical characteristics of human subjects used 
in this study 
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● Subject pairs used for microarray study.  
a C, normal comparison; S, schizophrenia;  
b A, age in years; B, black; F, female; M, male; R, race; S, sex; W, white;  
c PMI, postmortem interval (hours);  
d Storage time (months) at -80°C;  
e ASCVD, arteriosclerotic cardiovascular disease; GI, gastrointestinal; 
f DS, disorganized schizophrenia; N, none; PS, paranoid schizophrenia; SA, schizoaffective 
disorder; US, undifferentiated schizophrenia;  
g ADC, alcohol dependence, current at time of death; ADR, alcohol dependence, in remission at 
time of death; AAC, alcohol abuse, current at time of death; AAR, alcohol abuse, in remission at time of 
death; ODC, other substance dependence, current at time of death; ODR, other substance dependence, 
in remission at time of death; OAC, other substance abuse, current at time of death; OAR, other 
substance abuse, in remission at time of death;  
h BZ, benzodiazepines; VPA, sodium valproate; ATOD, at time of death;  
Y, yes; N, no. 
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Table 6. Table S2. Sequences and priming efficiency for all human qPCR primer sets used in this 
study 
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APPENDIX B 
Table 7. Supplemental Table 1: Rhesus Macaque Monkeys used in this study 
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Table 8. Supplemental Table 2: Primer sequences for transcripts assessed during postnatal 
development in monkey DLPFC 
 
 163 
BIBLIOGRAPHY 
Reference List 
 
Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, et al. 2002. Prefrontal dopamine D1 
receptors and working memory in schizophrenia. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 22: 3708-19 
Addington J, Addington D. 1999. Neurocognitive and social functioning in schizophrenia. 
Schizophrenia bulletin 25: 173-82 
Adesnik H, Scanziani M. 2010. Lateral competition for cortical space by layer-specific horizontal 
circuits. Nature 464: 1155-60 
Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, et al. 1995. Gene expression for 
glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of 
schizophrenics. Archives of general psychiatry 52: 258-66 
Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, et al. 1999. Lamina-specific alterations in 
the dopamine innervation of the prefrontal cortex in schizophrenic subjects. The 
American journal of psychiatry 156: 1580-9 
Aksay E, Gamkrelidze G, Seung HS, Baker R, Tank DW. 2001. In vivo intracellular recording 
and perturbation of persistent activity in a neural integrator. Nature neuroscience 4: 184-
93 
Alexander GE. 1982. Functional development of frontal association cortex in monkeys: 
behavioural and electrophysiological studies. Neurosciences Research Program bulletin 
20: 471-9 
Alexander GE, Goldman PS. 1978. Functional development of the dorsolateral prefrontal cortex: 
an analysis utlizing reversible cryogenic depression. Brain research 143: 233-49 
Ali AB, Thomson AM. 2008. Synaptic alpha 5 subunit-containing GABAA receptors mediate 
IPSPs elicited by dendrite-preferring cells in rat neocortex. Cerebral cortex 18: 1260-71 
Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, et al. 2008. Systematic meta-
analyses and field synopsis of genetic association studies in schizophrenia: the SzGene 
database. Nature genetics 40: 827-34 
Allen PB, Ouimet CC, Greengard P. 1997. Spinophilin, a novel protein phosphatase 1 binding 
protein localized to dendritic spines. Proceedings of the National Academy of Sciences 
of the United States of America 94: 9956-61 
Alvarez VA, Sabatini BL. 2007. Anatomical and physiological plasticity of dendritic spines. 
Annual review of neuroscience 30: 79-97 
Amateau SK, McCarthy MM. 2002. A novel mechanism of dendritic spine plasticity involving 
estradiol induction of prostaglandin-E2. The Journal of neuroscience : the official journal 
of the Society for Neuroscience 22: 8586-96 
Amatrudo JM, Weaver CM, Crimins JL, Hof PR, Rosene DL, Luebke JI. 2012. Influence of 
highly distinctive structural properties on the excitability of pyramidal neurons in monkey 
 164 
visual and prefrontal cortices. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 32: 13644-60 
Anderson SA, Classey JD, Conde F, Lund JS, Lewis DA. 1995. Synchronous development of 
pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron 
axon terminals in layer III of monkey prefrontal cortex. Neuroscience 67: 7-22 
Andreasen NC, Flaum M. 1991. Schizophrenia: the characteristic symptoms. Schizophrenia 
bulletin 17: 27-49 
Araya R, Eisenthal KB, Yuste R. 2006. Dendritic spines linearize the summation of excitatory 
potentials. Proceedings of the National Academy of Sciences of the United States of 
America 103: 18799-804 
Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, et al. 1998. Regulation of actin 
dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393: 805-9 
Arikkath J, Reichardt LF. 2008. Cadherins and catenins at synapses: roles in synaptogenesis 
and synaptic plasticity. Trends in neurosciences 31: 487-94 
Arion D, Corradi JP, Shaowu T, Datta D, Boothe F, et al. 2014. Distinctive transcriptome 
alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. 
Molecular psychiatry  
Arion D, Corradi JP, Tang S, Datta D, Boothe F, et al. 2015. Distinctive transcriptome alterations 
of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. Molecular 
psychiatry  
Arion D, Lewis DA. 2011. Altered expression of regulators of the cortical chloride transporters 
NKCC1 and KCC2 in schizophrenia. Archives of general psychiatry 68: 21-31 
Arion D, Unger T, Lewis DA, Mirnics K. 2007. Molecular markers distinguishing supragranular 
and infragranular layers in the human prefrontal cortex. The European journal of 
neuroscience 25: 1843-54 
Armstrong C, Soltesz I. 2012. Basket cell dichotomy in microcircuit function. The Journal of 
physiology 590: 683-94 
Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, et al. 1995. Smaller neuron size in 
schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. 
The American journal of psychiatry 152: 738-48 
Arnsten AF. 2009. Stress signalling pathways that impair prefrontal cortex structure and 
function. Nature reviews. Neuroscience 10: 410-22 
Arnsten AF, Wang MJ, Paspalas CD. 2012. Neuromodulation of thought: flexibilities and 
vulnerabilities in prefrontal cortical network synapses. Neuron 76: 223-39 
Baddeley A. 1992. Working memory. Science 255: 556-9 
Baddeley A. 2003. Working memory: looking back and looking forward. Nature reviews. 
Neuroscience 4: 829-39 
Baquet ZC, Gorski JA, Jones KR. 2004. Early striatal dendrite deficits followed by neuron loss 
with advanced age in the absence of anterograde cortical brain-derived neurotrophic 
factor. The Journal of neuroscience : the official journal of the Society for Neuroscience 
24: 4250-8 
Barbas H, Henion TH, Dermon CR. 1991. Diverse thalamic projections to the prefrontal cortex in 
the rhesus monkey. The Journal of comparative neurology 313: 65-94 
Barch DM. 2006. What can research on schizophrenia tell us about the cognitive neuroscience 
of working memory? Neuroscience 139: 73-84 
Bartos M, Vida I, Jonas P. 2007. Synaptic mechanisms of synchronized gamma oscillations in 
inhibitory interneuron networks. Nature reviews. Neuroscience 8: 45-56 
Beasley CL, Zhang ZJ, Patten I, Reynolds GP. 2002. Selective deficits in prefrontal cortical 
GABAergic neurons in schizophrenia defined by the presence of calcium-binding 
proteins. Biological psychiatry 52: 708-15 
 165 
Beaulieu C, Kisvarday Z, Somogyi P, Cynader M, Cowey A. 1992. Quantitative distribution of 
GABA-immunopositive and -immunonegative neurons and synapses in the monkey 
striate cortex (area 17). Cerebral cortex 2: 295-309 
Beed P, Bendels MH, Wiegand HF, Leibold C, Johenning FW, Schmitz D. 2010. Analysis of 
excitatory microcircuitry in the medial entorhinal cortex reveals cell-type-specific 
differences. Neuron 68: 1059-66 
Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, et al. 2007. Ketamine-induced loss of 
phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318: 
1645-7 
Beierlein M, Gibson JR, Connors BW. 2000. A network of electrically coupled interneurons 
drives synchronized inhibition in neocortex. Nature neuroscience 3: 904-10 
Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, et al. 2010. Postnatal NMDA receptor ablation in 
corticolimbic interneurons confers schizophrenia-like phenotypes. Nature neuroscience 
13: 76-83 
Benavides-Piccione R, Fernaud-Espinosa I, Robles V, Yuste R, DeFelipe J. 2013. Age-based 
comparison of human dendritic spine structure using complete three-dimensional 
reconstructions. Cerebral cortex 23: 1798-810 
Benes FM, Todtenkopf MS, Logiotatos P, Williams M. 2000. Glutamate decarboxylase(65)-
immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and 
bipolar brain. Journal of chemical neuroanatomy 20: 259-69 
Beneyto M, Abbott A, Hashimoto T, Lewis DA. 2011. Lamina-specific alterations in cortical 
GABA(A) receptor subunit expression in schizophrenia. Cerebral cortex 21: 999-1011 
Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - a practical and powerful 
approach to multiple testing. Journal of the Royal Statistical Society Series B-
Methodological 57: 289-300 
Benson DL, Huntsman MM, Jones EG. 1994. Activity-dependent changes in GAD and 
preprotachykinin mRNAs in visual cortex of adult monkeys. Cerebral cortex 4: 40-51 
Berry N, Jobanputra V, Pal H. 2003. Molecular genetics of schizophrenia: a critical review. 
Journal of psychiatry & neuroscience : JPN 28: 415-29 
Bezaire MJ, Soltesz I. 2013. Quantitative assessment of CA1 local circuits: knowledge base for 
interneuron-pyramidal cell connectivity. Hippocampus 23: 751-85 
Bharadwaj R, Jiang Y, Mao W, Jakovcevski M, Dincer A, et al. 2013. Conserved chromosome 
2q31 conformations are associated with transcriptional regulation of GAD1 GABA 
synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 33: 11839-
51 
Bian WJ, Miao WY, He SJ, Qiu Z, Yu X. 2015. Coordinated Spine Pruning and Maturation 
Mediated by Inter-Spine Competition for Cadherin/Catenin Complexes. Cell 162: 808-22 
Bitanihirwe BK, Lim MP, Kelley JF, Kaneko T, Woo TU. 2009. Glutamatergic deficits and 
parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC 
psychiatry 9: 71 
Bloodgood BL, Sabatini BL. 2005. Neuronal activity regulates diffusion across the neck of 
dendritic spines. Science 310: 866-9 
Boehm S, Betz H. 1997. Somatostatin inhibits excitatory transmission at rat hippocampal 
synapses via presynaptic receptors. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 17: 4066-75 
Bonhoeffer T, Yuste R. 2002. Spine motility. Phenomenology, mechanisms, and function. 
Neuron 35: 1019-27 
Bortone DS, Olsen SR, Scanziani M. 2014. Translaminar inhibitory cells recruited by layer 6 
corticothalamic neurons suppress visual cortex. Neuron 82: 474-85 
 166 
Bosman LW, Rosahl TW, Brussaard AB. 2002. Neonatal development of the rat visual cortex: 
synaptic function of GABAA receptor alpha subunits. The Journal of physiology 545: 
169-81 
Bourgeois JP, Goldman-Rakic PS, Rakic P. 1994. Synaptogenesis in the prefrontal cortex of 
rhesus monkeys. Cerebral cortex 4: 78-96 
Bourne JN, Harris KM. 2008. Balancing structure and function at hippocampal dendritic spines. 
Annual review of neuroscience 31: 47-67 
Brandon NJ, Sawa A. 2011. Linking neurodevelopmental and synaptic theories of mental illness 
through DISC1. Nature reviews. Neuroscience 12: 707-22 
Broadbelt K, Byne W, Jones LB. 2002. Evidence for a decrease in basilar dendrites of pyramidal 
cells in schizophrenic medial prefrontal cortex. Schizophrenia research 58: 75-81 
Brown SP, Hestrin S. 2009. Intracortical circuits of pyramidal neurons reflect their long-range 
axonal targets. Nature 457: 1133-6 
Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. 1979. Cognitive deficit caused by regional 
depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-32 
Buchanan RW, Vladar K, Barta PE, Pearlson GD. 1998. Structural evaluation of the prefrontal 
cortex in schizophrenia. The American journal of psychiatry 155: 1049-55 
Buffalo EA, Fries P, Landman R, Buschman TJ, Desimone R. 2011. Laminar differences in 
gamma and alpha coherence in the ventral stream. Proceedings of the National 
Academy of Sciences of the United States of America 108: 11262-7 
Buzsaki G, Draguhn A. 2004. Neuronal oscillations in cortical networks. Science 304: 1926-9 
Buzsaki G, Schomburg EW. 2015. What does gamma coherence tell us about inter-regional 
neural communication? Nature neuroscience 18: 484-9 
Buzsaki G, Wang XJ. 2012. Mechanisms of gamma oscillations. Annual review of neuroscience 
35: 203-25 
Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, et al. 2002. Postmortem 
assessment of thalamic nuclear volumes in subjects with schizophrenia. The American 
journal of psychiatry 159: 59-65 
Cabungcal JH, Steullet P, Morishita H, Kraftsik R, Cuenod M, et al. 2013. Perineuronal nets 
protect fast-spiking interneurons against oxidative stress. Proceedings of the National 
Academy of Sciences of the United States of America 110: 9130-5 
Cahill ME, Xie Z, Day M, Photowala H, Barbolina MV, et al. 2009. Kalirin regulates cortical spine 
morphogenesis and disease-related behavioral phenotypes. Proceedings of the National 
Academy of Sciences of the United States of America 106: 13058-63 
Calabrese B, Wilson MS, Halpain S. 2006. Development and regulation of dendritic spine 
synapses. Physiology 21: 38-47 
Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, et al. 1999. Physiological 
characteristics of capacity constraints in working memory as revealed by functional MRI. 
Cerebral cortex 9: 20-6 
Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. 2003. 
Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. 
The American journal of psychiatry 160: 2209-15 
Cannon M, Jones PB, Murray RM. 2002. Obstetric complications and schizophrenia: historical 
and meta-analytic review. The American journal of psychiatry 159: 1080-92 
Cannon TD, Glahn DC, Kim J, Van Erp TG, Karlsgodt K, et al. 2005. Dorsolateral prefrontal 
cortex activity during maintenance and manipulation of information in working memory in 
patients with schizophrenia. Archives of general psychiatry 62: 1071-80 
Capogna M, Gahwiler BH, Thompson SM. 1993. Mechanism of mu-opioid receptor-mediated 
presynaptic inhibition in the rat hippocampus in vitro. The Journal of physiology 470: 
539-58 
 167 
Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, et al. 2004. Tonic inhibition in 
mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing 
gamma-aminobutyric acid type A receptors. Proceedings of the National Academy of 
Sciences of the United States of America 101: 3662-7 
Cardin JA, Carlen M, Meletis K, Knoblich U, Zhang F, et al. 2009. Driving fast-spiking cells 
induces gamma rhythm and controls sensory responses. Nature 459: 663-7 
Cardno AG, Gottesman, II. 2000. Twin studies of schizophrenia: from bow-and-arrow 
concordances to star wars Mx and functional genomics. American journal of medical 
genetics 97: 12-7 
Carlen M, Meletis K, Siegle JH, Cardin JA, Futai K, et al. 2012. A critical role for NMDA 
receptors in parvalbumin interneurons for gamma rhythm induction and behavior. 
Molecular psychiatry 17: 537-48 
Carlier MF, Laurent V, Santolini J, Melki R, Didry D, et al. 1997. Actin depolymerizing factor 
(ADF/cofilin) enhances the rate of filament turnover: implication in actin-based motility. 
The Journal of cell biology 136: 1307-22 
Carlisle HJ, Manzerra P, Marcora E, Kennedy MB. 2008. SynGAP regulates steady-state and 
activity-dependent phosphorylation of cofilin. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 28: 13673-83 
Carr DB, Sesack SR. 2000a. GABA-containing neurons in the rat ventral tegmental area project 
to the prefrontal cortex. Synapse 38: 114-23 
Carr DB, Sesack SR. 2000b. Projections from the rat prefrontal cortex to the ventral tegmental 
area: target specificity in the synaptic associations with mesoaccumbens and 
mesocortical neurons. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 20: 3864-73 
Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, et al. 2008. Identifying cognitive 
mechanisms targeted for treatment development in schizophrenia: an overview of the 
first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in 
Schizophrenia Initiative. Biological psychiatry 64: 4-10 
Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG. 2010. Deficits in syntaxin 1 
phosphorylation in schizophrenia prefrontal cortex. Biological psychiatry 67: 208-16 
Cavada C, Goldman-Rakic PS. 1989. Posterior parietal cortex in rhesus monkey: I. Parcellation 
of areas based on distinctive limbic and sensory corticocortical connections. The Journal 
of comparative neurology 287: 393-421 
Chang MC, Park JM, Pelkey KA, Grabenstatter HL, Xu D, et al. 2010. Narp regulates 
homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons. 
Nature neuroscience 13: 1090-7 
Chardin P. 2006. Function and regulation of Rnd proteins. Nature reviews. Molecular cell 
biology 7: 54-62 
Chen JL, Villa KL, Cha JW, So PT, Kubota Y, Nedivi E. 2012. Clustered dynamics of inhibitory 
synapses and dendritic spines in the adult neocortex. Neuron 74: 361-73 
Chen TJ, Gehler S, Shaw AE, Bamburg JR, Letourneau PC. 2006. Cdc42 participates in the 
regulation of ADF/cofilin and retinal growth cone filopodia by brain derived neurotrophic 
factor. Journal of neurobiology 66: 103-14 
Chen Y, Wang Y, Erturk A, Kallop D, Jiang Z, et al. 2014. Activity-induced Nr4a1 regulates 
spine density and distribution pattern of excitatory synapses in pyramidal neurons. 
Neuron 83: 431-43 
Cheniaux E, Landeira-Fernandez J, Lessa Telles L, Lessa JL, Dias A, et al. 2008. Does 
schizoaffective disorder really exist? A systematic review of the studies that compared 
schizoaffective disorder with schizophrenia or mood disorders. Journal of affective 
disorders 106: 209-17 
 168 
Chia PH, Li P, Shen K. 2013. Cell biology in neuroscience: cellular and molecular mechanisms 
underlying presynapse formation. The Journal of cell biology 203: 11-22 
Chia PH, Patel MR, Shen K. 2012. NAB-1 instructs synapse assembly by linking adhesion 
molecules and F-actin to active zone proteins. Nature neuroscience 15: 234-42 
Chiu CQ, Lur G, Morse TM, Carnevale NT, Ellis-Davies GC, Higley MJ. 2013. 
Compartmentalization of GABAergic inhibition by dendritic spines. Science 340: 759-62 
Cho KK, Hoch R, Lee AT, Patel T, Rubenstein JL, Sohal VS. 2015a. Gamma rhythms link 
prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5/6(+/-) mice. Neuron 
85: 1332-43 
Cho RY, Konecky RO, Carter CS. 2006. Impairments in frontal cortical gamma synchrony and 
cognitive control in schizophrenia. Proceedings of the National Academy of Sciences of 
the United States of America 103: 19878-83 
Cho RY, Walker CP, Polizzotto NR, Wozny TA, Fissell C, et al. 2015b. Development of sensory 
gamma oscillations and cross-frequency coupling from childhood to early adulthood. 
Cerebral cortex 25: 1509-18 
Chung DW, Volk DW, Arion D, Zhang Y, Sampson AR, Lewis DA. 2015. Dysregulated ErbB4 
Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression. The American 
journal of psychiatry: appiajp201515020150 
Cingolani LA, Goda Y. 2008. Actin in action: the interplay between the actin cytoskeleton and 
synaptic efficacy. Nature reviews. Neuroscience 9: 344-56 
Clement JP, Aceti M, Creson TK, Ozkan ED, Shi Y, et al. 2012. Pathogenic SYNGAP1 
mutations impair cognitive development by disrupting maturation of dendritic spine 
synapses. Cell 151: 709-23 
Cline H, Haas K. 2008. The regulation of dendritic arbor development and plasticity by 
glutamatergic synaptic input: a review of the synaptotrophic hypothesis. The Journal of 
physiology 586: 1509-17 
Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ. 2003. Induction of 
metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to 
phencyclidine: differential modulation by antipsychotic drugs. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 28: 265-75 
Cohen AS, Lin DD, Coulter DA. 2000. Protracted postnatal development of inhibitory synaptic 
transmission in rat hippocampal area CA1 neurons. Journal of neurophysiology 84: 
2465-76 
Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, et al. 1997. Temporal dynamics of 
brain activation during a working memory task. Nature 386: 604-8 
Compte A, Brunel N, Goldman-Rakic PS, Wang XJ. 2000. Synaptic mechanisms and network 
dynamics underlying spatial working memory in a cortical network model. Cerebral 
cortex 10: 910-23 
Constantinidis C, Franowicz MN, Goldman-Rakic PS. 2001. The sensory nature of mnemonic 
representation in the primate prefrontal cortex. Nature neuroscience 4: 311-6 
Constantinidis C, Goldman-Rakic PS. 2002. Correlated discharges among putative pyramidal 
neurons and interneurons in the primate prefrontal cortex. Journal of neurophysiology 
88: 3487-97 
Constantinidis C, Williams GV, Goldman-Rakic PS. 2002. A role for inhibition in shaping the 
temporal flow of information in prefrontal cortex. Nature neuroscience 5: 175-80 
Coyle JT. 2004. The GABA-glutamate connection in schizophrenia: which is the proximate 
cause? Biochemical pharmacology 68: 1507-14 
Craig AM, Kang Y. 2007. Neurexin-neuroligin signaling in synapse development. Current 
opinion in neurobiology 17: 43-52 
 169 
Crowley JJ, Hilliard CE, Kim Y, Morgan MB, Lewis LR, et al. 2013. Deep resequencing and 
association analysis of schizophrenia candidate genes. Molecular psychiatry 18: 138-40 
Cruz DA, Eggan SM, Lewis DA. 2003. Postnatal development of pre- and postsynaptic GABA 
markers at chandelier cell connections with pyramidal neurons in monkey prefrontal 
cortex. The Journal of comparative neurology 465: 385-400 
Cruz DA, Weaver CL, Lovallo EM, Melchitzky DS, Lewis DA. 2009. Selective alterations in 
postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects 
with schizophrenia. Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology 34: 2112-24 
Cull-Candy S, Brickley S, Farrant M. 2001. NMDA receptor subunits: diversity, development and 
disease. Current opinion in neurobiology 11: 327-35 
Cullen TJ, Walker MA, Parkinson N, Craven R, Crow TJ, et al. 2003. A postmortem study of the 
mediodorsal nucleus of the thalamus in schizophrenia. Schizophrenia research 60: 157-
66 
Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, et al. 2011. Cortical deficits of 
glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell 
type-specific features. The American journal of psychiatry 168: 921-9 
Datta D, Arion D, Corradi JP, Lewis DA. 2015a. Altered Expression of CDC42 Signaling 
Pathway Components in Cortical Layer 3 Pyramidal Cells in Schizophrenia. Biological 
psychiatry  
Datta D, Arion D, Lewis DA. 2015b. Developmental Expression Patterns of GABAA Receptor 
Subunits in Layer 3 and 5 Pyramidal Cells of Monkey Prefrontal Cortex. Cerebral cortex 
25: 2295-305 
Dauvermann MR, Whalley HC, Schmidt A, Lee GL, Romaniuk L, et al. 2014. Computational 
neuropsychiatry - schizophrenia as a cognitive brain network disorder. Frontiers in 
psychiatry 5: 30 
Davis KL, Kahn RS, Ko G, Davidson M. 1991. Dopamine in schizophrenia: a review and 
reconceptualization. The American journal of psychiatry 148: 1474-86 
De Rubeis S, Pasciuto E, Li KW, Fernandez E, Di Marino D, et al. 2013. CYFIP1 coordinates 
mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine 
formation. Neuron 79: 1169-82 
DeFelipe J, Farinas I. 1992. The pyramidal neuron of the cerebral cortex: morphological and 
chemical characteristics of the synaptic inputs. Progress in neurobiology 39: 563-607 
DeFelipe J, Lopez-Cruz PL, Benavides-Piccione R, Bielza C, Larranaga P, et al. 2013. New 
insights into the classification and nomenclature of cortical GABAergic interneurons. 
Nature reviews. Neuroscience 14: 202-16 
Deguchi Y, Donato F, Galimberti I, Cabuy E, Caroni P. 2011. Temporally matched 
subpopulations of selectively interconnected principal neurons in the hippocampus. 
Nature neuroscience 14: 495-504 
Del Pino I, Garcia-Frigola C, Dehorter N, Brotons-Mas JR, Alvarez-Salvado E, et al. 2013. 
Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes. 
Neuron 79: 1152-68 
Deo AJ, Cahill ME, Li S, Goldszer I, Henteleff R, et al. 2012. Increased expression of Kalirin-9 in 
the auditory cortex of schizophrenia subjects: its role in dendritic pathology. 
Neurobiology of disease 45: 796-803 
Diamond A. 2002. Normal development of prefrontal cortex from birth to young adulthood: 
cognitive functions, anatomy and biochemistry. London: Oxford University Press. 466-
503 pp. 
Dillon C, Goda Y. 2005. The actin cytoskeleton: integrating form and function at the synapse. 
Annual review of neuroscience 28: 25-55 
 170 
Dityatev A, Bruckner G, Dityateva G, Grosche J, Kleene R, Schachner M. 2007. Activity-
dependent formation and functions of chondroitin sulfate-rich extracellular matrix of 
perineuronal nets. Developmental neurobiology 67: 570-88 
Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. 2009. Redox dysregulation, 
neurodevelopment, and schizophrenia. Current opinion in neurobiology 19: 220-30 
Doischer D, Hosp JA, Yanagawa Y, Obata K, Jonas P, et al. 2008. Postnatal differentiation of 
basket cells from slow to fast signaling devices. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 28: 12956-68 
Dorph-Petersen KA, Caric D, Saghafi R, Zhang W, Sampson AR, Lewis DA. 2009. Volume and 
neuron number of the lateral geniculate nucleus in schizophrenia and mood disorders. 
Acta neuropathologica 117: 369-84 
Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. 2005. The influence of 
chronic exposure to antipsychotic medications on brain size before and after tissue 
fixation: a comparison of haloperidol and olanzapine in macaque monkeys. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 30: 1649-61 
Dorph-Petersen KA, Pierri JN, Sun Z, Sampson AR, Lewis DA. 2004. Stereological analysis of 
the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell 
types. The Journal of comparative neurology 472: 449-62 
dos Remedios CG, Chhabra D, Kekic M, Dedova IV, Tsubakihara M, et al. 2003. Actin binding 
proteins: regulation of cytoskeletal microfilaments. Physiological reviews 83: 433-73 
Drake CT, Milner TA. 2002. Mu opioid receptors are in discrete hippocampal interneuron 
subpopulations. Hippocampus 12: 119-36 
Duncan CE, Webster MJ, Rothmond DA, Bahn S, Elashoff M, Shannon Weickert C. 2010. 
Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human 
development and schizophrenia. Journal of psychiatric research 44: 673-81 
Eaton BA, Davis GW. 2005. LIM Kinase1 controls synaptic stability downstream of the type II 
BMP receptor. Neuron 47: 695-708 
Edwards DC, Sanders LC, Bokoch GM, Gill GN. 1999. Activation of LIM-kinase by Pak1 
couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nature cell 
biology 1: 253-9 
Eggan SM, Hashimoto T, Lewis DA. 2008. Reduced cortical cannabinoid 1 receptor messenger 
RNA and protein expression in schizophrenia. Archives of general psychiatry 65: 772-84 
Eggan SM, Lazarus MS, Stoyak SR, Volk DW, Glausier JR, et al. 2012. Cortical glutamic acid 
decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA 
expression: implications for schizophrenia. Biological psychiatry 71: 114-9 
Eggan SM, Melchitzky DS, Sesack SR, Fish KN, Lewis DA. 2010. Relationship of cannabinoid 
CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal 
cortex. Neuroscience 169: 1651-61 
Eggermann E, Jonas P. 2012. How the 'slow' Ca(2+) buffer parvalbumin affects transmitter 
release in nanodomain-coupling regimes. Nature neuroscience 15: 20-2 
Elia LP, Yamamoto M, Zang K, Reichardt LF. 2006. p120 catenin regulates dendritic spine and 
synapse development through Rho-family GTPases and cadherins. Neuron 51: 43-56 
Elston GN. 2000. Pyramidal cells of the frontal lobe: all the more spinous to think with. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 20: RC95 
Elston GN. 2003. Cortex, cognition and the cell: new insights into the pyramidal neuron and 
prefrontal function. Cerebral cortex 13: 1124-38 
Elston GN, Rosa MG. 2000. Pyramidal cells, patches, and cortical columns: a comparative 
study of infragranular neurons in TEO, TE, and the superior temporal polysensory area 
of the macaque monkey. The Journal of neuroscience : the official journal of the Society 
for Neuroscience 20: RC117 
 171 
Elvevag B, Goldberg TE. 2000. Cognitive impairment in schizophrenia is the core of the 
disorder. Critical reviews in neurobiology 14: 1-21 
Erdely HA, Tamminga CA, Roberts RC, Vogel MW. 2006. Regional alterations in RGS4 protein 
in schizophrenia. Synapse 59: 472-9 
Erickson SL, Lewis DA. 2002. Postnatal development of parvalbumin- and GABA transporter-
immunoreactive axon terminals in monkey prefrontal cortex. The Journal of comparative 
neurology 448: 186-202 
Ethell IM, Irie F, Kalo MS, Couchman JR, Pasquale EB, Yamaguchi Y. 2001. EphB/syndecan-2 
signaling in dendritic spine morphogenesis. Neuron 31: 1001-13 
Farinas I, DeFelipe J. 1991. Patterns of synaptic input on corticocortical and corticothalamic 
cells in the cat visual cortex. I. The cell body. The Journal of comparative neurology 304: 
53-69 
Farrant M, Kaila K. 2007. The cellular, molecular and ionic basis of GABA(A) receptor signalling. 
Progress in brain research 160: 59-87 
Farrant M, Nusser Z. 2005. Variations on an inhibitory theme: phasic and tonic activation of 
GABA(A) receptors. Nature reviews. Neuroscience 6: 215-29 
Fazzari P, Paternain AV, Valiente M, Pla R, Lujan R, et al. 2010. Control of cortical GABA 
circuitry development by Nrg1 and ErbB4 signalling. Nature 464: 1376-80 
Feinberg I. 1982. Schizophrenia: caused by a fault in programmed synaptic elimination during 
adolescence? Journal of psychiatric research 17: 319-34 
Felleman DJ, Van Essen DC. 1991. Distributed hierarchical processing in the primate cerebral 
cortex. Cerebral cortex 1: 1-47 
Fillman SG, Duncan CE, Webster MJ, Elashoff M, Weickert CS. 2010. Developmental co-
regulation of the beta and gamma GABAA receptor subunits with distinct alpha subunits 
in the human dorsolateral prefrontal cortex. International journal of developmental 
neuroscience : the official journal of the International Society for Developmental 
Neuroscience 28: 513-9 
Fino E, Yuste R. 2011. Dense inhibitory connectivity in neocortex. Neuron 69: 1188-203 
Fish KN, Hoftman GD, Sheikh W, Kitchens M, Lewis DA. 2013. Parvalbumin-containing 
chandelier and basket cell boutons have distinctive modes of maturation in monkey 
prefrontal cortex. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 33: 8352-8 
Fish KN, Sweet RA, Deo AJ, Lewis DA. 2008. An automated segmentation methodology for 
quantifying immunoreactive puncta number and fluorescence intensity in tissue sections. 
Brain research 1240: 62-72 
Fish KN, Sweet RA, Lewis DA. 2011. Differential distribution of proteins regulating GABA 
synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. 
Cerebral cortex 21: 2450-60 
Fremeau RT, Jr., Kam K, Qureshi T, Johnson J, Copenhagen DR, et al. 2004. Vesicular 
glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. 
Science 304: 1815-9 
Fremeau RT, Jr., Troyer MD, Pahner I, Nygaard GO, Tran CH, et al. 2001. The expression of 
vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31: 
247-60 
Friedman HR, Goldman-Rakic PS. 1994. Coactivation of prefrontal cortex and inferior parietal 
cortex in working memory tasks revealed by 2DG functional mapping in the rhesus 
monkey. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 14: 2775-88 
Fries P. 2009. Neuronal gamma-band synchronization as a fundamental process in cortical 
computation. Annual review of neuroscience 32: 209-24 
 172 
Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, et al. 2014. De novo mutations 
in schizophrenia implicate synaptic networks. Nature 506: 179-84 
Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, et al. 2007. Recruitment of 
parvalbumin-positive interneurons determines hippocampal function and associated 
behavior. Neuron 53: 591-604 
Funahashi S, Bruce CJ, Goldman-Rakic PS. 1989. Mnemonic coding of visual space in the 
monkey's dorsolateral prefrontal cortex. Journal of neurophysiology 61: 331-49 
Fung SJ, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, Weickert CS. 2010. 
Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing 
human and in schizophrenia. The American journal of psychiatry 167: 1479-88 
Fuster JM. 1973. Unit activity in prefrontal cortex during delayed-response performance: 
neuronal correlates of transient memory. Journal of neurophysiology 36: 61-78 
Fuster JM, Alexander GE. 1971. Neuron activity related to short-term memory. Science 173: 
652-4 
Galarreta M, Hestrin S. 2001. Spike transmission and synchrony detection in networks of 
GABAergic interneurons. Science 292: 2295-9 
Galarreta M, Hestrin S. 2002. Electrical and chemical synapses among parvalbumin fast-spiking 
GABAergic interneurons in adult mouse neocortex. Proceedings of the National 
Academy of Sciences of the United States of America 99: 12438-43 
Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, et al. 1998. Reduced dendritic spine density 
on cerebral cortical pyramidal neurons in schizophrenia. Journal of neurology, 
neurosurgery, and psychiatry 65: 446-53 
Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT. 2011. Decreased levels of 
glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients 
with psychiatric disorders. The international journal of neuropsychopharmacology / 
official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 
14: 123-30 
Georgiev D, Arion D, Enwright JF, Kikuchi M, Minabe Y, et al. 2014. Lower gene expression for 
KCNS3 potassium channel subunit in parvalbumin-containing neurons in the prefrontal 
cortex in schizophrenia. The American journal of psychiatry 171: 62-71 
Georgiev D, Gonzalez-Burgos G, Kikuchi M, Minabe Y, Lewis DA, Hashimoto T. 2012. Selective 
expression of KCNS3 potassium channel alpha-subunit in parvalbumin-containing GABA 
neurons in the human prefrontal cortex. PloS one 7: e43904 
Gibbons JS, Horn SH, Powell JM, Gibbons JL. 1984. Schizophrenic patients and their families. 
A survey in a psychiatric service based on a DGH unit. The British journal of psychiatry : 
the journal of mental science 144: 70-7 
Gibson JR, Beierlein M, Connors BW. 2005. Functional properties of electrical synapses 
between inhibitory interneurons of neocortical layer 4. Journal of neurophysiology 93: 
467-80 
Giguere M, Goldman-Rakic PS. 1988. Mediodorsal nucleus: areal, laminar, and tangential 
distribution of afferents and efferents in the frontal lobe of rhesus monkeys. The Journal 
of comparative neurology 277: 195-213 
Gittis AH, Nelson AB, Thwin MT, Palop JJ, Kreitzer AC. 2010. Distinct roles of GABAergic 
interneurons in the regulation of striatal output pathways. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 30: 2223-34 
Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, et al. 2008. Meta-analysis of 
gray matter anomalies in schizophrenia: application of anatomic likelihood estimation 
and network analysis. Biological psychiatry 64: 774-81 
Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, et al. 2005. Beyond hypofrontality: a 
quantitative meta-analysis of functional neuroimaging studies of working memory in 
schizophrenia. Human brain mapping 25: 60-9 
 173 
Glantz LA, Lewis DA. 1997. Reduction of synaptophysin immunoreactivity in the prefrontal 
cortex of subjects with schizophrenia. Regional and diagnostic specificity. Archives of 
general psychiatry 54: 660-9 
Glantz LA, Lewis DA. 2000. Decreased dendritic spine density on prefrontal cortical pyramidal 
neurons in schizophrenia. Archives of general psychiatry 57: 65-73 
Glausier JR, Fish KN, Lewis DA. 2014. Altered parvalbumin basket cell inputs in the dorsolateral 
prefrontal cortex of schizophrenia subjects. Molecular psychiatry 19: 30-6 
Glausier JR, Lewis DA. 2011. Selective pyramidal cell reduction of GABA(A) receptor alpha1 
subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology : 
official publication of the American College of Neuropsychopharmacology 36: 2103-10 
Glausier JR, Lewis DA. 2013. Dendritic spine pathology in schizophrenia. Neuroscience 251: 
90-107 
Glickfeld LL, Atallah BV, Scanziani M. 2008. Complementary modulation of somatic inhibition by 
opioids and cannabinoids. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 28: 1824-32 
Gogtay N, Sporn A, Clasen LS, Nugent TF, 3rd, Greenstein D, et al. 2004. Comparison of 
progressive cortical gray matter loss in childhood-onset schizophrenia with that in 
childhood-onset atypical psychoses. Archives of general psychiatry 61: 17-22 
Goldberg TE, Ragland JD, Torrey EF, Gold JM, Bigelow LB, Weinberger DR. 1990. 
Neuropsychological assessment of monozygotic twins discordant for schizophrenia. 
Archives of general psychiatry 47: 1066-72 
Goldberg TE, Torrey EF, Gold JM, Bigelow LB, Ragland RD, et al. 1995. Genetic risk of 
neuropsychological impairment in schizophrenia: a study of monozygotic twins 
discordant and concordant for the disorder. Schizophrenia research 17: 77-84 
Goldman-Rakic PS. 1987. Development of cortical circuitry and cognitive function. Child 
development 58: 601-22 
Goldman-Rakic PS. 1995. Cellular basis of working memory. Neuron 14: 477-85 
Goldman-Rakic PS. 2002. The "psychic cell" of Ramon y Cajal. Progress in brain research 136: 
427-34 
Goldman PS. 1971. Functional development of the prefrontal cortex in early life and the problem 
of neuronal plasticity. Experimental neurology 32: 366-87 
Goley ED, Welch MD. 2006. The ARP2/3 complex: an actin nucleator comes of age. Nature 
reviews. Molecular cell biology 7: 713-26 
Gonzalez-Burgos G, Cho RY, Lewis DA. 2015. Alterations in cortical network oscillations and 
parvalbumin neurons in schizophrenia. Biological psychiatry 77: 1031-40 
Gonzalez-Burgos G, Krimer LS, Povysheva NV, Barrionuevo G, Lewis DA. 2005. Functional 
properties of fast spiking interneurons and their synaptic connections with pyramidal 
cells in primate dorsolateral prefrontal cortex. Journal of neurophysiology 93: 942-53 
Gonzalez-Burgos G, Kroener S, Zaitsev AV, Povysheva NV, Krimer LS, et al. 2008. Functional 
maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal 
development of the primate prefrontal cortex. Cerebral cortex 18: 626-37 
Gonzalez-Burgos G, Kroner S, Krimer LS, Seamans JK, Urban NN, et al. 2002. Dopamine 
modulation of neuronal function in the monkey prefrontal cortex. Physiology & behavior 
77: 537-43 
Gonzalez-Burgos G, Lewis DA. 2008. GABA neurons and the mechanisms of network 
oscillations: implications for understanding cortical dysfunction in schizophrenia. 
Schizophrenia bulletin 34: 944-61 
Gonzalez-Burgos G, Lewis DA. 2012. NMDA receptor hypofunction, parvalbumin-positive 
neurons, and cortical gamma oscillations in schizophrenia. Schizophrenia bulletin 38: 
950-7 
 174 
Gonzalez-Burgos G, Miyamae T, Pafundo DE, Yoshino H, Rotaru DC, et al. 2014. Functional 
Maturation of GABA Synapses During Postnatal Development of the Monkey 
Dorsolateral Prefrontal Cortex. Cerebral cortex  
Gorski JA, Zeiler SR, Tamowski S, Jones KR. 2003. Brain-derived neurotrophic factor is 
required for the maintenance of cortical dendrites. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 23: 6856-65 
Gorvel JP, Chang TC, Boretto J, Azuma T, Chavrier P. 1998. Differential properties of D4/LyGDI 
versus RhoGDI: phosphorylation and rho GTPase selectivity. FEBS letters 422: 269-73 
Gottesman, II, Shields J. 1976. A critical review of recent adoption, twin, and family studies of 
schizophrenia: behavioral genetics perspectives. Schizophrenia bulletin 2: 360-401 
Gottesman I. 1991. Is schizophrenia inherited genetically? Schizophrenia Genesis: The Origins 
of Madness: 84-103 
Gray EG. 1959. Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron 
microscope study. Journal of anatomy 93: 420-33 
Grayson DR, Guidotti A. 2013. The dynamics of DNA methylation in schizophrenia and related 
psychiatric disorders. Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology 38: 138-66 
Green MF, Kern RS, Braff DL, Mintz J. 2000. Neurocognitive deficits and functional outcome in 
schizophrenia: are we measuring the "right stuff"? Schizophrenia bulletin 26: 119-36 
Greig LC, Woodworth MB, Galazo MJ, Padmanabhan H, Macklis JD. 2013. Molecular logic of 
neocortical projection neuron specification, development and diversity. Nature reviews. 
Neuroscience 14: 755-69 
Grossman LS, Harrow M, Rosen C, Faull R, Strauss GP. 2008. Sex differences in 
schizophrenia and other psychotic disorders: a 20-year longitudinal study of psychosis 
and recovery. Comprehensive psychiatry 49: 523-9 
Gu Y, Huang S, Chang MC, Worley P, Kirkwood A, Quinlan EM. 2013. Obligatory role for the 
immediate early gene NARP in critical period plasticity. Neuron 79: 335-46 
Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, et al. 2000. Decrease in reelin 
and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar 
disorder: a postmortem brain study. Archives of general psychiatry 57: 1061-9 
Guillozet-Bongaarts AL, Hyde TM, Dalley RA, Hawrylycz MJ, Henry A, et al. 2014. Altered gene 
expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. 
Molecular psychiatry 19: 478-85 
Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, et al. 2013. Spatial and temporal 
mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 
154: 518-29 
Gulyas AI, Szabo GG, Ulbert I, Holderith N, Monyer H, et al. 2010. Parvalbumin-containing fast-
spiking basket cells generate the field potential oscillations induced by cholinergic 
receptor activation in the hippocampus. The Journal of neuroscience : the official journal 
of the Society for Neuroscience 30: 15134-45 
Hakami T, Jones NC, Tolmacheva EA, Gaudias J, Chaumont J, et al. 2009. NMDA receptor 
hypofunction leads to generalized and persistent aberrant gamma oscillations 
independent of hyperlocomotion and the state of consciousness. PloS one 4: e6755 
Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279: 509-14 
Harris KD, Shepherd GM. 2015. The neocortical circuit: themes and variations. Nature 
neuroscience 18: 170-81 
Harris KM, Kater SB. 1994. Dendritic spines: cellular specializations imparting both stability and 
flexibility to synaptic function. Annual review of neuroscience 17: 341-71 
Harrison G, Hopper K, Craig T, Laska E, Siegel C, et al. 2001. Recovery from psychotic illness: 
a 15- and 25-year international follow-up study. The British journal of psychiatry : the 
journal of mental science 178: 506-17 
 175 
Harvey PD, Keefe RS. 2001. Studies of cognitive change in patients with schizophrenia 
following novel antipsychotic treatment. The American journal of psychiatry 158: 176-84 
Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. 2004. 
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in 
schizophrenia. Molecular psychiatry 9: 299-307 
Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, et al. 2008a. Alterations in 
GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with 
schizophrenia. Molecular psychiatry 13: 147-61 
Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, Lewis DA. 2008b. Conserved regional 
patterns of GABA-related transcript expression in the neocortex of subjects with 
schizophrenia. The American journal of psychiatry 165: 479-89 
Hashimoto T, Bergen SE, Nguyen QL, Xu B, Monteggia LM, et al. 2005. Relationship of brain-
derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry 
in schizophrenia. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 25: 372-83 
Hashimoto T, Nguyen QL, Rotaru D, Keenan T, Arion D, et al. 2009. Protracted developmental 
trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate 
prefrontal cortex. Biological psychiatry 65: 1015-23 
Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, et al. 2003. Gene expression deficits in 
a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 23: 6315-26 
Hayama T, Noguchi J, Watanabe S, Takahashi N, Hayashi-Takagi A, et al. 2013. GABA 
promotes the competitive selection of dendritic spines by controlling local Ca2+ 
signaling. Nature neuroscience 16: 1409-16 
Hayashi-Takagi A, Araki Y, Nakamura M, Vollrath B, Duron SG, et al. 2014. PAKs inhibitors 
ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo 
during late adolescence. Proceedings of the National Academy of Sciences of the United 
States of America 111: 6461-6 
Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, et al. 2010. Disrupted-in-
Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nature 
neuroscience 13: 327-32 
Hayashi K, Ohshima T, Hashimoto M, Mikoshiba K. 2007. Pak1 regulates dendritic branching 
and spine formation. Developmental neurobiology 67: 655-69 
Hayashi Y, Majewska AK. 2005. Dendritic spine geometry: functional implication and regulation. 
Neuron 46: 529-32 
Hayes TL, Lewis DA. 1996. Magnopyramidal neurons in the anterior motor speech region. 
Dendritic features and interhemispheric comparisons. Archives of neurology 53: 1277-83 
Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. 2001. Stability and course 
of neuropsychological deficits in schizophrenia. Archives of general psychiatry 58: 24-32 
Hebert JM, Fishell G. 2008. The genetics of early telencephalon patterning: some assembly 
required. Nature reviews. Neuroscience 9: 678-85 
Henschel O, Gipson KE, Bordey A. 2008. GABAA receptors, anesthetics and anticonvulsants in 
brain development. CNS & neurological disorders drug targets 7: 211-24 
Henze DA, Gonzalez-Burgos GR, Urban NN, Lewis DA, Barrionuevo G. 2000. Dopamine 
increases excitability of pyramidal neurons in primate prefrontal cortex. Journal of 
neurophysiology 84: 2799-809 
Hestrin S. 1993. Different glutamate receptor channels mediate fast excitatory synaptic currents 
in inhibitory and excitatory cortical neurons. Neuron 11: 1083-91 
Higley MJ. 2014. Localized GABAergic inhibition of dendritic Ca(2+) signalling. Nature reviews. 
Neuroscience 15: 567-72 
 176 
Hikosaka O, Wurtz RH. 1983. Visual and oculomotor functions of monkey substantia nigra pars 
reticulata. III. Memory-contingent visual and saccade responses. Journal of 
neurophysiology 49: 1268-84 
Hill JJ, Hashimoto T, Lewis DA. 2006. Molecular mechanisms contributing to dendritic spine 
alterations in the prefrontal cortex of subjects with schizophrenia. Molecular psychiatry 
11: 557-66 
Hoffman GR, Nassar N, Cerione RA. 2000. Structure of the Rho family GTP-binding protein 
Cdc42 in complex with the multifunctional regulator RhoGDI. Cell 100: 345-56 
Hoffman RE, Dobscha SK. 1989. Cortical pruning and the development of schizophrenia: a 
computer model. Schizophrenia bulletin 15: 477-90 
Hoftman GD, Lewis DA. 2011. Postnatal developmental trajectories of neural circuits in the 
primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. 
Schizophrenia bulletin 37: 493-503 
Hoftman GD, Volk DW, Bazmi HH, Li S, Sampson AR, Lewis DA. 2015. Altered Cortical 
Expression of GABA-Related Genes in Schizophrenia: Illness Progression vs 
Developmental Disturbance. Schizophrenia bulletin 41: 180-91 
Hollis C. 2000. Adult outcomes of child- and adolescent-onset schizophrenia: diagnostic stability 
and predictive validity. The American journal of psychiatry 157: 1652-9 
Holtmaat A, Svoboda K. 2009. Experience-dependent structural synaptic plasticity in the 
mammalian brain. Nature reviews. Neuroscience 10: 647-58 
Holtmaat A, Wilbrecht L, Knott GW, Welker E, Svoboda K. 2006. Experience-dependent and 
cell-type-specific spine growth in the neocortex. Nature 441: 979-83 
Homayoun H, Moghaddam B. 2007. NMDA receptor hypofunction produces opposite effects on 
prefrontal cortex interneurons and pyramidal neurons. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 27: 11496-500 
Hong LE, Summerfelt A, Buchanan RW, O'Donnell P, Thaker GK, et al. 2010. Gamma and delta 
neural oscillations and association with clinical symptoms under subanesthetic ketamine. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 35: 632-40 
Honkura N, Matsuzaki M, Noguchi J, Ellis-Davies GC, Kasai H. 2008. The subspine 
organization of actin fibers regulates the structure and plasticity of dendritic spines. 
Neuron 57: 719-29 
Hotulainen P, Hoogenraad CC. 2010. Actin in dendritic spines: connecting dynamics to function. 
The Journal of cell biology 189: 619-29 
Hotulainen P, Llano O, Smirnov S, Tanhuanpaa K, Faix J, et al. 2009. Defining mechanisms of 
actin polymerization and depolymerization during dendritic spine morphogenesis. The 
Journal of cell biology 185: 323-39 
Hotulainen P, Paunola E, Vartiainen MK, Lappalainen P. 2005. Actin-depolymerizing factor and 
cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in 
mammalian nonmuscle cells. Molecular biology of the cell 16: 649-64 
Howard MW, Rizzuto DS, Caplan JB, Madsen JR, Lisman J, et al. 2003. Gamma oscillations 
correlate with working memory load in humans. Cerebral cortex 13: 1369-74 
Howes OD, Kapur S. 2009. The dopamine hypothesis of schizophrenia: version III--the final 
common pathway. Schizophrenia bulletin 35: 549-62 
Hu H, Gan J, Jonas P. 2014. Interneurons. Fast-spiking, parvalbumin(+) GABAergic 
interneurons: from cellular design to microcircuit function. Science 345: 1255263 
Hu H, Martina M, Jonas P. 2010. Dendritic mechanisms underlying rapid synaptic activation of 
fast-spiking hippocampal interneurons. Science 327: 52-8 
Huang HS, Matevossian A, Whittle C, Kim SY, Schumacher A, et al. 2007a. Prefrontal 
dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone 
 177 
methylation at GABAergic gene promoters. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 27: 11254-62 
Huang ZJ. 2014. Toward a genetic dissection of cortical circuits in the mouse. Neuron 83: 1284-
302 
Huang ZJ, Di Cristo G, Ango F. 2007b. Development of GABA innervation in the cerebral and 
cerebellar cortices. Nature reviews. Neuroscience 8: 673-86 
Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, et al. 2009. A primate-specific, 
brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization 
and risk of schizophrenia. Nature medicine 15: 509-18 
Hull C, Isaacson JS, Scanziani M. 2009. Postsynaptic mechanisms govern the differential 
excitation of cortical neurons by thalamic inputs. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 29: 9127-36 
Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, et al. 2008. Smaller dendritic spines, weaker 
synaptic transmission, but enhanced spatial learning in mice lacking Shank1. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 28: 1697-
708 
Huttenlocher PR. 1979. Synaptic density in human frontal cortex - developmental changes and 
effects of aging. Brain research 163: 195-205 
Huttenlocher PR, Dabholkar AS. 1997. Regional differences in synaptogenesis in human 
cerebral cortex. The Journal of comparative neurology 387: 167-78 
Ide M, Lewis DA. 2010. Altered cortical CDC42 signaling pathways in schizophrenia: 
implications for dendritic spine deficits. Biological psychiatry 68: 25-32 
Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, et al. 2011. Genome-wide association 
study of schizophrenia in a Japanese population. Biological psychiatry 69: 472-8 
Inan M, Blazquez-Llorca L, Merchan-Perez A, Anderson SA, DeFelipe J, Yuste R. 2013. Dense 
and overlapping innervation of pyramidal neurons by chandelier cells. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 33: 1907-14 
Ingvar DH, Franzen G. 1974. Distribution of cerebral activity in chronic schizophrenia. Lancet 2: 
1484-6 
Insel TR. 2010. Rethinking schizophrenia. Nature 468: 187-93 
Insel TR, Scolnick EM. 2006. Cure therapeutics and strategic prevention: raising the bar for 
mental health research. Molecular psychiatry 11: 11-7 
International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, et al. 2009. 
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. 
Nature 460: 748-52 
Isaacson JS, Scanziani M. 2011. How inhibition shapes cortical activity. Neuron 72: 231-43 
Jacob TC, Moss SJ, Jurd R. 2008. GABA(A) receptor trafficking and its role in the dynamic 
modulation of neuronal inhibition. Nature reviews. Neuroscience 9: 331-43 
Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. The 
American journal of psychiatry 148: 1301-8 
Jiao Y, Sun Z, Lee T, Fusco FR, Kimble TD, et al. 1999. A simple and sensitive antigen retrieval 
method for free-floating and slide-mounted tissue sections. Journal of neuroscience 
methods 93: 149-62 
Joberty G, Perlungher RR, Sheffield PJ, Kinoshita M, Noda M, et al. 2001. Borg proteins control 
septin organization and are negatively regulated by Cdc42. Nature cell biology 3: 861-6 
Joho RH, Ho CS, Marks GA. 1999. Increased gamma- and decreased delta-oscillations in a 
mouse deficient for a potassium channel expressed in fast-spiking interneurons. Journal 
of neurophysiology 82: 1855-64 
Jones EG. 1984. Laminar distribution of cortical efferent cells. pp. 521-553. New York: Plenum 
Press.  
 178 
Jones EG. 1998. Viewpoint: the core and matrix of thalamic organization. Neuroscience 85: 
331-45 
Jones EG, Powell TP. 1969. Morphological variations in the dendritic spines of the neocortex. 
Journal of cell science 5: 509-29 
Kahle KT, Staley KJ, Nahed BV, Gamba G, Hebert SC, et al. 2008. Roles of the cation-chloride 
cotransporters in neurological disease. Nature clinical practice. Neurology 4: 490-503 
Kahn RS, Keefe RS. 2013. Schizophrenia is a cognitive illness: time for a change in focus. 
JAMA psychiatry 70: 1107-12 
Kapfer C, Glickfeld LL, Atallah BV, Scanziani M. 2007. Supralinear increase of recurrent 
inhibition during sparse activity in the somatosensory cortex. Nature neuroscience 10: 
743-53 
Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H. 2003. Structure-stability-function 
relationships of dendritic spines. Trends in neurosciences 26: 360-8 
Kawaguchi Y, Kubota Y. 1996. Physiological and morphological identification of somatostatin- or 
vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat 
frontal cortex. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 16: 2701-15 
Kawaguchi Y, Kubota Y. 1998. Neurochemical features and synaptic connections of large 
physiologically-identified GABAergic cells in the rat frontal cortex. Neuroscience 85: 677-
701 
Kepecs A, Fishell G. 2014. Interneuron cell types are fit to function. Nature 505: 318-26 
Kern RS, Horan WP, Barch DM. 2013. On altered patterns of brain activation in at-risk 
adolescents and young adults. The American journal of psychiatry 170: 1226-31 
Kerschensteiner D, Stocker M. 1999. Heteromeric assembly of Kv2.1 with Kv9.3: effect on the 
state dependence of inactivation. Biophysical journal 77: 248-57 
Keshavan MS, Anderson S, Pettegrew JW. 1994. Is schizophrenia due to excessive synaptic 
pruning in the prefrontal cortex? The Feinberg hypothesis revisited. Journal of 
psychiatric research 28: 239-65 
Kim IH, Racz B, Wang H, Burianek L, Weinberg R, et al. 2013. Disruption of Arp2/3 results in 
asymmetric structural plasticity of dendritic spines and progressive synaptic and 
behavioral abnormalities. The Journal of neuroscience : the official journal of the Society 
for Neuroscience 33: 6081-92 
Kim IH, Rossi MA, Aryal DK, Racz B, Kim N, et al. 2015. Spine pruning drives antipsychotic-
sensitive locomotion via circuit control of striatal dopamine. Nature neuroscience 18: 
883-91 
Kim J, Glahn DC, Nuechterlein KH, Cannon TD. 2004. Maintenance and manipulation of 
information in schizophrenia: further evidence for impairment in the central executive 
component of working memory. Schizophrenia research 68: 173-87 
Kimoto S, Bazmi HH, Lewis DA. 2014. Lower expression of glutamic acid decarboxylase 67 in 
the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. The 
American journal of psychiatry 171: 969-78 
Kimoto S, Zaki MM, Bazmi HH, Lewis DA. 2015. Altered Markers of Cortical gamma-
Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene. JAMA 
psychiatry 72: 747-56 
Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM. 2006. A specific role for 
NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 
immunoreactivity in cultured interneurons. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 26: 1604-15 
Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, et al. 2012. De novo CNV analysis 
implicates specific abnormalities of postsynaptic signalling complexes in the 
pathogenesis of schizophrenia. Molecular psychiatry 17: 142-53 
 179 
Klausberger T, Roberts JD, Somogyi P. 2002. Cell type- and input-specific differences in the 
number and subtypes of synaptic GABA(A) receptors in the hippocampus. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 22: 2513-21 
Klausberger T, Somogyi P. 2008. Neuronal diversity and temporal dynamics: the unity of 
hippocampal circuit operations. Science 321: 53-7 
Knapp M, Mangalore R, Simon J. 2004. The global costs of schizophrenia. Schizophrenia 
bulletin 30: 279-93 
Knott GW, Quairiaux C, Genoud C, Welker E. 2002. Formation of dendritic spines with 
GABAergic synapses induced by whisker stimulation in adult mice. Neuron 34: 265-73 
Koleske AJ. 2013. Molecular mechanisms of dendrite stability. Nature reviews. Neuroscience 
14: 536-50 
Kolluri N, Sun Z, Sampson AR, Lewis DA. 2005. Lamina-specific reductions in dendritic spine 
density in the prefrontal cortex of subjects with schizophrenia. The American journal of 
psychiatry 162: 1200-2 
Konopaske GT, Lange N, Coyle JT, Benes FM. 2014. Prefrontal cortical dendritic spine 
pathology in schizophrenia and bipolar disorder. JAMA psychiatry 71: 1323-31 
Konradi C, Heckers S. 2003. Molecular aspects of glutamate dysregulation: implications for 
schizophrenia and its treatment. Pharmacology & therapeutics 97: 153-79 
Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H. 2010. NMDA receptor 
ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial 
representations, and working memory. Neuron 68: 557-69 
Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT. 2000. The paradox of normal 
neuropsychological function in schizophrenia. Journal of abnormal psychology 109: 743-
52 
Kristiansen LV, Huerta I, Beneyto M, Meador-Woodruff JH. 2007. NMDA receptors and 
schizophrenia. Current opinion in pharmacology 7: 48-55 
Kritzer MF, Goldman-Rakic PS. 1995. Intrinsic circuit organization of the major layers and 
sublayers of the dorsolateral prefrontal cortex in the rhesus monkey. The Journal of 
comparative neurology 359: 131-43 
Krook-Magnuson E, Varga C, Lee SH, Soltesz I. 2012. New dimensions of interneuronal 
specialization unmasked by principal cell heterogeneity. Trends in neurosciences 35: 
175-84 
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, et al. 1994. Subanesthetic effects of 
the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, 
perceptual, cognitive, and neuroendocrine responses. Archives of general psychiatry 51: 
199-214 
Kubota K, Niki H. 1971. Prefrontal cortical unit activity and delayed alternation performance in 
monkeys. Journal of neurophysiology 34: 337-47 
Kubota Y, Hatada S, Kondo S, Karube F, Kawaguchi Y. 2007. Neocortical inhibitory terminals 
innervate dendritic spines targeted by thalamocortical afferents. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 27: 1139-50 
Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, et al. 2012. Resequencing and association 
analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia 
susceptibility. Schizophrenia bulletin 38: 552-60 
Kwok JC, Dick G, Wang D, Fawcett JW. 2011. Extracellular matrix and perineuronal nets in 
CNS repair. Developmental neurobiology 71: 1073-89 
Lahti AC, Koffel B, LaPorte D, Tamminga CA. 1995. Subanesthetic doses of ketamine stimulate 
psychosis in schizophrenia. Neuropsychopharmacology : official publication of the 
American College of Neuropsychopharmacology 13: 9-19 
 180 
Lambert M, Naber D, Schacht A, Wagner T, Hundemer HP, et al. 2008. Rates and predictors of 
remission and recovery during 3 years in 392 never-treated patients with schizophrenia. 
Acta psychiatrica Scandinavica 118: 220-9 
Lamsa KP, Heeroma JH, Somogyi P, Rusakov DA, Kullmann DM. 2007. Anti-Hebbian long-term 
potentiation in the hippocampal feedback inhibitory circuit. Science 315: 1262-6 
Lau CG, Murthy VN. 2012. Activity-dependent regulation of inhibition via GAD67. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 32: 8521-31 
Lau D, Vega-Saenz de Miera EC, Contreras D, Ozaita A, Harvey M, et al. 2000. Impaired fast-
spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice 
lacking Kv3.2 K+ channel proteins. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 20: 9071-85 
Lavoie AM, Tingey JJ, Harrison NL, Pritchett DB, Twyman RE. 1997. Activation and 
deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-
subunit isoform. Biophysical journal 73: 2518-26 
Law AJ, Kleinman JE, Weinberger DR, Weickert CS. 2007. Disease-associated intronic variants 
in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in 
schizophrenia. Human molecular genetics 16: 129-41 
Lawrie SM, Abukmeil SS. 1998. Brain abnormality in schizophrenia. A systematic and 
quantitative review of volumetric magnetic resonance imaging studies. The British 
journal of psychiatry : the journal of mental science 172: 110-20 
Le Be JV, Markram H. 2006. Spontaneous and evoked synaptic rewiring in the neonatal 
neocortex. Proceedings of the National Academy of Sciences of the United States of 
America 103: 13214-9 
Le Be JV, Silberberg G, Wang Y, Markram H. 2007. Morphological, electrophysiological, and 
synaptic properties of corticocallosal pyramidal cells in the neonatal rat neocortex. 
Cerebral cortex 17: 2204-13 
Le Magueresse C, Monyer H. 2013. GABAergic interneurons shape the functional maturation of 
the cortex. Neuron 77: 388-405 
Lee AT, Gee SM, Vogt D, Patel T, Rubenstein JL, Sohal VS. 2014a. Pyramidal neurons in 
prefrontal cortex receive subtype-specific forms of excitation and inhibition. Neuron 81: 
61-8 
Lee SH, Kwan AC, Zhang S, Phoumthipphavong V, Flannery JG, et al. 2012. Activation of 
specific interneurons improves V1 feature selectivity and visual perception. Nature 488: 
379-83 
Lee SH, Marchionni I, Bezaire M, Varga C, Danielson N, et al. 2014b. Parvalbumin-positive 
basket cells differentiate among hippocampal pyramidal cells. Neuron 82: 1129-44 
Lennertz L, Wagner M, Wolwer W, Schuhmacher A, Frommann I, et al. 2012. A promoter 
variant of SHANK1 affects auditory working memory in schizophrenia patients and in 
subjects clinically at risk for psychosis. European archives of psychiatry and clinical 
neuroscience 262: 117-24 
Lesh TA, Niendam TA, Minzenberg MJ, Carter CS. 2011. Cognitive control deficits in 
schizophrenia: mechanisms and meaning. Neuropsychopharmacology : official 
publication of the American College of Neuropsychopharmacology 36: 316-38 
Levitt JB, Lewis DA, Yoshioka T, Lund JS. 1993. Topography of pyramidal neuron intrinsic 
connections in macaque monkey prefrontal cortex (areas 9 and 46). The Journal of 
comparative neurology 338: 360-76 
Lewis DA, Cruz DA, Melchitzky DS, Pierri JN. 2001. Lamina-specific deficits in parvalbumin-
immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: 
evidence for fewer projections from the thalamus. The American journal of psychiatry 
158: 1411-22 
 181 
Lewis DA, Curley AA, Glausier JR, Volk DW. 2012. Cortical parvalbumin interneurons and 
cognitive dysfunction in schizophrenia. Trends in neurosciences 35: 57-67 
Lewis DA, Gonzalez-Burgos G. 2006. Pathophysiologically based treatment interventions in 
schizophrenia. Nature medicine 12: 1016-22 
Lewis DA, Gonzalez-Burgos G. 2008. Neuroplasticity of neocortical circuits in schizophrenia. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 33: 141-65 
Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nature 
reviews. Neuroscience 6: 312-24 
Lewis DA, Levitt P. 2002. Schizophrenia as a disorder of neurodevelopment. Annual review of 
neuroscience 25: 409-32 
Lewis DA, Lieberman JA. 2000. Catching up on schizophrenia: natural history and neurobiology. 
Neuron 28: 325-34 
Lewis DA, Moghaddam B. 2006. Cognitive dysfunction in schizophrenia: convergence of 
gamma-aminobutyric acid and glutamate alterations. Archives of neurology 63: 1372-6 
Lewis DA, Sweet RA. 2009. Schizophrenia from a neural circuitry perspective: advancing 
toward rational pharmacological therapies. The Journal of clinical investigation 119: 706-
16 
Li J, Tseng GC. 2011. An adaptively weighted statistic for detecting differential gene expression 
when combining multiple transcriptomic studies. Ann Appl Stat 5: 994-1019 
Lipska BK, Mitkus SN, Mathew SV, Fatula R, Hyde TM, et al. 2006a. Functional genomics in 
postmortem human brain: abnormalities in a DISC1 molecular pathway in schizophrenia. 
Dialogues in clinical neuroscience 8: 353-7 
Lipska BK, Peters T, Hyde TM, Halim N, Horowitz C, et al. 2006b. Expression of DISC1 binding 
partners is reduced in schizophrenia and associated with DISC1 SNPs. Human 
molecular genetics 15: 1245-58 
Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, et al. 2008. Circuit-based framework for 
understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in 
neurosciences 31: 234-42 
Lisman JE, Fellous JM, Wang XJ. 1998. A role for NMDA-receptor channels in working memory. 
Nature neuroscience 1: 273-5 
Loup F, Weinmann O, Yonekawa Y, Aguzzi A, Wieser HG, Fritschy JM. 1998. A highly sensitive 
immunofluorescence procedure for analyzing the subcellular distribution of GABAA 
receptor subunits in the human brain. The journal of histochemistry and cytochemistry : 
official journal of the Histochemistry Society 46: 1129-39 
Lu JT, Li CY, Zhao JP, Poo MM, Zhang XH. 2007. Spike-timing-dependent plasticity of 
neocortical excitatory synapses on inhibitory interneurons depends on target cell type. 
The Journal of neuroscience : the official journal of the Society for Neuroscience 27: 
9711-20 
Luebke JI, Medalla M, Amatrudo JM, Weaver CM, Crimins JL, et al. 2015. Age-related changes 
to layer 3 pyramidal cells in the rhesus monkey visual cortex. Cerebral cortex 25: 1454-
68 
Luna B, Padmanabhan A, O'Hearn K. 2010. What has fMRI told us about the development of 
cognitive control through adolescence? Brain and cognition 72: 101-13 
Luna B, Sweeney JA. 2004. The emergence of collaborative brain function: FMRI studies of the 
development of response inhibition. Annals of the New York Academy of Sciences 1021: 
296-309 
Lund JS, Lund RD, Hendrickson AE, Bunt AH, Fuchs AF. 1975. The origin of efferent pathways 
from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde 
transport of horseradish peroxidase. The Journal of comparative neurology 164: 287-303 
 182 
Luo L. 2000. Rho GTPases in neuronal morphogenesis. Nature reviews. Neuroscience 1: 173-
80 
Luo Y, Lathia J, Mughal M, Mattson MP. 2008. SDF1alpha/CXCR4 signaling, via ERKs and the 
transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid 
decarboxylase in embryonic hippocampal neurons. The Journal of biological chemistry 
283: 24789-800 
Luscher B, Fuchs T, Kilpatrick CL. 2011. GABAA receptor trafficking-mediated plasticity of 
inhibitory synapses. Neuron 70: 385-409 
MacGrath SM, Koleske AJ. 2012. Arg/Abl2 modulates the affinity and stoichiometry of binding of 
cortactin to F-actin. Biochemistry 51: 6644-53 
Magri C, Schridde U, Murayama Y, Panzeri S, Logothetis NK. 2012. The amplitude and timing 
of the BOLD signal reflects the relationship between local field potential power at 
different frequencies. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 32: 1395-407 
Malaspina D, Goetz RR, Yale S, Berman A, Friedman JH, et al. 2000. Relation of familial 
schizophrenia to negative symptoms but not to the deficit syndrome. The American 
journal of psychiatry 157: 994-1003 
Maldonado-Aviles JG, Curley AA, Hashimoto T, Morrow AL, Ramsey AJ, et al. 2009. Altered 
markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with 
schizophrenia. The American journal of psychiatry 166: 450-9 
Malhotra D, Sebat J. 2012. CNVs: harbingers of a rare variant revolution in psychiatric genetics. 
Cell 148: 1223-41 
Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L. 1994. A brain serine/threonine protein 
kinase activated by Cdc42 and Rac1. Nature 367: 40-6 
Marenco S, Stein JL, Savostyanova AA, Sambataro F, Tan HY, et al. 2012. Investigation of 
anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 37: 499-507 
Marin O, Rubenstein JL. 2001. A long, remarkable journey: tangential migration in the 
telencephalon. Nature reviews. Neuroscience 2: 780-90 
Mateos JM, Luthi A, Savic N, Stierli B, Streit P, et al. 2007. Synaptic modifications at the CA3-
CA1 synapse after chronic AMPA receptor blockade in rat hippocampal slices. The 
Journal of physiology 581: 129-38 
Matsuzaki M. 2007. Factors critical for the plasticity of dendritic spines and memory storage. 
Neuroscience research 57: 1-9 
Matus A. 2000. Actin-based plasticity in dendritic spines. Science 290: 754-8 
Mauney SA, Athanas KM, Pantazopoulos H, Shaskan N, Passeri E, et al. 2013. Developmental 
pattern of perineuronal nets in the human prefrontal cortex and their deficit in 
schizophrenia. Biological psychiatry 74: 427-35 
McClellan AM, Twyman RE. 1999. Receptor system response kinetics reveal functional 
subtypes of native murine and recombinant human GABAA receptors. The Journal of 
physiology 515 ( Pt 3): 711-27 
McGrath J, Saha S, Chant D, Welham J. 2008. Schizophrenia: a concise overview of incidence, 
prevalence, and mortality. Epidemiologic reviews 30: 67-76 
McQuiston AR, Saggau P. 2003. Mu-opioid receptors facilitate the propagation of excitatory 
activity in rat hippocampal area CA1 by disinhibition of all anatomical layers. Journal of 
neurophysiology 90: 1936-48 
Melchitzky DS, Eggan SM, Lewis DA. 2005. Synaptic targets of calretinin-containing axon 
terminals in macaque monkey prefrontal cortex. Neuroscience 130: 185-95 
 183 
Melchitzky DS, Gonzalez-Burgos G, Barrionuevo G, Lewis DA. 2001. Synaptic targets of the 
intrinsic axon collaterals of supragranular pyramidal neurons in monkey prefrontal 
cortex. The Journal of comparative neurology 430: 209-21 
Melchitzky DS, Lewis DA. 2003. Pyramidal neuron local axon terminals in monkey prefrontal 
cortex: differential targeting of subclasses of GABA neurons. Cerebral cortex 13: 452-60 
Melchitzky DS, Lewis DA. 2008. Dendritic-targeting GABA neurons in monkey prefrontal cortex: 
comparison of somatostatin- and calretinin-immunoreactive axon terminals. Synapse 62: 
456-65 
Melchitzky DS, Sesack SR, Lewis DA. 1999. Parvalbumin-immunoreactive axon terminals in 
macaque monkey and human prefrontal cortex: laminar, regional, and target specificity 
of type I and type II synapses. The Journal of comparative neurology 408: 11-22 
Melchitzky DS, Sesack SR, Pucak ML, Lewis DA. 1998. Synaptic targets of pyramidal neurons 
providing intrinsic horizontal connections in monkey prefrontal cortex. The Journal of 
comparative neurology 390: 211-24 
Mellios N, Huang HS, Baker SP, Galdzicka M, Ginns E, Akbarian S. 2009. Molecular 
determinants of dysregulated GABAergic gene expression in the prefrontal cortex of 
subjects with schizophrenia. Biological psychiatry 65: 1006-14 
Menezes NM, Arenovich T, Zipursky RB. 2006. A systematic review of longitudinal outcome 
studies of first-episode psychosis. Psychological medicine 36: 1349-62 
Merritt K, McGuire P, Egerton A. 2013. Relationship between Glutamate Dysfunction and 
Symptoms and Cognitive Function in Psychosis. Frontiers in psychiatry 4: 151 
Messias EL, Chen CY, Eaton WW. 2007. Epidemiology of schizophrenia: review of findings and 
myths. The Psychiatric clinics of North America 30: 323-38 
Millard TH, Sharp SJ, Machesky LM. 2004. Signalling to actin assembly via the WASP (Wiskott-
Aldrich syndrome protein)-family proteins and the Arp2/3 complex. The Biochemical 
journal 380: 1-17 
Miller EK, Cohen JD. 2001. An integrative theory of prefrontal cortex function. Annual review of 
neuroscience 24: 167-202 
Mimmack ML, Brooking J, Bahn S. 2004. Quantitative polymerase chain reaction: validation of 
microarray results from postmortem brain studies. Biological psychiatry 55: 337-45 
Minzenberg MJ, Firl AJ, Yoon JH, Gomes GC, Reinking C, Carter CS. 2010. Gamma oscillatory 
power is impaired during cognitive control independent of medication status in first-
episode schizophrenia. Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology 35: 2590-9 
Minzenberg MJ, Laird AR, Thelen S, Carter CS, Glahn DC. 2009. Meta-analysis of 41 functional 
neuroimaging studies of executive function in schizophrenia. Archives of general 
psychiatry 66: 811-22 
Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. 2000. Molecular characterization of 
schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. 
Neuron 28: 53-67 
Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. 2001. Disease-specific changes in 
regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Molecular 
psychiatry 6: 293-301 
Moghaddam B. 2004. Targeting metabotropic glutamate receptors for treatment of the cognitive 
symptoms of schizophrenia. Psychopharmacology 174: 39-44 
Mohler H. 2006. GABA(A) receptor diversity and pharmacology. Cell and tissue research 326: 
505-16 
Molnar Z, Clowry G. 2012. Cerebral cortical development in rodents and primates. Progress in 
brain research 195: 45-70 
Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD. 2007. Neuronal subtype specification in the 
cerebral cortex. Nature reviews. Neuroscience 8: 427-37 
 184 
Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, et al. 1992. Heteromeric NMDA 
receptors: molecular and functional distinction of subtypes. Science 256: 1217-21 
Morishima M, Kawaguchi Y. 2006. Recurrent connection patterns of corticostriatal pyramidal 
cells in frontal cortex. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 26: 4394-405 
Morishima M, Morita K, Kubota Y, Kawaguchi Y. 2011. Highly differentiated projection-specific 
cortical subnetworks. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 31: 10380-91 
Morishita H, Cabungcal JH, Chen Y, Do KQ, Hensch TK. 2015. Prolonged Period of Cortical 
Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons. Biological psychiatry 
78: 396-402 
Morris HM, Hashimoto T, Lewis DA. 2008. Alterations in somatostatin mRNA expression in the 
dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. 
Cerebral cortex 18: 1575-87 
Moyer CE, Delevich KM, Fish KN, Asafu-Adjei JK, Sampson AR, et al. 2013. Intracortical 
excitatory and thalamocortical boutons are intact in primary auditory cortex in 
schizophrenia. Schizophrenia research 149: 127-34 
Muly EC, Smith Y, Allen P, Greengard P. 2004. Subcellular distribution of spinophilin 
immunolabeling in primate prefrontal cortex: localization to and within dendritic spines. 
The Journal of comparative neurology 469: 185-97 
Murakoshi H, Wang H, Yasuda R. 2011. Local, persistent activation of Rho GTPases during 
plasticity of single dendritic spines. Nature 472: 100-4 
Murayama M, Perez-Garci E, Nevian T, Bock T, Senn W, Larkum ME. 2009. Dendritic encoding 
of sensory stimuli controlled by deep cortical interneurons. Nature 457: 1137-41 
Murray RM, Lewis SW. 1987. Is schizophrenia a neurodevelopmental disorder? British medical 
journal 295: 681-2 
Nadarajah B, Brunstrom JE, Grutzendler J, Wong RO, Pearlman AL. 2001. Two modes of radial 
migration in early development of the cerebral cortex. Nature neuroscience 4: 143-50 
Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, et al. 1999. Shank, a novel family of postsynaptic 
density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. 
Neuron 23: 569-82 
Nakazawa K, Zsiros V, Jiang Z, Nakao K, Kolata S, et al. 2012. GABAergic interneuron origin of 
schizophrenia pathophysiology. Neuropharmacology 62: 1574-83 
Neddens J, Fish KN, Tricoire L, Vullhorst D, Shamir A, et al. 2011. Conserved interneuron-
specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: 
implications for schizophrenia. Biological psychiatry 70: 636-45 
Negishi M, Katoh H. 2005. Rho family GTPases and dendrite plasticity. The Neuroscientist : a 
review journal bringing neurobiology, neurology and psychiatry 11: 187-91 
Nelson EE, Winslow JT. 2009. Non-human primates: model animals for developmental 
psychopathology. Neuropsychopharmacology : official publication of the American 
College of Neuropsychopharmacology 34: 90-105 
Newey SE, Velamoor V, Govek EE, Van Aelst L. 2005. Rho GTPases, dendritic structure, and 
mental retardation. Journal of neurobiology 64: 58-74 
Niessing J, Ebisch B, Schmidt KE, Niessing M, Singer W, Galuske RA. 2005. Hemodynamic 
signals correlate tightly with synchronized gamma oscillations. Science 309: 948-51 
Nusser Z, Sieghart W, Benke D, Fritschy JM, Somogyi P. 1996. Differential synaptic localization 
of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal 
pyramidal cells. Proceedings of the National Academy of Sciences of the United States 
of America 93: 11939-44 
 185 
Nusser Z, Sieghart W, Somogyi P. 1998. Segregation of different GABAA receptors to synaptic 
and extrasynaptic membranes of cerebellar granule cells. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 18: 1693-703 
Nyiri G, Stephenson FA, Freund TF, Somogyi P. 2003. Large variability in synaptic N-methyl-D-
aspartate receptor density on interneurons and a comparison with pyramidal-cell spines 
in the rat hippocampus. Neuroscience 119: 347-63 
Oeth KM, Lewis DA. 1993. Postnatal development of the cholecystokinin innervation of monkey 
prefrontal cortex. The Journal of comparative neurology 336: 400-18 
Okamoto K, Nagai T, Miyawaki A, Hayashi Y. 2004. Rapid and persistent modulation of actin 
dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nature 
neuroscience 7: 1104-12 
Olsen RW, Sieghart W. 2009. GABA A receptors: subtypes provide diversity of function and 
pharmacology. Neuropharmacology 56: 141-8 
Otsuka T, Kawaguchi Y. 2008. Firing-pattern-dependent specificity of cortical excitatory feed-
forward subnetworks. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 28: 11186-95 
Ouyang Y, Wong M, Capani F, Rensing N, Lee CS, et al. 2005. Transient decrease in F-actin 
may be necessary for translocation of proteins into dendritic spines. The European 
journal of neuroscience 22: 2995-3005 
Packer AM, Yuste R. 2011. Dense, unspecific connectivity of neocortical parvalbumin-positive 
interneurons: a canonical microcircuit for inhibition? The Journal of neuroscience : the 
official journal of the Society for Neuroscience 31: 13260-71 
Pakkenberg B. 1990. Pronounced reduction of total neuron number in mediodorsal thalamic 
nucleus and nucleus accumbens in schizophrenics. Archives of general psychiatry 47: 
1023-8 
Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, et al. 1997. Is it possible to be 
schizophrenic yet neuropsychologically normal? Neuropsychology 11: 437-46 
Parnaudeau S, O'Neill PK, Bolkan SS, Ward RD, Abbas AI, et al. 2013. Inhibition of 
mediodorsal thalamus disrupts thalamofrontal connectivity and cognition. Neuron 77: 
1151-62 
Parrini MC, Lei M, Harrison SC, Mayer BJ. 2002. Pak1 kinase homodimers are autoinhibited in 
trans and dissociated upon activation by Cdc42 and Rac1. Molecular cell 9: 73-83 
Paspalas CD, Wang M, Arnsten AF. 2013. Constellation of HCN channels and cAMP regulating 
proteins in dendritic spines of the primate prefrontal cortex: potential substrate for 
working memory deficits in schizophrenia. Cerebral cortex 23: 1643-54 
Patel AJ, Lazdunski M, Honore E. 1997. Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier 
K+ channel in oxygen-sensitive pulmonary artery myocytes. The EMBO journal 16: 
6615-25 
Pathania M, Davenport EC, Muir J, Sheehan DF, Lopez-Domenech G, Kittler JT. 2014. The 
autism and schizophrenia associated gene CYFIP1 is critical for the maintenance of 
dendritic complexity and the stabilization of mature spines. Translational psychiatry 4: 
e374 
Pelkey KA, Barksdale E, Craig MT, Yuan X, Sukumaran M, et al. 2015. Pentraxins coordinate 
excitatory synapse maturation and circuit integration of parvalbumin interneurons. 
Neuron 85: 1257-72 
Penn DL, Guynan K, Daily T, Spaulding WD, Garbin CP, Sullivan M. 1994. Dispelling the stigma 
of schizophrenia: what sort of information is best? Schizophrenia bulletin 20: 567-78 
Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, et al. 2003. Rapid induction of 
dendritic spine morphogenesis by trans-synaptic ephrinB-EphB receptor activation of the 
Rho-GEF kalirin. Neuron 37: 263-74 
 186 
Perlstein WM, Carter CS, Noll DC, Cohen JD. 2001. Relation of prefrontal cortex dysfunction to 
working memory and symptoms in schizophrenia. The American journal of psychiatry 
158: 1105-13 
Petanjek Z, Judas M, Simic G, Rasin MR, Uylings HB, et al. 2011. Extraordinary neoteny of 
synaptic spines in the human prefrontal cortex. Proceedings of the National Academy of 
Sciences of the United States of America 108: 13281-6 
Peters A, Kaiserman-Abramof IR. 1970. The small pyramidal neuron of the rat cerebral cortex. 
The perikaryon, dendrites and spines. The American journal of anatomy 127: 321-55 
Pfeffer CK, Xue M, He M, Huang ZJ, Scanziani M. 2013. Inhibition of inhibition in visual cortex: 
the logic of connections between molecularly distinct interneurons. Nature neuroscience 
16: 1068-76 
Pi HJ, Hangya B, Kvitsiani D, Sanders JI, Huang ZJ, Kepecs A. 2013. Cortical interneurons that 
specialize in disinhibitory control. Nature 503: 521-4 
Pierri JN, Chaudry AS, Woo TU, Lewis DA. 1999. Alterations in chandelier neuron axon 
terminals in the prefrontal cortex of schizophrenic subjects. The American journal of 
psychiatry 156: 1709-19 
Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA. 2001. Decreased somal size of deep layer 3 
pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Archives of 
general psychiatry 58: 466-73 
Pinto JG, Hornby KR, Jones DG, Murphy KM. 2010. Developmental changes in GABAergic 
mechanisms in human visual cortex across the lifespan. Frontiers in cellular 
neuroscience 4: 16 
Pistis M, Muntoni AL, Pillolla G, Gessa GL. 2002. Cannabinoids inhibit excitatory inputs to 
neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. 
The European journal of neuroscience 15: 1795-802 
Pocklington AJ, Rees E, Walters JT, Han J, Kavanagh DH, et al. 2015. Novel Findings from 
CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia. Neuron 
86: 1203-14 
Pouille F, Scanziani M. 2001. Enforcement of temporal fidelity in pyramidal cells by somatic 
feed-forward inhibition. Science 293: 1159-63 
Pozo K, Goda Y. 2010. Unraveling mechanisms of homeostatic synaptic plasticity. Neuron 66: 
337-51 
Psychiatric Association A. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. 
Washington, DC. American Psychiatric Press  
Pucak ML, Levitt JB, Lund JS, Lewis DA. 1996. Patterns of intrinsic and associational circuitry in 
monkey prefrontal cortex. The Journal of comparative neurology 376: 614-30 
Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, et al. 2014. A polygenic burden of 
rare disruptive mutations in schizophrenia. Nature 506: 185-90 
Quilichini P, Sirota A, Buzsaki G. 2010. Intrinsic circuit organization and theta-gamma oscillation 
dynamics in the entorhinal cortex of the rat. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 30: 11128-42 
Racz B, Weinberg RJ. 2008. Organization of the Arp2/3 complex in hippocampal spines. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 28: 5654-9 
Radomsky ED, Haas GL, Mann JJ, Sweeney JA. 1999. Suicidal behavior in patients with 
schizophrenia and other psychotic disorders. The American journal of psychiatry 156: 
1590-5 
Rajkowska G, Selemon LD, Goldman-Rakic PS. 1998. Neuronal and glial somal size in the 
prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington 
disease. Archives of general psychiatry 55: 215-24 
Rakic P. 1988. Specification of cerebral cortical areas. Science 241: 170-6 
 187 
Rakic P. 1995. Radial versus tangential migration of neuronal clones in the developing cerebral 
cortex. Proceedings of the National Academy of Sciences of the United States of 
America 92: 11323-7 
Rakic P. 2008. Confusing cortical columns. Proceedings of the National Academy of Sciences 
of the United States of America 105: 12099-100 
Rakic P. 2009. Evolution of the neocortex: a perspective from developmental biology. Nature 
reviews. Neuroscience 10: 724-35 
Rakic P, Stensas LJ, Sayre E, Sidman RL. 1974. Computer-aided three-dimensional 
reconstruction and quantitative analysis of cells from serial electron microscopic 
montages of foetal monkey brain. Nature 250: 31-4 
Ramos-Miguel A, Beasley CL, Dwork AJ, Mann JJ, Rosoklija G, et al. 2015. Increased SNARE 
Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in 
Schizophrenia. Biological psychiatry 78: 361-73 
Rao SG, Williams GV, Goldman-Rakic PS. 1999. Isodirectional tuning of adjacent interneurons 
and pyramidal cells during working memory: evidence for microcolumnar organization in 
PFC. Journal of neurophysiology 81: 1903-16 
Rao SG, Williams GV, Goldman-Rakic PS. 2000. Destruction and creation of spatial tuning by 
disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working 
memory. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 20: 485-94 
Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, et al. 2010. Static and dynamic 
cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. The 
American journal of psychiatry 167: 160-9 
Rex CS, Lin CY, Kramar EA, Chen LY, Gall CM, Lynch G. 2007. Brain-derived neurotrophic 
factor promotes long-term potentiation-related cytoskeletal changes in adult 
hippocampus. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 27: 3017-29 
Ridley AJ. 2006. Rho GTPases and actin dynamics in membrane protrusions and vesicle 
trafficking. Trends in cell biology 16: 522-9 
Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, et al. 2013. Genome-wide 
association analysis identifies 13 new risk loci for schizophrenia. Nature genetics 45: 
1150-9 
Rippey C, Walsh T, Gulsuner S, Brodsky M, Nord AS, et al. 2013. Formation of chimeric genes 
by copy-number variation as a mutational mechanism in schizophrenia. American journal 
of human genetics 93: 697-710 
Risher WC, Patel S, Kim IH, Uezu A, Bhagat S, et al. 2014. Astrocytes refine cortical 
connectivity at dendritic spines. eLife 3 
Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. 2004. Symptomatic and 
functional recovery from a first episode of schizophrenia or schizoaffective disorder. The 
American journal of psychiatry 161: 473-9 
Rocco BR, Sweet RA, Lewis DA, Fish KN. 2015. GABA-Synthesizing Enzymes in Calbindin and 
Calretinin Neurons in Monkey Prefrontal Cortex. Cerebral cortex  
Rosenthal D. 1971. A program of research on heredity in schizophrenia. Behavioral science 16: 
191-201 
Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, et al. 2000. Structural abnormalities of 
subicular dendrites in subjects with schizophrenia and mood disorders: preliminary 
findings. Archives of general psychiatry 57: 349-56 
Rotaru DC, Yoshino H, Lewis DA, Ermentrout GB, Gonzalez-Burgos G. 2011. Glutamate 
receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance 
for schizophrenia. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 31: 142-56 
 188 
Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V. 2012. A system-level transcriptomic 
analysis of schizophrenia using postmortem brain tissue samples. Archives of general 
psychiatry 69: 1205-13 
Roux F, Wibral M, Mohr HM, Singer W, Uhlhaas PJ. 2012. Gamma-band activity in human 
prefrontal cortex codes for the number of relevant items maintained in working memory. 
The Journal of neuroscience : the official journal of the Society for Neuroscience 32: 
12411-20 
Rubio MD, Haroutunian V, Meador-Woodruff JH. 2012. Abnormalities of the Duo/Ras-related C3 
botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain 
phosphorylation in frontal cortex in schizophrenia. Biological psychiatry 71: 906-14 
Russell TA, Blizinsky KD, Cobia DJ, Cahill ME, Xie Z, et al. 2014. A sequence variant in human 
KALRN impairs protein function and coincides with reduced cortical thickness. Nature 
communications 5: 4858 
Ruzicka WB, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A. 2007. Selective epigenetic 
alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia 
patients using laser-assisted microdissection. Molecular psychiatry 12: 385-97 
Saalmann YB, Kastner S. 2011. Cognitive and perceptual functions of the visual thalamus. 
Neuron 71: 209-23 
Saha S, Chant D, McGrath J. 2007. A systematic review of mortality in schizophrenia: is the 
differential mortality gap worsening over time? Archives of general psychiatry 64: 1123-
31 
Sala C, Piech V, Wilson NR, Passafaro M, Liu G, Sheng M. 2001. Regulation of dendritic spine 
morphology and synaptic function by Shank and Homer. Neuron 31: 115-30 
Saneyoshi T, Fortin DA, Soderling TR. 2010. Regulation of spine and synapse formation by 
activity-dependent intracellular signaling pathways. Current opinion in neurobiology 20: 
108-15 
Sawaguchi T. 2001. The effects of dopamine and its antagonists on directional delay-period 
activity of prefrontal neurons in monkeys during an oculomotor delayed-response task. 
Neuroscience research 41: 115-28 
Sawaguchi T, Goldman-Rakic PS. 1991. D1 dopamine receptors in prefrontal cortex: 
involvement in working memory. Science 251: 947-50 
Sawaguchi T, Goldman-Rakic PS. 1994. The role of D1-dopamine receptor in working memory: 
local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys 
performing an oculomotor delayed-response task. Journal of neurophysiology 71: 515-
28 
Sawaguchi T, Matsumura M, Kubota K. 1989. Depth distribution of neuronal activity related to a 
visual reaction time task in the monkey prefrontal cortex. Journal of neurophysiology 61: 
435-46 
Sawaguchi T, Matsumura M, Kubota K. 1990. Catecholaminergic effects on neuronal activity 
related to a delayed response task in monkey prefrontal cortex. Journal of 
neurophysiology 63: 1385-400 
Scannevin RH, Huganir RL. 2000. Postsynaptic organization and regulation of excitatory 
synapses. Nature reviews. Neuroscience 1: 133-41 
Scherf KS, Sweeney JA, Luna B. 2006. Brain basis of developmental change in visuospatial 
working memory. Journal of cognitive neuroscience 18: 1045-58 
Schizophrenia Working Group of the Psychiatric Genomics C. 2014. Biological insights from 108 
schizophrenia-associated genetic loci. Nature 511: 421-7 
Schorge S, Colquhoun D. 2003. Studies of NMDA receptor function and stoichiometry with 
truncated and tandem subunits. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 23: 1151-8 
 189 
Schubert D, Martens GJ, Kolk SM. 2015. Molecular underpinnings of prefrontal cortex 
development in rodents provide insights into the etiology of neurodevelopmental 
disorders. Molecular psychiatry 20: 795-809 
Schwartz ML, Goldman-Rakic PS. 1984. Callosal and intrahemispheric connectivity of the 
prefrontal association cortex in rhesus monkey: relation between intraparietal and 
principal sulcal cortex. The Journal of comparative neurology 226: 403-20 
Scott RW, Olson MF. 2007. LIM kinases: function, regulation and association with human 
disease. Journal of molecular medicine 85: 555-68 
Seamans J. 2008. Losing inhibition with ketamine. Nature chemical biology 4: 91-3 
Serwanski DR, Miralles CP, Christie SB, Mehta AK, Li X, De Blas AL. 2006. Synaptic and 
nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat 
brain. The Journal of comparative neurology 499: 458-70 
Shelton MA, Newman JT, Gu H, Sampson AR, Fish KN, et al. 2015. Loss of Microtubule-
Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia. 
Biological psychiatry 78: 374-85 
Sheng M, Hoogenraad CC. 2007. The postsynaptic architecture of excitatory synapses: a more 
quantitative view. Annual review of biochemistry 76: 823-47 
Shepherd GM. 2011. The microcircuit concept applied to cortical evolution: from three-layer to 
six-layer cortex. Frontiers in neuroanatomy 5: 30 
Shi Y, Ethell IM. 2006. Integrins control dendritic spine plasticity in hippocampal neurons 
through NMDA receptor and Ca2+/calmodulin-dependent protein kinase II-mediated 
actin reorganization. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 26: 1813-22 
Silberberg G, Markram H. 2007. Disynaptic inhibition between neocortical pyramidal cells 
mediated by Martinotti cells. Neuron 53: 735-46 
Sitskoorn MM, Aleman A, Ebisch SJ, Appels MC, Kahn RS. 2004. Cognitive deficits in relatives 
of patients with schizophrenia: a meta-analysis. Schizophrenia research 71: 285-95 
Soderling SH, Guire ES, Kaech S, White J, Zhang F, et al. 2007. A WAVE-1 and WRP signaling 
complex regulates spine density, synaptic plasticity, and memory. The Journal of 
neuroscience : the official journal of the Society for Neuroscience 27: 355-65 
Sodhi MS, Simmons M, McCullumsmith R, Haroutunian V, Meador-Woodruff JH. 2011. 
Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay 
neurons in schizophrenia. Biological psychiatry 70: 646-54 
Sohal VS, Zhang F, Yizhar O, Deisseroth K. 2009. Parvalbumin neurons and gamma rhythms 
enhance cortical circuit performance. Nature 459: 698-702 
Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW. 2003. 
Abnormal neural synchrony in schizophrenia. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 23: 7407-11 
Spruston N. 2008. Pyramidal neurons: dendritic structure and synaptic integration. Nature 
reviews. Neuroscience 9: 206-21 
Star EN, Kwiatkowski DJ, Murthy VN. 2002. Rapid turnover of actin in dendritic spines and its 
regulation by activity. Nature neuroscience 5: 239-46 
Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. 2006. Brain volume in first-episode 
schizophrenia: systematic review and meta-analysis of magnetic resonance imaging 
studies. The British journal of psychiatry : the journal of mental science 188: 510-8 
Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, et al. 2008. Large recurrent 
microdeletions associated with schizophrenia. Nature 455: 232-6 
Steriade M, Deschenes M. 1984. The thalamus as a neuronal oscillator. Brain research 320: 1-
63 
Stettler DD, Yamahachi H, Li W, Denk W, Gilbert CD. 2006. Axons and synaptic boutons are 
highly dynamic in adult visual cortex. Neuron 49: 877-87 
 190 
Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, et al. 2007. Allelic variation in 
GAD1 (GAD67) is associated with schizophrenia and influences cortical function and 
gene expression. Molecular psychiatry 12: 854-69 
Stumm RK, Zhou C, Schulz S, Hollt V. 2004. Neuronal types expressing mu- and delta-opioid 
receptor mRNA in the rat hippocampal formation. The Journal of comparative neurology 
469: 107-18 
Sullivan PF, Daly MJ, O'Donovan M. 2012. Genetic architectures of psychiatric disorders: the 
emerging picture and its implications. Nature reviews. Genetics 13: 537-51 
Sumi T, Matsumoto K, Nakamura T. 2001. Specific activation of LIM kinase 2 via 
phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. The 
Journal of biological chemistry 276: 670-6 
Sumi T, Matsumoto K, Takai Y, Nakamura T. 1999. Cofilin phosphorylation and actin 
cytoskeletal dynamics regulated by rho- and Cdc42-activated LIM-kinase 2. The Journal 
of cell biology 147: 1519-32 
Sweet RA, Bergen SE, Sun Z, Sampson AR, Pierri JN, Lewis DA. 2004. Pyramidal cell size 
reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. 
Biological psychiatry 55: 1128-37 
Sweet RA, Henteleff RA, Zhang W, Sampson AR, Lewis DA. 2009. Reduced dendritic spine 
density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology : 
official publication of the American College of Neuropsychopharmacology 34: 374-89 
Sweet RA, Pierri JN, Auh S, Sampson AR, Lewis DA. 2003. Reduced pyramidal cell somal 
volume in auditory association cortex of subjects with schizophrenia. 
Neuropsychopharmacology : official publication of the American College of 
Neuropsychopharmacology 28: 599-609 
Szabo G, Katarova Z, Kortvely E, Greenspan RJ, Urban Z. 1996. Structure and the promoter 
region of the mouse gene encoding the 67-kD form of glutamic acid decarboxylase. DNA 
and cell biology 15: 1081-91 
Tabares-Seisdedos R, Balanza-Martinez V, Salazar-Fraile J, Selva-Vera G, Leal-Cercos C, 
Gomez-Beneyto M. 2003. Specific executive/attentional deficits in patients with 
schizophrenia or bipolar disorder who have a positive family history of psychosis. 
Journal of psychiatric research 37: 479-86 
Tada T, Sheng M. 2006. Molecular mechanisms of dendritic spine morphogenesis. Current 
opinion in neurobiology 16: 95-101 
Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J. 1998. Induced gamma-band activity during 
the delay of a visual short-term memory task in humans. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 18: 4244-54 
Tallon-Baudry C, Kreiter A, Bertrand O. 1999. Sustained and transient oscillatory responses in 
the gamma and beta bands in a visual short-term memory task in humans. Visual 
neuroscience 16: 449-59 
Tang Y, Janssen WG, Hao J, Roberts JA, McKay H, et al. 2004. Estrogen replacement 
increases spinophilin-immunoreactive spine number in the prefrontal cortex of female 
rhesus monkeys. Cerebral cortex 14: 215-23 
Thomas P, Mathur P, Gottesman, II, Nagpal R, Nimgaonkar VL, Deshpande SN. 2007. 
Correlates of hallucinations in schizophrenia: A cross-cultural evaluation. Schizophrenia 
research 92: 41-9 
Thomases DR, Cass DK, Tseng KY. 2013. Periadolescent exposure to the NMDA receptor 
antagonist MK-801 impairs the functional maturation of local GABAergic circuits in the 
adult prefrontal cortex. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 33: 26-34 
 191 
Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M, Group IS. 2009. Global pattern of 
experienced and anticipated discrimination against people with schizophrenia: a cross-
sectional survey. Lancet 373: 408-15 
Timms AE, Dorschner MO, Wechsler J, Choi KY, Kirkwood R, et al. 2013. Support for the N-
methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome 
sequencing in multiplex families. JAMA psychiatry 70: 582-90 
Torres-Reveron A, Williams TJ, Chapleau JD, Waters EM, McEwen BS, et al. 2009. Ovarian 
steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic 
interneurons. Experimental neurology 219: 319-27 
Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, et al. 2002. Long-term in vivo 
imaging of experience-dependent synaptic plasticity in adult cortex. Nature 420: 788-94 
Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, et al. 2010. Glutamate receptor 
ion channels: structure, regulation, and function. Pharmacological reviews 62: 405-96 
Tsang HW, Leung AY, Chung RC, Bell M, Cheung WM. 2010. Review on vocational predictors: 
a systematic review of predictors of vocational outcomes among individuals with 
schizophrenia: an update since 1998. The Australian and New Zealand journal of 
psychiatry 44: 495-504 
Turrigiano G. 2011. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical 
circuit refinement. Annual review of neuroscience 34: 89-103 
Turrigiano GG. 2008. The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135: 
422-35 
Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB. 1998. Activity-dependent 
scaling of quantal amplitude in neocortical neurons. Nature 391: 892-6 
Tyagarajan SK, Fritschy JM. 2014. Gephyrin: a master regulator of neuronal function? Nature 
reviews. Neuroscience 15: 141-56 
Uhlhaas PJ, Roux F, Singer W, Haenschel C, Sireteanu R, Rodriguez E. 2009. The 
development of neural synchrony reflects late maturation and restructuring of functional 
networks in humans. Proceedings of the National Academy of Sciences of the United 
States of America 106: 9866-71 
Uhlhaas PJ, Singer W. 2006. Neural synchrony in brain disorders: relevance for cognitive 
dysfunctions and pathophysiology. Neuron 52: 155-68 
Uhlhaas PJ, Singer W. 2010. Abnormal neural oscillations and synchrony in schizophrenia. 
Nature reviews. Neuroscience 11: 100-13 
Ulbrich MH, Isacoff EY. 2008. Rules of engagement for NMDA receptor subunits. Proceedings 
of the National Academy of Sciences of the United States of America 105: 14163-8 
Urban NN, Gonzalez-Burgos G, Henze DA, Lewis DA, Barrionuevo G. 2002. Selective reduction 
by dopamine of excitatory synaptic inputs to pyramidal neurons in primate prefrontal 
cortex. The Journal of physiology 539: 707-12 
Valverde F. 1967. Apical dendritic spines of the visual cortex and light deprivation in the mouse. 
Experimental brain research 3: 337-52 
van Os J, Kenis G, Rutten BP. 2010. The environment and schizophrenia. Nature 468: 203-12 
van Os J, Rutten BP, Poulton R. 2008. Gene-environment interactions in schizophrenia: review 
of epidemiological findings and future directions. Schizophrenia bulletin 34: 1066-82 
van Versendaal D, Rajendran R, Saiepour MH, Klooster J, Smit-Rigter L, et al. 2012. 
Elimination of inhibitory synapses is a major component of adult ocular dominance 
plasticity. Neuron 74: 374-83 
Varga C, Lee SY, Soltesz I. 2010. Target-selective GABAergic control of entorhinal cortex 
output. Nature neuroscience 13: 822-4 
Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF. 2007. Inverted-U dopamine 
D1 receptor actions on prefrontal neurons engaged in working memory. Nature 
neuroscience 10: 376-84 
 192 
Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. 2000. Decreased glutamic acid 
decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-
aminobutyric acid neurons in subjects with schizophrenia. Archives of general psychiatry 
57: 237-45 
Volk DW, Chitrapu A, Edelson JR, Lewis DA. 2014a. Chemokine receptors and cortical 
interneuron dysfunction in schizophrenia. Schizophrenia research  
Volk DW, Edelson JR, Lewis DA. 2014b. Cortical inhibitory neuron disturbances in 
schizophrenia: role of the ontogenetic transcription factor Lhx6. Schizophrenia bulletin 
40: 1053-61 
Volk DW, Eggan SM, Lewis DA. 2010. Alterations in metabotropic glutamate receptor 1alpha 
and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. The 
American journal of psychiatry 167: 1489-98 
Volk DW, Matsubara T, Li S, Sengupta EJ, Georgiev D, et al. 2012a. Deficits in transcriptional 
regulators of cortical parvalbumin neurons in schizophrenia. The American journal of 
psychiatry 169: 1082-91 
Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA. 2002. Reciprocal alterations in 
pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in 
schizophrenia. Cerebral cortex 12: 1063-70 
Volk DW, Radchenkova PV, Walker EM, Sengupta EJ, Lewis DA. 2012b. Cortical opioid 
markers in schizophrenia and across postnatal development. Cerebral cortex 22: 1215-
23 
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al. 2008. Rare structural 
variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. 
Science 320: 539-43 
Wang HX, Gao WJ. 2010. Development of calcium-permeable AMPA receptors and their 
correlation with NMDA receptors in fast-spiking interneurons of rat prefrontal cortex. The 
Journal of physiology 588: 2823-38 
Wang M, Yang Y, Wang CJ, Gamo NJ, Jin LE, et al. 2013. NMDA receptors subserve persistent 
neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron 77: 736-
49 
Wang X, Lin Y, Song C, Sibille E, Tseng GC. 2012. Detecting disease-associated genes with 
confounding variable adjustment and the impact on genomic meta-analysis: with 
application to major depressive disorder. BMC bioinformatics 13: 52 
Wang XJ. 1999. Synaptic basis of cortical persistent activity: the importance of NMDA receptors 
to working memory. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 19: 9587-603 
Wang XJ. 2001. Synaptic reverberation underlying mnemonic persistent activity. Trends in 
neurosciences 24: 455-63 
Wei W, Zhang N, Peng Z, Houser CR, Mody I. 2003. Perisynaptic localization of delta subunit-
containing GABA(A) receptors and their activation by GABA spillover in the mouse 
dentate gyrus. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 23: 10650-61 
Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. 2003. Reduced 
brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. 
Molecular psychiatry 8: 592-610 
Weickert CS, Tiwari Y, Schofield PR, Mowry BJ, Fullerton JM. 2012. Schizophrenia-associated 
HapICE haplotype is associated with increased NRG1 type III expression and high 
nucleotide diversity. Translational psychiatry 2: e104 
Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of 
schizophrenia. Archives of general psychiatry 44: 660-9 
 193 
Wheeler AL, Voineskos AN. 2014. A review of structural neuroimaging in schizophrenia: from 
connectivity to connectomics. Frontiers in human neuroscience 8: 653 
Whittington MA, Traub RD, Faulkner HJ, Jefferys JG, Chettiar K. 1998. Morphine disrupts long-
range synchrony of gamma oscillations in hippocampal slices. Proceedings of the 
National Academy of Sciences of the United States of America 95: 5807-11 
Whittington MA, Traub RD, Kopell N, Ermentrout B, Buhl EH. 2000. Inhibition-based rhythms: 
experimental and mathematical observations on network dynamics. International journal 
of psychophysiology : official journal of the International Organization of 
Psychophysiology 38: 315-36 
WHO. 2008. The Global Burden of Disease: 2004 Update.  
Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. 2004. Brief cognitive 
assessment in schizophrenia: normative data for the Repeatable Battery for the 
Assessment of Neuropsychological Status. Schizophrenia research 70: 175-86 
Williams GV, Goldman-Rakic PS. 1995. Modulation of memory fields by dopamine D1 receptors 
in prefrontal cortex. Nature 376: 572-5 
Wilson FA, O'Scalaidhe SP, Goldman-Rakic PS. 1994. Functional synergism between putative 
gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex. 
Proceedings of the National Academy of Sciences of the United States of America 91: 
4009-13 
Wilson RI, Nicoll RA. 2001. Endogenous cannabinoids mediate retrograde signalling at 
hippocampal synapses. Nature 410: 588-92 
Wimpey TL, Chavkin C. 1991. Opioids activate both an inward rectifier and a novel voltage-
gated potassium conductance in the hippocampal formation. Neuron 6: 281-9 
Wohr M, Roullet FI, Hung AY, Sheng M, Crawley JN. 2011. Communication impairments in 
mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking 
behavior. PloS one 6: e20631 
Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. 1998. A subclass of prefrontal gamma-
aminobutyric acid axon terminals are selectively altered in schizophrenia. Proceedings of 
the National Academy of Sciences of the United States of America 95: 5341-6 
Woods GF, Oh WC, Boudewyn LC, Mikula SK, Zito K. 2011. Loss of PSD-95 enrichment is not 
a prerequisite for spine retraction. The Journal of neuroscience : the official journal of the 
Society for Neuroscience 31: 12129-38 
Woodward ND, Karbasforoushan H, Heckers S. 2012. Thalamocortical dysconnectivity in 
schizophrenia. The American journal of psychiatry 169: 1092-9 
Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, et al. 2005. The economic burden of 
schizophrenia in the United States in 2002. The Journal of clinical psychiatry 66: 1122-9 
Wu GY, Zou DJ, Rajan I, Cline H. 1999. Dendritic dynamics in vivo change during neuronal 
maturation. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 19: 4472-83 
Xing L, Yao X, Williams KR, Bassell GJ. 2012. Negative regulation of RhoA translation and 
signaling by hnRNP-Q1 affects cellular morphogenesis. Molecular biology of the cell 23: 
1500-9 
Xue M, Atallah BV, Scanziani M. 2014. Equalizing excitation-inhibition ratios across visual 
cortical neurons. Nature 511: 596-600 
Yanagawa Y, Kobayashi T, Kamei T, Ishii K, Nishijima M, et al. 1997. Structure and alternative 
promoters of the mouse glutamic acid decarboxylase 67 gene. The Biochemical journal 
326 ( Pt 2): 573-8 
Yanagi M, Joho RH, Southcott SA, Shukla AA, Ghose S, Tamminga CA. 2014. Kv3.1-containing 
K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic 
drugs. Molecular psychiatry 19: 573-9 
 194 
Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, et al. 1998. Cofilin phosphorylation by LIM-
kinase 1 and its role in Rac-mediated actin reorganization. Nature 393: 809-12 
Yin DM, Chen YJ, Lu YS, Bean JC, Sathyamurthy A, et al. 2013a. Reversal of behavioral 
deficits and synaptic dysfunction in mice overexpressing neuregulin 1. Neuron 78: 644-
57 
Yin DM, Sun XD, Bean JC, Lin TW, Sathyamurthy A, et al. 2013b. Regulation of spine formation 
by ErbB4 in PV-positive interneurons. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 33: 19295-303 
Yoon KJ, Nguyen HN, Ursini G, Zhang F, Kim NS, et al. 2014. Modeling a genetic risk for 
schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with 
adherens junctions and polarity. Cell stem cell 15: 79-91 
Yoshimura Y, Callaway EM. 2005. Fine-scale specificity of cortical networks depends on 
inhibitory cell type and connectivity. Nature neuroscience 8: 1552-9 
Young KA, Manaye KF, Liang C, Hicks PB, German DC. 2000. Reduced number of mediodorsal 
and anterior thalamic neurons in schizophrenia. Biological psychiatry 47: 944-53 
Yu YC, Bultje RS, Wang X, Shi SH. 2009. Specific synapses develop preferentially among sister 
excitatory neurons in the neocortex. Nature 458: 501-4 
Yuste R. 2011. Dendritic spines and distributed circuits. Neuron 71: 772-81 
Yuste R, Majewska A, Holthoff K. 2000. From form to function: calcium compartmentalization in 
dendritic spines. Nature neuroscience 3: 653-9 
Zahrt J, Taylor JR, Mathew RG, Arnsten AF. 1997. Supranormal stimulation of D1 dopamine 
receptors in the rodent prefrontal cortex impairs spatial working memory performance. 
The Journal of neuroscience : the official journal of the Society for Neuroscience 17: 
8528-35 
Zaitsev AV, Gonzalez-Burgos G, Povysheva NV, Kroner S, Lewis DA, Krimer LS. 2005. 
Localization of calcium-binding proteins in physiologically and morphologically 
characterized interneurons of monkey dorsolateral prefrontal cortex. Cerebral cortex 15: 
1178-86 
Zhang H, Webb DJ, Asmussen H, Niu S, Horwitz AF. 2005. A GIT1/PIX/Rac/PAK signaling 
module regulates spine morphogenesis and synapse formation through MLC. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 25: 3379-88 
Zhang W, Benson DL. 2001. Stages of synapse development defined by dependence on F-
actin. The Journal of neuroscience : the official journal of the Society for Neuroscience 
21: 5169-81 
Zhao Z, Xu J, Chen J, Kim S, Reimers M, et al. 2015. Transcriptome sequencing and genome-
wide association analyses reveal lysosomal function and actin cytoskeleton remodeling 
in schizophrenia and bipolar disorder. Molecular psychiatry 20: 563-72 
Zhou Q, Homma KJ, Poo MM. 2004. Shrinkage of dendritic spines associated with long-term 
depression of hippocampal synapses. Neuron 44: 749-57 
 
 
